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ABSTRACT OF THE DISSERTATION 
 
Investigating Hemoglobin Capture and Heme Acquisition 
by the Pathogen Staphylococcus aureus 
 
by 
 
Megan Marie Sjodt 
Doctor of Philosophy in Biochemistry and Molecular Biology 
University of California, Los Angeles, 2016 
Professor Robert Thompson Clubb, Chair 
 
Staphylococcus aureus is a medically important Gram-positive bacterial pathogen that 
actively procures heme from human hemoglobin (Hb) using the iron-regulated surface 
determinant (Isd) system. Research described in this dissertation investigated how the Isd system 
uses the IsdH receptor protein to capture Hb and extract its hemin (the oxidized form of heme). 
To rapidly extract Hb’s hemin, IsdH employs a conserved tri-domain unit that contains two 
NEAr iron Transporter (NEAT) domains that are connected by a helical linker domain. The work 
described in chapter 2 used UV-Vis spectroscopy, nuclear magnetic resonance (NMR) 
spectroscopy, and electrospray ionization mass spectrometry (ESI-MS) methods to define the 
importance of the conserved linker domain in hemin extraction and revealed that this domain 
 iii 
enables the NEAT domains within the tri-domain unit to work together to synergistically extract 
hemin. Chapter 3 of this thesis describes the structure and dynamics of the tri-domain unit 
(IsdHN2N3). The solution structure of the apo-receptor was defined using small angle X-ray 
scattering, and advanced NMR methods such as paramagnetic relaxation enhancement (PRE), 
residual dipolar coupling (RDC), and selective methyl labeling approaches. The structure and 
inter-domain dynamics of IsdHN2N3 in the absence of Hb were further defined using ensemble 
modeling calculations. The results of these studies illustrated that the receptor adaptively 
recognizes Hb using a combination of conformational selection and induced fit mechanisms, and 
suggests that the linker domain may facilitate hemin transfer by destabilizing the iron-
coordinating F-helix in Hb. Chapter 4 describes studies that investigated the kinetic and 
thermodynamic basis of hemin transfer using stopped-flow UV-Vis spectroscopy, analytical 
ultracentrifugation sedimentation equilibrium, and isothermal titration methods. The results of 
this work provide insight into the kinetic and thermodynamic determinants that facilitate 
receptor-mediated hemin release from Hb. Lastly, Chapter 5 describes the methods that were 
used to site-specifically label proteins with nitroxide spin-label probes and the subsequent 
derivation of paramagnetic NMR distance restraints. Altogether, the results of the work 
described in this dissertation have advanced our knowledge of Hb recognition and hemin 
acquisition by the pathogen S. aureus.  
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Chapter 1 
 
Heme Acquisition Systems in Staphylococcus aureus and other 
Gram-Positive Bacteria 
 
 
 
 
 
 
 
 
 2 
1.1 Overview   
 Staphylococcus aureus is Gram-positive pathogen capable of causing a wide range of 
life-threatening illnesses such as septicemia, meningitis, endocarditis, pneumonia, and toxic 
shock syndrome [1]. The pervasiveness of antibiotic resistant S. aureus strains has made it a 
major health threat and imperative to understand the molecular mechanisms used by this microbe 
to establish an infection. S. aureus and other bacterial pathogens require iron to survive as this 
element is a key biocatalyst involved in the synthesis of DNA, RNA, and amino acids, microbial 
electron transport, and peroxide reduction [2–4]. In the human body, free iron isn’t readily 
available and is therefore actively procured by S. aureus during infections. Heme-iron 
(protoporphyrin IX + iron) bound to the oxygen carrying protein, hemoglobin, accounts for 75-
80% of the total iron in the human body and is a preferred iron-source for S. aureus [5,6]. As a 
result, studying the mechanisms of heme acquisition could lead to the development of novel anti-
infective therapeutics that prevent access to this essential nutrient. The scope of this introduction 
is to review what is currently known about the mechanisms through which S. aureus and other 
medically important Gram-positive pathogens acquire heme from the human host. Additionally, 
Gram-negative bacterial iron acquisition systems do exist and have been extensively 
characterized; however, they have been reviewed elsewhere [7–9] and are therefore outside the 
scope of this introductory chapter. 
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1.2  Staphylococcus aureus 
 S. aureus is a Gram-positive bacterium that colonizes the anterior nares of approximately 
30% of people in the United States asymptomatically [10]. Since the beginning of the modern 
antibiotic era in the 1940’s, S. aureus and other pathogenic bacteria have evolved resistance 
mechanisms to nearly all antibiotics that have been deployed resulting in a worldwide problem 
[11,12]. In particular, methicillin-resistant Staphylococcus aureus (MRSA) is one of the leading 
causes of hospital-acquired infections and accounts for up to 50% of infectious S. aureus isolates 
[13]. Moreover, community-associated MRSA strains have become commonplace with some 
regions reporting that up to 75% of S. aureus infections were MRSA [14]. The widespread 
colonization by this microbe has been implicated as a risk factor for subsequent infections as 2% 
of the population carry methicillin-resistant Staphylococcus aureus (MRSA) strains and as high 
as 7% of hospital patients are MRSA carriers [10,15]. In 2013, the Centers for Disease Control 
(CDC) estimated that MRSA infections are responsible for 11,285 deaths with other reports 
attributing that these infections impose an economic burden of approximately $14 billion 
annually [12,16]. Moreover, last resort antibiotics traditionally used to treat MRSA infections 
such as vancomycin, linezolid, daptomycin, and ceftaroline have decreasing efficacy as strains of 
S. aureus resistant to those treatments are on the rise [17]. While staphylococcal infections are 
most commonly found in skin and soft tissues and are usually not serious, the bacterium can 
cause lethal infections when it breaches the body’s defense mechanisms [18].  
 The success of S. aureus as a human pathogen can be attributed to its vast array of 
virulence factors that circumvent the host’s defense mechanisms (Figure 1.1). Several 
noteworthy features that promote S. aureus survival within its human host include, but are not 
limited to, surface proteins called microbial surface components recognizing adhesive matrix 
 4 
molecules (MSCRAMMs) that promote adherence to host tissues, such as fibronectin-binding 
protein and collagen-binding protein [19], as well as proteins involved in immune evasion such 
as protein A binding to the Fc region of IgG preventing phagocytosis [20,21], the chemotaxis 
inhibitory protein of staphylococci (CHIPS) that prevents neutrophil chemotaxis [22], and lastly 
secreted cytolytic toxins such as enterotoxins, leukocidins, hemolysins, and phenol soluble 
modulins (PSMs), which commonly form pores in the cytoplasmic membranes of host cells 
resulting in cell lysis [23–26]. In particular, these lytic agents such as a-toxin and d-hemolysin 
can lyse erythrocytes releasing large amounts of the iron-rich protein, hemoglobin (Hb), which 
provides S. aureus access to this essential element that is necessary to sustain its growth within 
its host [27]. 
 
 
1.3  Nutritional Necessity of Iron 
1.3.1 The Role of Iron in Biology 
 Iron is an essential nutrient for nearly all forms of life because this element is required for 
several critical cellular processes. The utility of iron in biology lies within its ability to cycle 
between two different oxidation states, ferrous (Fe2+) and ferric (Fe3+), rendering it capable of 
accepting and donating electrons. Therefore, iron serves as a redox active molecule used by 
many enzymes that mediate basic biochemical processes required to support life [28,29]. 
However, the iron levels within cells must be tightly regulated as high levels of iron can be toxic 
to cells. The deleterious effects of iron are due to its participation in the Fenton reaction that 
forms hydroxyl and superoxide free radicals (Equations 1 & 2) [29–31]. 
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These reactive oxygen species are highly toxic since they react readily with nearly every 
biomolecule found in cells. As a result, DNA is damaged, synthesis of proteins, carbohydrates 
and lipids is impaired, expression of proteases is increased, and cell proliferation is altered [29]. 
Furthermore, iron-induced oxidative stress has been implicated in the various processes of 
carcinogenesis, atherosclerosis, diabetes, as well as neurodegenerative disorders such as 
Parkinson’s, Alzheimer’s, and Huntington’s disease [32–34]. Consequently, the human body has 
evolved elaborate mechanisms to sequester free iron for its own protection and to prevent its 
access to potential pathogens. 
 
1.3.1 Nutritional Immunity  
Humans and other vertebrates exhibit nutritional immunity; a process in which they 
sequester iron and other essential nutrients to restrict pathogens from establishing infections 
(Figure 1.b) [35]. The majority of iron in the human body is complexed to protoporphyrin-IX, 
which is called heme. This cofactor is bound tightly to an array of proteins, including the oxygen 
carrying protein, hemoglobin (Hb). Hb is present in erythrocytes and is a tetrameric protein 
consisting of two heterodimers of a- and b-globin chains, with each subunit capable of binding 
one heme molecule [35]. Each erythrocyte contains approximately 280 million Hb molecules, 
each of which is capable of binding four iron atoms resulting in an overall iron capacity of 
greater than 1 billion atoms per erythrocyte cell [6,28]. If heme or hemoglobin is released from 
erythrocytes by spontaneous lysis or the action of a pathogen, they are rapidly cleared from the 
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bloodstream by binding to hemopexin (HPX) and haptoglobin (Hp), respectively. Heme-bound 
HPX is then targeted to liver parenchymal cells to be catabolized, allowing for the iron to be 
recycled [36], whereas the Hp:Hb complex is eliminated from the bloodstream via macrophage 
uptake by CD163 receptor mediated endocytosis [37]. 
Iron is also bound to other proteins in the human body. Within cells is it is bound to 
ferritin, a 24 subunit protein complex that binds over 4000 ferric iron atoms [28]. However, less 
iron is stored in ferritin as it accounts for less than 30% of the total body’s iron content compared 
to 70-80% found in heme [5,38]. Humans also restrict access to extracellular iron to prevent 
infections. Extracellular iron primarily exists in its ferric state and is insoluble at physiological 
pH. Outside the cell it is chelated by the protein transferrin in blood serum, and by the 
glycoprotein, lactoferrin in tears, breast milk, seminal fluid, and saliva [28,35,39,40]. Beyond 
sequestration by binding to proteins, the host exhibits nutritional immunity against intracellular 
pathogens that reside within phagosomes using the natural resistance-associated macrophage 
protein 1, NRAMP1. It pumps ferrous iron and manganese out of the phagosomal compartment, 
starving the microbe of these nutrients [41]. Overall these mechanisms limit iron bioavailability, 
lowering the concentration of free iron to 10-24 M [42], far below what is needed for S. aureus 
growth (~10-6 M). 
 
 
1.4 Iron-Acquisition During Staphylococcal Infections 
 To overcome human nutritional immunity, pathogens like S. aureus actively acquire iron. 
Discussed below are the two main strategies S. aureus employs to obtain iron from its human 
host: siderophores and heme acquisition systems.  
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1.4.1 Iron Procurement by Siderophores  
 S. aureus steals iron from host proteins like transferrin and lactoferrin by secreting iron-
chelating molecules called siderophores. These small molecules are usually < 1 kDa, and 
outcompete host proteins for ferric iron by binding this metal with extremely high affinity; they 
exhibit ferric iron binding constants (Ka) on the order of 1030 to 1052 M-1 [43,44]. S. aureus 
produces two main carboxylate-type siderophores, staphyloferrin A (SA) and staphyloferrin B 
(SB) (Figure 1.3) [27]. They outcompete host proteins for iron, and then bind to cognate 
receptors on the surface of S. aureus that import them into the cytoplasm where the iron is 
released from the siderophore. Both of the genes involved in the biosynthesis and import of SA 
and SB are upregulated during iron-deplete conditions by the ferric uptake regulator, Fur [45]. 
Import of SB is mediated by the staphylococcal iron regulated transporter complex (SirABC), 
while import of SA occurs via the heme transport system (HtsABC). The system was originally 
misnamed as a heme importer, but subsequently shown only to import SA [6,46]. The role of the 
HtsA lipoprotein receptor component in HtsABC was verified by determining crystal structures 
of it bound to SA [47]. Interestingly, both SA and SB siderophore operons lack the ATPase gene 
whose product provides the energy needed to transport them into the cytoplasm. Instead, the 
FhuC ATPase expressed from the ferric hydroxymate uptake (fhuCBG) operon drives both SA 
and SB import [46,48]. Once the siderophore is imported into the cell, the mechanism to release 
iron remains unknown. The most widely accepted method is thought to involve iron reduction of 
the ferric-siderophore complex into a ferrous-siderophore state that is both thermodynamically 
and kinetically less stable [49]. To support this notion, a very recent study showed that the 
nitroreductase, NrtA, is necessary for SA-iron utilization. However, it was not necessary for iron 
release from SB [50].  
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 Humans have also evolved mechanisms to prevent iron-laden siderophores from reaching 
potential pathogens. The host secretes proteins called siderocalins (also known as lipocalins), 
which bind siderophores with high affinity, disrupting the access of pathogens to extracellular 
iron [51]. However, some bacteria are capable of secreting stealth siderophores that are 
chemically modified to prevent siderocalin binding, thus enabling the pathogen to overcome this 
defense mechanism. 
 
1.4.2  Heme Acquisition by S. aureus 
The vast majority of iron in the human body is found in heme (protoporphyrin-IX bound 
to ferrous iron), which has been shown to be preferentially used by S. aureus as an iron source 
[6]. Most heme is bound to Hb, but it is also present in hemoproteins such as: myoglobin (Mb), 
hemopexin (HPX), and cytochromes (CYPs). Only Hb and Mb appear to be important sources of 
iron during infections, as CYPs are localized to the mitochondria and are not thought to be easily 
accessible to extracellular pathogens, and studies have shown HPX does not support S. aureus 
growth in cell culture [52]. While it’s unclear if Mb’s heme-iron is used by S. aureus during 
infection, S. aureus colonization can damage cardiac myocytes, which contain large amounts of 
Mb [40,53]. In contrast, it is well established that Hb is an important iron source for S. aureus, 
and intact erythrocytes have been reported to be used by S. aureus as the sole source of iron in 
vitro [52]. Utilization of heme-iron from Hb has also been shown to play an important role in S. 
aureus virulence, as microbes lacking their Hb receptors show reduced abscess formation [52] 
and are impaired in their ability to establish systemic infections in murine models [54]. Other 
bacterial pathogens also use Hb as an iron source, including Pseudomonas aeruginosa [55], 
Bacillus anthracis [56], Bacillus cereus [57], Streptococcus pyogenes [58,59], Streptococcus 
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pneumoniae [60], Staphylococcus lugdunensis [61], Staphylococcus simulans [62], and 
Corynebacterium diphtheriae [63]. Interestingly, similar to S. aureus, several of these microbes 
preferentially use the human variant of Hb as a nutrient source [62], suggesting that these 
pathogens are optimized to infect humans.  
 
 
1.5 Heme Acquisition Systems in Gram-Positive Bacteria 
1.5.1  The Iron Regulated Surface Determinant (Isd) System in S. aureus 
 S. aureus captures heme using the iron-regulated surface determinant (Isd) system. Since 
the system’s discovery in 2002, extensive work has shown that the Isd system is comprised of 
nine proteins that form a heme relay system. In this process, the Isd-system captures Hb on the 
cell surface, extracts its heme molecule, shuttles heme across the bacterial cell wall, and 
transports it into the cytoplasm where it is degraded to release free iron [2,64–75] (Figure 1.4, 
left panel). The Isd system is believed to capture heme from lysed erythrocytes. Heme 
procurement is initiated when S. aureus secretes cytolytic agents such as a-toxin and d-
hemolysin in response to iron insufficiency in human blood [43,76]. These toxins lyse 
erythrocytes, thereby releasing significant amounts of iron-rich Hb into the bloodstream, which 
is then harvested by the microbe’s Isd system. Like siderophores, the genes encoding proteins 
within the Isd system are regulated by the ferric uptake regulator (Fur) protein and are maximally 
expressed during iron-deplete conditions [66,77]. Four Isd proteins (IsdA, IsdB, IsdC, and 
IsdH/HarA) are covalently tethered by their C-termini to the cell wall by sortase transpeptidases 
[66,78,79]. While the exact architectural arrangement of these cell wall anchored proteins isn’t 
known, protease sensitivity experiments suggest that they form a heme funnel within the cell 
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wall with proteins that have increasing affinity for heme situated closer to the membrane. The 
IsdB and IsdH proteins are positioned on the cell surface, while IsdA and IsdC proteins are 
partially and fully buried within the cell wall, respectively. The funnel terminates at the cell 
membrane, where the ABC transporter complex, IsdDEF, is located and has the highest affinity 
for heme [64]. Biochemical, kinetic, and thermodynamic studies indicate that heme transfer 
across the cell wall occurs in a unidirectional fashion via protein-protein heme transfer 
complexes, with the heme flowing from Hb à IsdB/H à IsdA à IsdC à IsdE [67,72–
74,80,81]. Heme is then transported into the bacterial cytoplasm through the IsdDEF transporter 
complex and is thereafter degraded by IsdG (or its paralog IsdI), releasing free iron to be used by 
the microbe.  
The cell wall anchored Isd proteins (IsdA, IsdB, IsdC, and IsdH) bind to the oxidized 
form of heme (hereafter referred to as hemin) and Hb using NEAr iron Transporter (NEAT) 
domains. These domains were initially named because they were found in genes that are 
proximal to putative Fe3+ siderophore transporter genes [82]. NEAT domains are ~125 residues 
in length and adopt a conserved immunoglobulin fold consisting of 8 b-strands [83]. Numerous 
structural studies of both the apo- and holo- forms of NEAT domains have elucidated the 
molecular determinants of hemin and Hb binding [81,84–90]. NEAT domains bind hemin via a 
pocket formed by residues in strands b7 and b8 (the b7-b8 sheet), which contains the iron-
coordinating tyrosine residue. The hemin moiety is further stabilized by a 310-helical “lip” that is 
situated above the b7-b8 sheet. Residues forming the b7-b8 sheet contain a YxxxY sequence 
motif; the side chain of the first tyrosine coordinates the hemin-iron atom, while the second 
tyrosine residue stabilizes the iron-coordinating tyrosine through hydrogen bonding, and 
participates in favorable π-stacking interactions with the porphyrin ring [83,91]. Intriguingly, the 
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same region used to bind hemin is also used by NEAT domains that interact with Hb in the IsdH 
and IsdB proteins. However, these domains lack the conserved YxxxY motif and are incapable 
of binding hemin. Instead the 310-helical lip portion contains a conserved aromatic-rich region 
that has been shown to interact the A- and E-helices of Hb [89,92–95].  
The first step in hemin-acquisition by the Isd system is the capture of Hb by the 
receptors, IsdB and IsdH. Upon hemolysis, these surface receptors bind liberated Hb molecules 
and extract their hemin. IsdB and IsdH are the only Isd system proteins that contain multiple 
NEAT domains, with two and three domains, respectively. The domains in the protein have 
distinct functions; their N-terminal domain(s) (IsdBN1, IsdHN1, and IsdHN2) only bind Hb, while 
their C-terminal NEAT domain (IsdBN2 and IsdHN3) binds hemin [95–97]. Interestingly, IsdHN1 
and IsdHN2 also bind haptoglobin (Hp) through an unknown mechanism [84,95,96]. A 
considerable body of work demonstrates that IsdB and IsdH use a conserved tri-domain unit to 
synergistically extract hemin from Hb [69,98,99]. Studies of the IsdH protein are presented in 
this thesis. Its tri-domain unit consists of the second (N2, IsdHN2) and third (N3, IsdHN3) NEAT 
domains and a conserved helical linker domain that connects the NEAT domains (the tri-domain 
receptor is denoted IsdHN2N3, residues A326-D660). A detailed and complete description of the 
molecular basis through which IsdH captures Hb and extracts its hemin is presented in chapters 
2-4.  
After the IsdB/IsdH surface receptors capture hemin from Hb, hemin is transferred to the 
IsdA protein. In vitro studies have shown that it has higher affinity than IsdB, and that holo-IsdB 
passes hemin to apo-IsdA at a rate that is ~87,000 times faster than the rate of spontaneous 
hemin release from IsdB. Therefore, hemin transfer is believed to occur via a protein-protein 
hemin transfer complex [73,100]. Like other Isd NEAT domains, the single NEAT domain in 
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IsdA binds hemin-iron in the high-spin penta-coordinate ferric (Fe(III)) state using the conserved 
YxxxY motif [80,88,100]. However, IsdA is unique as it is also capable of binding the low-spin 
hexa-coordinate ferrous (Fe(II)) state in which the iron atom is no longer coordinated by the 
tyrosine in the b7/b8 loop, but instead by a histidine residue in the 310-helical lip region [88,101]. 
IsdA is also unusual since unlike other Isd proteins it binds to host proteins such as fibronectin, 
fibrinogen, transferrin, fetuin, and asialofetuin, and possibly hemoglobin [64,102,103]. 
Adherence to these host proteins may facilitate infections, as IsdA has been shown to be 
necessary for adhesion of S. aureus to human desquamated epithelial cells [104,105].  
In the third stage of the acquisition process hemin is transferred from IsdA to the IsdC 
protein. Of the NEAT-domain containing Isd proteins, IsdC has the highest affinity for hemin 
[100]. The structure of apo-IsdC is not known, but NMR experiments demonstrate that there is a 
flexible to rigid transition of the 310-helical lip upon binding hemin [85]. The structural plasticity 
of this region presumably promotes rapid hemin transfer from holo-IsdA to apo-IsdC, which 
occurs a rate that is > 70,000 times faster than the rate of simple hemin dissociation from IsdA 
[106]. As in the IsdH/B à IsdA hemin transfer step, IsdA à IsdC is believed to occur via an 
activated protein-protein hemin transfer complex. Paramagnetic NMR relaxation experiments 
have demonstrated that IsdA and IsdC associate via a transient ultra-weak “handclasp” complex, 
which juxtaposes their respective b7/b8 loops and 310-helical lip regions. This handclasp model 
has been further probed by molecular dynamics (MD) and quantum mechanics/molecular 
mechanics (QM/MM) simulations, which illustrated that NEAT domains orient themselves such 
that they there is two-fold symmetry about the hemin axis. From these studies it is thought that 
hemin transfer most likely proceeds through the simultaneous coordination of the iron atom by 
the conserved tyrosine residues in both the donor (IsdA) and acceptor (IsdC) proteins [72]. 
 13 
Interestingly, the ability of NEAT domains to transfer hemin to the IsdE protein is dependent 
upon stereospecific interactions. This is substantiated by the documented inability of holo-IsdA 
to transfer hemin to apo-IsdE, despite IsdE’s higher affinity for hemin [74]. Photo-crosslinking 
experiments were able to localize the source of this specificity to a six-amino acid region that 
extends the b7/b8 loop of IsdC enabling hemin transfer to IsdE, whereas this section is absent in 
IsdA [107]. Interestingly, a chimera of IsdA that includes this extended region was indeed 
capable of rapidly transferring hemin to apo-IsdE. In addition to heterotypic hemin transfer 
between different types of proteins, homotypic transfer is also thought to mediate transfer across 
the cell wall between multiple copies of IsdA and/or IsdC [108]. In support of this notion, 
homotypic, self-transfer between either IsdA and IsdC proteins has been reported in vitro [107].  
The fourth stage of hemin procurement is the passage of hemin from holo-IsdC to the 
IsdDEF ABC transporter, which imports hemin into the bacterial cytoplasm. Typical ABC 
transporters contain three main parts: a substrate binding component, a membrane permease, and 
an ATP hydrolase [109]. The substrate binding component, IsdE, is externally anchored to the 
cell membrane via a covalently attached lipid anchor. IsdE has the highest affinity for hemin of 
all the Isd proteins, but does not contain a NEAT domain. Instead, a crystal structure of IsdE 
revealed that it contains two domains bridged by a long helical backbone that provides a hemin 
binding grove at the domain-domain interface [110]. Unlike NEAT domains, the hemin moiety is 
completely buried and the hemin-iron is six-coordinate with protein axial ligands that originate 
from each domain, M78 and H229 [110–112]. It is unclear how hemin is passed through the 
membrane, but it has been suggested that interactions between IsdE and the membrane permease, 
IsdF, may facilitate this process. The energy needed to transport nutrients across the membrane 
usually involves the hydrolysis of ATP [113], but the ATP hydrolase that drives hemin import 
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has not been identified. IsdD is a putative membrane protein thought to act in conjunction with 
IsdE and IsdF, but its role in the hemin acquisition pathway has not been established and there 
are no known IsdD homologs in other Gram-positive bacteria. Interestingly, other S.aureus ABC 
transporters, like the siderophore transporters HtsABC and SiaABC, lack a dedicated ATP 
hydrolase and instead utilize FhuC to provide the power necessary to transport their cognate 
siderophores. Therefore, it is possible that FhuC could interact with the IsdEF complex to pump 
hemin into the cytoplasm [46,48]. Additionally, S. aureus strains lacking isdDEF are not growth 
impaired when hemin is the sole source of iron, further supporting the notion that alternative 
systems may exist that transport hemin across the cell membrane [6,64]. 
Upon reaching the bacterial cytoplasm, the hemin molecule is degraded by hemin 
oxygenases, IsdG or IsdI. While many bacterial hemin oxygenases (HO), such as HmuO in C. 
diphtheriae, share structurally similarity with known eukaryotic HOs, IsdG and IsdI are novel 
[114]. In particular, canonical HOs adopt structures that are predominantly formed by a-helices, 
whereas members of the IsdG family adopt ferrodoxin-like homodimeric structures [115]. 
Another unique feature of members of the IsdG family of HOs is that their bound hemin 
porphyrin rings are distorted or “ruffled” by a conserved tryptophan residue within their NWH 
catalytic triad [116]. Hemin-ruffling is thought to enhance the reactivity of IsdG and IsdI by 
eliminating the need for a catalytic hydrogen-bonding network that is usually present in 
canonical HOs. Unlike canonical HOs that break hemin down into biliverdin and carbon 
monoxide via cleavage at the a-meso carbon position, hemin ruffling by IsdG-like HOs 
facilitates cleavage at either the b- or d-meso carbons, resulting in the release of two distinct 
staphylobilins (5-oxo-d-bilirubin and 15-oxo-b-bilirubin) as well as formaldehyde. [114,117]. 
Since their discovery by Skaar and coworkers [75], IsdG homologs have been also been 
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characterized in Bacillus anthracis [118] and Staphylococcus lugdunensis [119], suggesting that 
Gram-positive pathogens use a conserved mechanism of hemin degradation.  
 The Isd hemin acquisition system is required by S. aureus to successfully establish 
infections [94,97,120]. Notably, work reported in two papers have suggested that the IsdA, IsdB, 
IsdH, and IsdE proteins are dispensable for S. aureus hemin-iron utilization from Hb [121,122]. 
However, the results of these studies are likely erroneous as they employed a lyophilized version 
of Hb that is structurally compromised [94,123]. This presumably led to supraphysiological 
concentrations of free hemin in these studies, which would mask the utility of the Isd system. 
Evidence that the Isd-system is important includes the results of numerous studies that have 
shown that even single deletions in isdA, isdB, isdC, isdG, isdH, or isdI are sufficient to 
significantly reduce S. aureus infectivity [52,94,124,125]. Furthermore, IsdA and IsdB have been 
shown to be required for the formation of staphylococcal abscesses, which are known to help 
prolong and disseminate infections [126,127].  
 
1.5.2  Hemin Acquisition Systems in Other Gram-Positive Pathogens  
Similar to Staphylococcus aureus, several other Gram-positive bacterial pathogens 
employ surface displayed proteins to capture hemin from human hemoglobin during infections. 
These hemin acquisition systems also employ proteins that contain NEAT domains, which are 
capable of either binding to hemin or hemoglobin. Below I briefly summarize what is known 
about these hemin acquisition systems and their relationship to the S. aureus Isd system.  
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1.5.3 Streptococcus pyogenes  
Streptococcus pyogenes, commonly known as group A streptococcus (GAS), S. pyogenes 
is a b-hemolytic extracellular pathogen that causes disease directly (e.g. pharyngitis, sepsis, and 
impetigo) and indirectly (e.g. immune-mediated rheumatic fever, or toxin-mediated scarlet fever 
and toxic shock syndrome) [128–130]. GAS utilize host hemin-iron sources but there is no 
precedence for them to obtain iron from transferrin or lactoferrin, which is supported by their 
apparent lack of endogenous siderophore production [59]. GAS acquire hemin-iron using a 10-
gene iron-regulated operon called the streptococcal iron acquisition (Sia) system that contains 
proteins that function similar to the Isd system (Figure 1.4, panel second from the left) [58]. In 
particular, the streptococcal hemoprotein receptor, Shr, is a large 145 kDa muti-domain protein 
that is functionally analogous to the Hb receptors, IsdB and IsdH. However, Shr lacks the overall 
sequence homology and domain architecture of these proteins. Shr is therefore a novel Hb 
receptor that consists of an N-terminal domain (NTD), an EF-hand motif and leucine rich repeat 
(LRR) sequences that are flanked by two NEAT domains (N1 and N2) [131]. Shr localizes to the 
cell membrane and spans the entire cell wall, exposing it to the extracellular environment and 
allowing it to also act as a bacterial adhesion to host proteins fibronectin and laminin [132]. 
Interestingly, it was shown that only the NTD was sufficient to mediate binding to Hb and there 
was no significant contribution to Hb binding by the two NEAT domains. This is consistent with 
both domains lacking the conserved aromatic-rich 310-helix found in IsdB and IsdH in S. aureus 
[83,93,131]. Within the NTD are two domains of unknown function (DUF1533), and future 
work characterizing these domains will shed light on the novel method GAS utilizes for Hb 
recognition. While the two NEAT domains bind hemin, they also lack the conserved iron-
coordinating tyrosine found in many other NEAT domains suggesting a novel axial-ligand 
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mechanism by Shr. Furthermore, the C-terminal NEAT domain, N2, was shown to bind both 
ferrous and ferric heme-iron states, which has only been seen elsewhere in the S. aureus IsdA 
protein [101,131]. The function of the LRR region in Shr is also unknown. This architectural 
element is known to form horseshoe like structures [133], so it could position the N1 and N2 
domains in close proximity to facilitate inter-domain hemin transfer. In support of this notion, 
isolated N1 and N2 domains rapidly transfer hemin to one another in vitro [134]. Furthermore, 
hemoproteins Hal and IlsA in B. anthracis [135] and B. cereus [57], respectively, also contain 
LRRs, suggesting a conserved function for these regions in hemin-iron acquisition.  
Shr can rapidly remove hemin from Hb and transfer it to the streptococcal hemin-
associated cell-surface protein, Shp [134,136]. Evidence suggests that Shp is a cell wall 
associated hemoprotein like acts similarly to IsdC in S. aureus [133]. It is the central conduit of 
the system, accepting hemin from Shr and passing it to the lipoprotein component of the ABC 
transporter complex, HtsABC (also known as SiaABC) [137]. The structure of Shp bound to 
hemin has been solved revealing a novel bis-methionyl hemin-iron ligation with an otherwise 
similar NEAT domain fold [138]. Holo-Shp rapidly transfers hemin to HtsA, which binds hemin 
vis a Met/His bis-ligation similar to IsdE [139,140]. Like the Isd system, hemin transfer is 
unidirectional with hemin flowing from Hb à Shr à Shp à HtsA [136,141,142]. After HtsA 
receives the hemin from Shp, it is translocated into the bacterial cytoplasm by the membrane 
permease, HtsB, which is powered by the ATP hydrolase, HtsC. However, once the hemin 
reaches the cytoplasm, the mechanisms by which it is degraded remain unclear, as no genes with 
homology to known hemin oxygenases have been discovered.  
 
 
 18 
1.5.4 Bacillus anthracis  
Bacillus anthracis is an endospore-forming anaerobe that is the causative agent of 
anthrax, which is a rare, but deadly disease that has a mortality rate as high as 90% [143]. The 
resilience of B. anthracis spores and its high lethality rate make this microbe a potential 
bioweapon [144]. B. anthracis’ life cycle is complex and dynamic [145]. Initially, infectious 
spores enter the host via inhalation, ingestion, or a breach in the host’s cutaneous layer. The 
spores are then rapidly phagocytosed by macrophages, where they subsequently germinate 
within the phagosome and proliferate in a vegetative state to cause macrophage lysis. Once 
liberated from the macrophages, bacteria disseminate throughout the host via the bloodstream. 
Siderophore production is essential for the intracellular survival of B. anthracis in locations 
where hemin isn’t readily available [146]. However, the bacterium also employs hemin 
acquisition systems to access iron from host proteins to rapidly propagate within its host.  
B. anthracis acquires hemin using proteins that are similar to those found in the S. 
aureus’ Isd system, as well as other proteins that have unique localization and ligand binding 
characteristics (Figure 1.4, middle panel). Similar to the Isd system in S. aureus, B. anthracis 
encodes a cog-wheel for hemin transport, IsdC, as well as an ABC hemin transporter complex, 
IsdEF, and a hemin oxygenase, IsdG. However, it is distinct from S. aureus, as it secretes two 
hemophores, IsdX1 and IsdX2. It also displays a surface associated BslK protein that is non-
covalently attached to the bacterium’s protein rich crystalline S-layer, as well as the cell wall 
attached Hal protein [145]. The IsdX1 and IsdX2 hemophores contain one and five NEAT 
domains, respectively. [56,147]. Unlike characterized hemophores described in Gram-negative 
bacteria that scavenge hemin from various host proteins [9], the IsdX1 and IsdX2 proteins have 
limited specificity as they only appear to procure hemin from hemoglobin, and not from 
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myoglobin or the haptoglobin/hemoglobin complex [56,147]. Interestingly, biochemical studies 
indicate that the NEAT domains within these hemophores have distinct functionalities 
[56,148,149]. IsdX1, and IsdX2’s N1, N3, N4, and N5 domains bind hemin using a canonical 
YxxxY motif, with N5 displaying the highest affinity for hemin. With the exception of the N5 
domain in IsdX2 that is believed to function as a “hemin sponge”, all of these domains are 
capable of rapidly transferring hemin to apo-IsdC. Intriguingly, IsdX2N2 does not bind hemin, 
but has been reported to bind Hb through a modified hemin-binding YxxxY motif in which the 
second tyrosine is replaced with a histidine residue [149]. Furthermore, it has also been reported 
that IsdX1, IsdX2N2, IsdX2N5, are capable of acquiring hemin from Hb. Notably, all of the NEAT 
domains in IsdX1 and IsdX2 lack the canonical aromatic-rich Hb-binding motif that is present in 
the S. aureus’ IsdBN1, IsdHN1, and IsdHN2 Hb domains. This suggests that these domains will 
bind Hb via a novel mechanism. The mechanism of hemin extraction from Hb is not known, but 
recent studies have implicated residues within the 310-helix of IsdX1, IsdX2N2, and IsdX2N5 
proteins to be involved in Hb recognition [86,150]. Binding and transport of hemin at the cell 
surface is further facilitated by the B. anthracis S-layer homology protein K (BlsK) protein, 
which is localized to the bacterium’s S-layer by its SLH (S-layer homology) domains. BlsK has 
been shown to rapidly transfer hemin to apo-IsdC, but the biological relevance of this event 
remains to be determined [151]. The fate of the hemin after reaching IsdC is believed to be 
similar to S. aureus, in which IsdC passes hemin to the IsdEF complex that transports hemin 
across the cell membrane into the cytoplasm where it is degraded by the IsdG hemin oxygenase 
[118]. 
Interestingly, the virulence of B. anthracis is not attenuated when the isdC, isdX1, and 
isdX2 genes are the deleted, and utilization of hemin from Hb is not completely abolished in isdC 
 20 
and BslK deletion strains [135,147,152]. This finding led to the discovery of the last protein 
implicated in B. anthracis hemin-iron acquisition, Hal (hemin-acquisition leucine-rich repeat 
protein). Hal contributes to B. anthracis virulence in a murine model of inhalational anthrax 
[153] and contains one NEAT domain and a LRR region that are capable of directly acquiring 
hemin from Hb [135]. However, how hemin is procured by Hal and imported into the cytoplasm 
remains a mystery.  
 
1.5.5  Listeria monocytogenes 
Listeria monocytogenes is a facultative intracellular pathogen that is the causative agent 
of listeriosis, a rare food-borne illness that has a mortality rate as high as 30% [154]. L. 
monocytogenes proliferates within its host using an array of virulence factors, including some 
that can promote its internalization into non-phagocytic cells [155]. L. monocytogenes contains 
an iron-regulated operon that contains nine protein encoding genes. Two of the genes encode for 
proteins that contain NEAT domains: Hbp1 and Hbp2 (for hemin binding protein, formally 
known as Lmo2186/SvpB and Lmo2185/SvpA, respectively) (Figure 1.4, panel second from 
the right). [156]. Previous immuno-labeling studies of Hbp1 and Hbp2 have shown that they are 
surface-exposed, whereas a western blot analysis has illustrated that most of the Hbp2 protein is 
secreted. Hbp1 and Hbp2 contain one and three NEAT domains, respectively [157–159]. 
Biochemical studies have shown that all of the domains bind to hemin, and have provided 
evidence that Hbp1 and the first (N1) and third (N3) NEAT domains in Hbp2 bind Hb. Although 
Hbp1 and Hbp2 are capable of binding Hb and hemin [160], there is no evidence that these 
proteins actively extract hemin from hemoglobin similar to the IsdB and IsdH proteins in S. 
aureus [68,69,99]. However, the hemophore characteristics of acquiring hemin from Hb and 
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inter-domain hemin transfer are analogous to B. anthracis proteins IsdX1 and IsdX2 [56,149]. 
While the hemin transfer mechanism is not known, it most likely occurs via a transient handclasp 
complex proposed for staphylococcal Isd proteins, as the individual NEAT domains in listerial 
proteins can transfer hemin rapidly between NEAT domains [160]. Interestingly, the second 
NEAT domain (N2) within Hbp2 that binds hemin lacks the second conserved tyrosine residue in 
the YxxxY hemin-binding motif. A recent structural study of the hemin-free and –bound states 
of Hbp2N2 elucidated the molecular basis of hemin recognition, revealing an unusual mode of 
binding in which a tyrosine in the b7 strand (Y280) coordinates the hemin-iron atom instead of 
the canonical tyrosine located in the b8 strand [160]. Furthermore, a comparison of the structures 
of apo- and holo-Hbp2N2 revealed unusually large hemin independent conformational changes. 
Cellular studies have suggested that Hbp1 and Hbp2 are required to scavenge hemin when it is at 
low concentrations (< 50 nM), [161] but that they are not needed when hemin is abundant. At 
these conditions hemin is thought to be transported into the cytoplasm by the HupDGC ABC 
transporter complex, which is required for growth on Hb or hemin as the sole source of iron 
[161,162]. The other protein products in the iron regulated operon of the L. monocytogenes’ 
hemin acquisition locus have not been characterized. However, that locus contains a putative 
ABC transporter (Lmo2184, Lmo2183, and Lmo2182) that has been proposed to function 
similarly to the IsdDEF complex in S. aureus [156]. L. monocytogenes also encodes for proteins 
that are homologous to the IsdG hemin oxygenase in S. aureus [75,163], but they have not been 
characterized. 
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1.5.6  Corynebacterium diphtheriae 
C. diphtheriae is a non-motile, non-spore forming anaerobe that is the causative agent of 
diphtheria, a severe respiratory disease that can lead to death [164]. The C. diphtheriae 
diphtheria toxin, DT, is a primary contributor to virulence as it inhibits protein synthesis. DT 
dissemination is believed to cause systemic toxic effects, particularly in the nervous system 
[165]. A hemin uptake system (Hmu) system is encoded by the hmu locus (Figure 1.4, right 
panel) [9]. It encodes for three proteins, a membrane-associated hemin/hemoglobin-binding 
protein (HmuT), a permease (HumU), and an ATPase (HmuV) [166]. HmuT is a lipoprotein and 
is thought to function similarly to S. aureus IsdE. However, unlike IsdE, HmuT has been 
reported in vitro to bind Hb [166]. Moreover, a recent study revealed that HmuT uses a 
conserved Tyr-His pair as axial ligands for hemin, which differs from the bis-Met-His ligands 
employed by IsdE [111,139,140,167,168]. Subsequent studies found additional genes located 
upstream of the hmu locus that are involved in hemin capture. Three genes are located in the 
htaABC operon positioned upstream [169]. These genes encode for HtaA and HtaB proteins, 
with the latter localizing to the cell membrane. This is in contrast to the HtaA protein, which is 
secreted into the extracellular environment when cells are grown in nutrient rich media, but 
associated with the cell membrane when they are grown in minimal media [169]. The role of the 
HtaC protein is unknown. Hemin and hemoprotein binding by HtaA and HtaB is facilitated by 
conserved regions, termed CR domains, that are ~150 amino acids in length and are believed to 
be structurally distinct from NEAT domains found in the aforementioned systems [170]. Hemin 
binding by CR domains is mediated by two conserved tyrosine residues and a conserved 
histidine residue, but the molecular basis of hemin binding has not been characterized. HtaB and 
HtaA contain one and two CR domains, respectively. HtaB has only been shown to bind hemin, 
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suggesting that it plays a intermediator role in hemin transport, whereas both CR domains in 
HtaA bind hemin, Hb, the Hp:Hb complex, Mb, and serum albumin [63]. HtaA can acquire 
hemin from host hemoproteins and transfer it to HtaB and/or HmuT, which is then transported 
into C. diphtheriae’s cytoplasm by HmuTUV to be degraded by a canonical hemin oxygenase, 
HmuO. This suggests a generally similar hemin uptake pathway as the Isd system in S. aureus 
despite the absence of NEAT domains [170,171]. 
The Hmu-Hta locus seems to be required for maximal growth during low concentrations 
of hemin and host proteins. However, deletion of the Hmu-Hta locus does not completely abolish 
growth when hemin is the sole source of iron [166,169,170]. This finding led to the discovery of 
the second and third corynebacterial hemin transport loci called chtAB and cirA-chtC [172]. 
Ongoing work has shed light on a complex yet redundant interplay between ChtA/ChtB, 
CirA/ChtC, and HtaA/HtaB systems in hemin acquisition by C. diphtheriae. ChtA, ChtB, and 
ChrC are membrane associated and surface exposed with each containing a single CR domain 
that mediates binding to hemin and Hb. In contrast, CirA lacks a CR domain and apparently does 
not bind hemin and/or Hb. Therefore, its role in hemin acquisition remains unclear. Recently it 
was shown that, like IsdH in S. aureus, HtaA, ChtA, and ChtC are able to bind the 
haptoglobin/hemoglobin complex and are required for utilization of Hp:Hb as an iron source 
[63,95,97]. ChtB was shown to not bind Hb, suggesting a similar functional role as HtaB. The 
fate of hemin procured by ChtA and ChtC is not known, but it has been suggested that these 
proteins could interact with HtaA, which could then transfer the hemin to HtaB (or ChtB), and 
then transport the hemin into the cytoplasm via HmuTUV [173]. However, future studies are 
necessary to test this hypothesis. Finally, isolates of C. diphtheriae that lack htaA, chtA, and chtC 
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are still capable of exploiting host hemoproteins as sources of iron [173], suggesting the presence 
of yet another unidentified hemin acquisition system. 
 
1.6 Scope of the Dissertation 
 During infections the pathogen Staphylococcus aureus actively procures hemin-iron from 
human hemoglobin (Hb) using the iron-regulated surface determinant (Isd) system. Related 
systems are also used by other Gram-positive pathogens to acquire hemin from hemoglobin. 
Research described in this dissertation investigated how the Isd system uses the IsdH protein to 
extract hemin from Hb. IsdH uses NEAr iron Transporter (NEAT) domains with a conserved tri-
domain unit to rapidly extract Hb’s hemin. Research described in Chapter 2 used UV-Vis 
spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and electrospray ionization 
mass spectrometry (ESI-MS) methods to illustrate that the components of the tri-domain unit 
work together to synergistically extract hemin. Among other findings, the results highlighted the 
importance of the conserved linker domain. The work described in Chapter 3 defined the 
structure and dynamics of the tri-domain unit, hereafter referred to as IsdHN2N3. The structure of 
the apo-receptor in solution was defined using small angle X-ray scattering, and advanced NMR 
methods such as paramagnetic relaxation enhancement (PRE), residual dipolar coupling (RDC), 
and selective methyl labeling approaches. Using ensemble modeling calculations, the structure 
and inter-domain dynamics of IsdHN2N3 were defined. The results of these studies indicate that 
the receptor binds to Hb using a combination of conformational selection and induced fit 
mechanisms, and suggest that the linker domain may facilitate hemin transfer by destabilizing 
the F-helix in Hb. In chapter 4, the kinetic and thermodynamic basis of hemin transfer were 
investigated using stopped-flow UV-Vis spectroscopy, analytical ultracentrifugation 
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sedimentation equilibrium and isothermal titration experiments. The results of this work shed 
light on the kinetic and thermodynamic determinants that facilitate receptor-mediated hemin 
release from Hb. Lastly, Chapter 5 describes the methods that were used to site-specifically label 
proteins with nitroxide probes and to derive paramagnetic distance restraints. Combined, the 
results of the work described in this dissertation have advanced our knowledge of Hb recognition 
and hemin acquisition by the medically important pathogen, S. aureus.  
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1.7  Figures 
 
 
Figure 1.1 Virulence factors of Staphylococcus aureus 
Both structural and secreted virulence factors play a direct role in S. aureus infectivity. 
Clockwise from the top right, secreted cytolytic agents such as a-toxin and leukocidin are pore-
forming proteins that lyse host cells to gain access to their nutrients or to neutralize the innate 
host immune defense. Adhesion to the host is mediated by MSCRAMMs (microbial surface 
components recognizing adhesive matrix molecules) which is a large family of proteins that 
contain two subdomains with IgG-like folds. Generally, these factors facilitate binding to 
extracellular matrix molecules such as fibronectin and collagen. Coagulase interacts with 
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protothrombin that catalyzes the conversion of fibrinogen to fibrin leading to blood clotting. 
Immune evasion is carried out by structural proteins such as protein A that binds the Fc region of 
IgG inhibiting phagocytic engulfment, while secreted CHIPS (chemotaxis inhibitory protein of S. 
aureus) inhibit neutrophil and monocyte chemotaxis. Nutrient acquisition allows the microbe to 
proliferate within its host. In particular, iron acquisition is mediated by surface proteins that 
capture iron-laden hemin (oxidized form of heme) and hemoglobin (Hb) from lysed erythrocytes 
as well as small siderophore molecules that bind extracellular iron with high affinity. This image 
was adapted from [24].  
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Figure 1.2  Overview of human nutritional immunity strategies 
Iron is stored intracellularly by complexing with ferritin, or bound extracellularly by binding to 
transferrin in serum or lactoferrin at mucosal surfaces. In blood, iron is complexed with heme, 
which is bound by hemoglobin found in erythrocytes. Upon erythrocyte lysis, hemoglobin is 
released and dissociates into its respective dimeric units, which is bound by haptoglobin. Any 
free heme is scavenged by hemopexin. In addition, any intracellular pathogens are limited in 
their access to metal ions, as the natural resistance-associated macrophage protein 1 (NRAMP1) 
found in the phagosomal membrane, pumps Fe2+ and Mn2+out of the phagosomal compartment. 
This image was adapted from [35]. 
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Figure 1.3  Siderophore transport in S. aureus 
Secreted siderophores, Staphyloferrin A and B, bind ferric iron extracellularly and are 
transported into the bacterium by their respective ABC transporters. Staphyloferrin A import is 
facilitated by the HtsA lipoprotein and HtsBC permease, whereas the liprotein, SirA, is the 
receptor for staphyloferrin B and translocation across the membrane is mediated by the SirBC 
permease. The FhuC ATPase provides the energy necessary to drive translocation for both 
siderophores’ import. Once in the cytoplasm, iron release from siderophores is facilitated by 
reductases that reduce the ferric-siderophore complex to the less stable ferrous state, releasing 
free iron for the microbe to use. For staphyloferrin A, the reductase is an iron-regulated 
nitroreductase, NrtA, while the reductase for staphyloferrin B remains unknown. 
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Figure 1.4  Heme acquisition systems in Gram-positive bacteria 
Iron import varies greatly among various Gram-positive microbes. In general, hemoglobin is 
captured by surface receptors that acquire its hemin which is then transferred through the cell 
wall by other hemoproteins (colored blue and purple). The hemin is then translocated through the 
cell membrane by bacterial ABC transporters (colored in green). Once in the cytoplasm, the 
hemin is degraded by hemin oxygenases (colored in orange) that release free iron for the 
bacterium to use. Proteins that bind hemin and/or Hb using NEAT and CR domains are colored 
in blue and purple, respectively. Proteins known to have different localizations have dotted lines, 
whereas solid lines represent covalent attachment to the cell wall. A ‘‘?’’ denotes 
uncharacterized proteins or stages in hemin transport. 
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Staphylococcus aureus Uses a Novel Multidomain Receptor to Break 
Apart Human Hemoglobin and Steal its Heme  
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2.1 Overview 
Staphylococcus aureus is a leading cause of life-threatening infections in the United 
States. It requires iron to grow, which must be actively procured from its host to successfully 
mount an infection. Heme-iron within hemoglobin (Hb) is the most abundant source of iron in 
the human body and is captured by S. aureus using two closely related receptors, IsdH and IsdB. 
Here we demonstrate that each receptor captures heme using two conserved near iron transporter 
(NEAT) domains that function synergistically. NMR studies of the 39-kDa conserved unit from 
IsdH (IsdHN2N3, Ala326–Asp660) reveals that it adopts an elongated dumbbell-shaped structure in 
which its NEAT domains are properly positioned by a helical linker domain, whose three-
dimensional structure is determined here in detail. Electrospray ionization mass spectrometry and 
heme transfer measurements indicate that IsdHN2N3 extracts heme from Hb via an ordered process 
in which the receptor promotes heme release by inducing steric strain that dissociates the Hb 
tetramer. Other clinically significant Gram-positive pathogens capture Hb using receptors that 
contain multiple NEAT domains, suggesting that they use a conserved mechanism. 
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2.2 Introduction 
Staphylococcus aureus is a leading cause of lethal hospital- and community-acquired 
infections in the United States. These infections result in a range of life-threatening diseases, 
such as pneumonia, meningitis, osteomyelitis, endocarditis, toxic shock syndrome, bacteremia, 
and sepsis. Highly virulent methicillin-resistant strains of S. aureus are now common, which 
annually cause more deaths in the United States (over 18,500) than any other single infectious 
agent [1). Iron is an essential nutrient required for S. aureus growth and is actively procured from 
its host during infections. As an innate defense mechanism, humans and other vertebrates exploit 
this dependence by sequestering the majority of the body’s total iron within cells and by binding 
extracellular iron to transferrin and lactoferrin glycoproteins [2, 3]. Iron-protoporphyrin IX 
(heme), found in the oxygen transport protein hemoglobin (Hb), contains 75% of the body’s total 
iron. As a result, S. aureus and other microbial pathogens have developed elaborate heme 
acquisition systems to exploit this rich nutrient source.  
S. aureus captures heme-iron from human Hb using nine iron-regulated surface 
determinant (Isd) proteins [4–7]. Four Isd proteins are attached to the cell wall and capture Hb, 
extract its heme, and pass it across the peptidoglycan to the membrane. These proteins include 
IsdA, IsdB, and IsdH (also known as HarA), which are attached to the cell wall by the SrtA 
sortase enzyme [8 –11), and IsdC, which is attached to the cell wall by the SrtB sortase [12]. 
Biochemical and cellular localization studies indicate that heme capture is mediated by an 
ordered set of heme transfer reactions. This process is initiated when the IsdH and IsdB proteins 
exposed on the cell surface bind Hb and remove its heme [8, 11]. Heme is then transferred to 
IsdA, which, in turn, relays it to the IsdC protein buried within the cell wall [11, 13, 14]. Holo-
IsdC then passes heme to the IsdE-IsdF complex, a transporter that pumps heme across the 
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membrane into the cytoplasm. In the cytoplasm, the heme oxygenase IsdG or its paralog, IsdI, 
degrades the tetrapyrrole ring to release free iron for use by the bacterium [15]. A molecular 
level under- standing of the Isd system could facilitate the development of new anti-infective 
agents that work by disrupting heme uptake, because several studies have shown that its 
components are required for S. aureus virulence [12, 16 –19), and related systems are present in 
a number of other important pathogens, including Listeria monocytogenes [20, 21), Bacillus 
anthracis [22), and Streptococcus pyogenes [23–25].  
In the Isd system, both Hb and heme are captured by near iron transporter (NEAT) 
domains that are located within the IsdA, IsdB, IsdC, and IsdH proteins. These conserved 
binding modules are 125 residues in length and are named for the location of their genes, which 
are proximal to putative Fe3+ siderophore transporter genes [26]. Biochemical studies of isolated 
NEAT domains indicate that they have distinct binding specificities that enable interactions with 
one or more distinct ligands, including heme, Hb, haptoglobin, and other host proteins. The 
atomic structures of several isolated NEAT domains have now been determined, revealing the 
mechanism of heme and Hb binding [27–29]. In addition, recent studies have shown that heme 
transfer from IsdA to IsdC occurs when their NEAT domains transiently associate via an ultra-
low affinity hand clasp complex [30, 31].  
The first step in heme acquisition is the capture of Hb and the extraction of its heme 
molecules by IsdH and IsdB. Both receptors are potential targets for the development of novel 
antibiotics because isdH and isdB mutant strains of S. aureus are reduced in their ability to infect 
mice [16, 19, 32, 33), and purified antibodies against IsdH and IsdB confer protection from 
staphylococcal infections in animal models [33]. IsdH and IsdB share a significant degree of 
primary sequence homology, and, unlike other components of the Isd system, they contain 
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multiple NEAT domains. IsdB has been shown to bind Hb and capture its heme at least 150 
times faster than the rate at which Hb spontaneously releases heme into the solvent, suggesting 
that the receptors capture heme via an activated receptor-Hb complex [14, 34]. Here we 
demonstrate that heme capture by IsdB and IsdH is mediated by a conserved structured unit that 
contains two NEAT domains that are connected by an -helical linker domain. We show, based on 
absorbance spectroscopy and electrospray ionization mass spectrometry (ESI-MS) 
measurements, that the linker domain in IsdH forms a three-helix bundle structure that is 
essential for efficient heme capture. NMR studies of a 39-kDa polypeptide containing the 
conserved unit from IsdH indicate that it adopts an extended but ordered structure. A model of 
the heme extraction process is presented in which IsdH dissociates the Hb tetramer to promote 
heme release.  
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2.3 Results 
2.3.1 A Conserved Unit in IsdB and IsdH Containing Two NEAT Domains 
Rapidly Captures Heme from Hb 
The S. aureus Hb receptors IsdB and IsdH contain two and three NEAT domains, 
respectively (Figure 2.1A). Isolated domains from these receptors have been characterized in 
vitro and bind to either Hb or heme; the IsdHN1, IsdHN2, and IsdBN1 NEAT domains bind to Hb, 
whereas the C-terminal NEAT domains in both proteins interact with heme (IsdHN3 and IsdBN2) 
[32, 38, 50–54]. Interestingly, a sequence alignment reveals that IsdB and IsdH share 64% 
primary sequence identity with one another over a region that encodes two NEAT domains 
(Figs. 1A and 2). This conserved unit contains two NEAT domains that are joined by a 70-amino 
acid segment, hereafter referred to as the “linker.” In IsdH, the unit corresponds to the N2 and 
N3 domains, which are homologous to the N1 and N2 domains in IsdB, respectively (Figure 
2.1A, enclosed in a dashed box). In vitro, full-length IsdB rapidly captures heme from Hb [14]. 
To determine if the con- served unit within IsdB and IsdH is responsible for efficient heme 
capture, UV-visible absorption spectroscopy was used to measure the rate of heme transfer from 
heme-loaded methemoglobin (MetHb) to either IsdBN1N2 (residues Thr121–Asn458, containing the 
N1 and N2 domains in IsdB) or IsdHN2N3 (Ala326–Asp660, containing the N2 and N3 domains in 
IsdH). All studies were performed under oxidizing conditions, in which heme is in its ferric 
form. Upon mixing of MetHb with apo-IsdHN2N3, a rapid shift of the UV absorbance spectrum of 
Hb to the heme bound spectrum of IsdHN2N3 is observed (Figure 2.1B). This spectral change is 
indicative of heme transfer to IsdH and is most pronounced at 371 and 406 nm where the 
absorbance increases and decreases, respectively. A kinetic analysis of the heme transfer data 
indicates that IsdBN1N2 and IsdHN2N3 capture heme from Hb at similar rates, 0.055 0.001 and 
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0.048 0.001 s-1, respectively (Figure 2.1C). These rates are similar to those measured for intact 
IsdB and are up to 580 times faster than the rate at which tetrameric Hb spontaneously releases 
heme into the solvent, suggesting that heme transfer to IsdB and IsdH occurs via a MetHb-
receptor complex [14, 34].  
To determine if the NEAT domains within IsdH need to be part of the same polypeptide 
to rapidly extract heme, we measured the rate of heme transfer from MetHb to the isolated N3 
domain in the presence and absence of the Hb binding N2 domain (Figure 2.3, A and B). 
Compared with IsdHN2N3, the isolated heme binding domain IsdHN3 (Leu544–Asp660) acquires 
heme from MetHb very slowly, which is consistent with an indirect transfer mechanism in which 
heme is first released from MetHb into the solvent before it is acquired by IsdHN3 (Figure 2.3B). 
The addition of the MetHb binding IsdHN2 protein (Ala326– Pro466) in trans to this transfer 
reaction fails to increase the rate of heme transfer from MetHb to IsdHN3 (Figure 2.3B, N2 + 
N3). This indicates that IsdHN2 binding to MetHb itself does not perturb its structure so as to 
promote heme release and subsequent capture by the isolated N3 domain. The presence of the N2 
domain also does not significantly alter the heme binding affinity of the N3 domain within 
IsdHN2N3, because IsdHN2N3 and IsdHN3 bind heme with similar affinities, KD values of 3.2 ± 0.7 
and 3.4 ± 0.6 µM, respectively (Figure 2.4). Combined, these data strongly suggest that the N2 
and N3 domains of IsdH need to reside within the same polypeptide to efficiently capture heme 
from Hb. Because IsdB contains this conserved unit, its NEAT domains also presumably 
synergistically extract heme (Figure 2.2).  
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2.3.2 The NEAT Domains within IsdH and IsdB Are Connected by a 
Functionally Important Helical Linker 
The 70-amino acid linker segments that connect the NEAT domains in IsdB and IsdH 
share 70% sequence identity (Figure 2.2). To investigate their structure, we purified 
polypeptides containing this segment from IsdB (IsdBlinker, Ser263–Ser361) and IsdH (IsdHlinker, 
Pro466–Val564). Their circular dichroism (CD) spectra indicate that IsdBlinker and IsdHlinker adopt a 
helical conformation, which is evident by negative bands in their CD spectra at 222 and 208 nm 
and a positive band at 193 nm (Figure 2.5A). This is consistent with secondary structure 
predictions, which propose that amino acids in this region form several -helices. To explore the 
functional role of the linker domain in IsdH, UV-visible absorbance spectroscopy was used to 
follow heme cap- ture from MetHb. IsdHlinker was unable to acquire heme from MetHb (Figure 
2.3B). Moreover, the presence of IsdHlinker and IsdHN2 did not accelerate the rate at which IsdHN3 
captures heme from MetHb (Figure 2.3C, N2 + linker + N3). This indicates that the isolated 
components of the conserved unit in IsdH are unable to associate with one another via non-
covalent interactions to form a fully functioning receptor. To further investigate the function of 
the linker, polypeptides in which the linker was fused to either the N2 (IsdHN2-linker, Ala326–
Gln543) or N3 (IsdHlinker-N3, Leu-544–Asp660) domains were studied. Slow transfer from MetHb to 
the isolated N3 domain was observed when IsdHN2-linker was added in trans, indicating that 
MetHb binding by IsdHN2-lnker did not significantly promote heme release and subsequent capture 
by IsdHN3. Similarly, IsdHlinker-N3 captures heme slowly from MetHb in either the presence or 
absence of IsdHN2, indicating that the presence of the helical linker does not influence the N3 
domain’s ability to scavenge heme (Figure 2.3C). To determine if the structure of the linker is 
important for function, we studied IsdHN2-GS-N3, which replaces the linker with a nine-residue 
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glycine- and serine-rich polypeptide (GSGSGSGSG). Spectroscopic measurements reveal that 
IsdHN2-GS-N3 captures heme slowly from MetHb at a rate that is similar to that of the isolated N3 
domain (Figure 2.3, compare B and C). Combined, these data indicate that the NEAT domains 
in IsdB and IsdH are connected by a helical linker, whose primary function is to properly 
position the domains so as to specifically facilitate heme transfer from MetHb to the N3 domain.  
 
2.3.3 IsdH Destabilizes Hb to Promote Heme Release 
We used ESI-mass spectrometry to investigate the mechanism through which IsdH 
accelerates heme release from Hb. ESI-MS allows the quantification of different Hb oligomers in 
the presence and absence of IsdH [55]. Hb consists of a- and b-globin chains each bound to a 
heme. The globins assemble into a noncovalently bound (ab)2 tetramer that dissociates into (ab) 
dimers with a dissociation constant (KD) of 2 µM [56]. This is evident from the ESI-MS 
spectrum of a 10 µM solution of Hb; from the ratio of the signal from the dimer and tetramer 
ions, the dimer/ tetramer ratio is 1:1.4. This is consistent with previously reported studies [57, 
58) and validates the use of ESI-MS to estimate the relative abundances of Hb species. ESI-MS 
spectra of Hb were acquired in the presence or absence of either wildtype IsdHN2N3, IsdHN2-GS-N3, 
or IsdHN2N3(Y642A), which contains a Y642A mutation in the N3 domain that disrupts heme 
binding (Figure 2.6, A–D). In all of the experiments, the receptors were present at a 2-fold molar 
excess relative to Hb (expressed in tetrameric units). The ESI-MS data are summarized in Figure 
2.6E, which shows a histogram plot of the relative abundances of the various forms of Hb (the 
sum of the monomeric a- or b-globins (M); (ab) dimer (D); and (ab)2 tetramer (T)), as well as 
receptor-bound forms of the (ab)2 tetramer (T:R), and (ab) dimer (D:R). Incubation of IsdH
N2N3 
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with Hb substantially reduces the amount of dimeric and tetrameric Hb, which is converted into 
monomeric globins. This is consistent with previous studies that have shown that Hb dissociates 
into its component globins upon heme removal [58, 59]. Because substoichiometric amounts of 
the receptor were used, Hb dissociation is not complete, leaving mostly a mixture of dimeric Hb 
and the (ab) dimer-receptor complex. Importantly, after the IsdHN2N3 addition, most of the Hb 
tetramer disappears, and very little (ab)2 tetramer-receptor complex is formed. This indicates 
that receptor binding and/or heme removal significantly destabilizes the tetramer.  
To gain insight into the role of the linker and heme binding in the acquisition process, 
ESI-MS spectra of Hb in the presence of IsdHN2-GS-N3 or IsdHN2N3(Y642A) were acquired. Unlike 
the wild-type receptor, when the IsdHN2-GS-N3 linker mutant is incubated with Hb, the majority of 
the receptor binds to the (ab)2 tetramer to form a (ab)2-IsdH
N2-GS-N3 complex, and a significant 
fraction of the tetramer remains intact (Figure 2.6E). Moreover, smaller amounts of Hb are 
converted to its monomeric globins, whereas roughly similar amounts of (ab) dimer and (ab) 
dimer-receptor complex are present. The absence of monomeric globins is compatible with the 
kinetic data that showed that IsdHN2-GS-N3 extracted heme from Hb inefficiently. The fact that the 
linker mutant does not disrupt the tetramer suggests that it adopts a unique structure as compared 
with the wildtype protein, such that the mutant receptor can no longer impart sufficient structural 
strain to rupture the tetramer. To determine if the receptor needs to bind heme in order to 
dissociate the Hb tetramer, we studied IsdHN2N3(Y642A) which contains a Y642A mutation in the 
N3 domain that disrupts heme binding. When Hb is incubated with IsdHN2N3(Y642A), the amount 
of tetrameric Hb is significantly reduced as a result of its conversion into the (ab)-
IsdHN2N3(Y642A) complex. However, only small amounts of monomeric globin are produced. This 
suggests that heme removal from the tetramer by the receptor is not required to dissociate it into 
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its dimeric state. However, heme removal appears to be required to convert Hb into its 
monomeric units. A working model of the extraction process is presented under “Discussion.”  
 
2.3.4 Structure of the Linker Domain 
To gain a better under- standing of the molecular basis of heme capture, we determined 
the NMR solution structure of IsdHlinker (Protein Data Bank accession code 2LHR). The NMR 
spectra of IsdHlinker are well resolved, enabling nearly complete 1H, 13C, and 15N resonance 
assignments (Figure 2.5B). A total of 1793 experimentally derived restraints were used to 
determine the structure, including 1469 interproton distance restraints, 118 dihedral angle 
restraints, 54 3JHNa restraints, and 152 
13C secondary shift restraints. An ensemble of 20 
conformers representing the structure of IsdHlinker is displayed in Figure 2.7A. The structure is 
well defined by the NMR data; the backbone and heavy atom coordinates of the structured 
residues Val470–Val531 can be superimposed with a root mean square deviation of 0.42 ± 0.10 and 
0.87 ± 0.07 Å, respectively (experimental and structural parameters are presented in Table 2.1).  
The linker forms a three-helix bundle that is composed of helices a1 (Asp471–Lys486), a2 
(Leu490–Lys503), and a3 (Glu506–Ala530) (Figure 2.7B). In the bundle, the long axes of the helices 
are co-linear and are connected by short reverse turns. The structure is stabilized by a 
hydrophobic core that is formed by nine leucine and tyrosine residues (Leu477, Leu480, Leu481, 
Tyr484, Leu497, Leu500, Leu504, Tyr508, and Tyr512; Figure 2.7C). Although each helix contributes 
residues to the hydrophobic core, helix a3 is longer than the other helices, such that its C 
terminus projects from the bundle. This region and residues immediately following it presumably 
facilitate interactions with the N3 domain in the intact receptor (see below). {1H}15N-
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heteronuclear NOE measurements are compatible with the structure because residues Val470–
Val531, whose coordinates are precisely defined in the ensemble, exhibit large magnitude NOE 
values, indicating that they are immobile on the picosecond time scale (Figure 2.5C).  
 
2.3.5 IsdHN2N3 Adopts an Extended but Ordered Multidomain Structure 
We used NMR to investigate the structure and dynamics of IsdHN2N3(Y642A). It is 
structurally identical to the wild-type protein based on its HSQC spectrum but is reduced in its 
ability to bind heme. Previously, we sequence-specifically assigned the chemical shifts of its 
backbone atoms [36]. To learn whether the domains form a rigid unit within IsdHN2N3(Y642A), we 
measured {1H}15N-heteronuclear NOE relaxation parameters. As shown in Figure 2.8A, residues 
spanning the N2, linker, and N3 domains exhibit positive and mostly uniform {1H}15N-
heteronuclear NOEs, which indicates that they are structurally ordered. Notably, residues that 
connect the domains also exhibit positive NOEs. Because some of these residues are 
unstructured in the isolated linker polypeptide (Figure 2.5C), this suggests that in the context of 
IsdHN2N3(Y642A), they form stabilizing interactions with residues located in the N2 and/or N3 
domains and that the domains form a single structured unit. Although the structure of the full 
receptor is unknown, the structures of the isolated linker and N3 domains are known, and the 
structure of the N2 domain can be accurately modeled using the previously determined NMR and 
crystal structures of IsdHN1, which shares 54% sequence identity with N2 [50, 51, 53]. To 
determine whether the domains undergo major structural changes upon incorporation into 
IsdHN2N3, we measured 15N-1H residual dipolar couplings (1DNH RDCs) in a sample of IsdHN2N3 
partially aligned in pentaethylene glycol monododecyl ether (C12E5 PEG)/hexanol. The 
1DNH 
data provide information about the angle of each backbone N–H bond relative to an alignment 
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tensor. The compatibility of the individual domain structures with the RDC data was evaluated 
by plotting the back-calculated versus experimental 1DNH values (Figure 2.9). There is good 
agreement between the experimental data and the individual structures of the N2, linker, and N3 
domains, which have calculated Q-factors of 0.28, 0.10, and 0.23, respectively. This indicates 
that incorporation of the domains into IsdHN2N3 does not significantly alter their structure and is 
consistent with our previously reported Ca and Cb backbone secondary chemical shifts of 
IsdHN2N3, which suggested that the domains have similar secondary structures in isolation and 
when incorporated into IsdHN2N3 [36].  
The chemical shifts of IsdHN2N3(Y642A) and polypeptides containing its isolated domains 
were compared with the aim of learning if the domains interact with one another in the context of 
IsdHN2N3(Y642A). Figure 2.8B shows an overlay of the secondary chemical shifts of 
IsdHN2N3(Y642A) and IsdHlinker. Similar secondary chemical shifts were observed for the structured 
part of the linker, suggesting that its conformation is preserved in IsdHN2N3(Y642A). Average 
chemical shift differences of the backbone amide signals of isolated linker and the corresponding 
residues in IsdHN2N3 are displayed in Figure 2.8C. In general, small chemical shift differences 
were observed for residues in the core helices of the linker, indicating that they do not form a 
molecular surface that interacts with the N2 or the N3 domains. However, significant chemical 
shift differences in the linker occur for residues located at the beginning of helix a2 (Leu490– 
Arg492) and at its N terminus (Asp468-Glu472, Thr474–Tyr475) and C terminus (Gln526–Ser529, 
Val531–Thr538, Thr540– Gln543). Mapping these changes onto the NMR structure of the linker 
reveals that they reside at distinct ends of the domain (Figure 2.8D). This is consistent with 
residues at the beginning of helix a2 and the N terminus of the linker contacting the N2 domain, 
while residues at the C-terminal end interact with the N3 domain. Interestingly, comparison of 
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the secondary chemical shifts suggests that helix a3 in the linker domain is lengthened at its C 
terminus when it is incorporated into IsdHN2N3 (Figure 2.8B). Moreover, residues immediately 
following this segment, based on their secondary chemical shifts, do not participate in regular 
secondary structure when located in IsdHN2N3 but are nevertheless highly ordered, based on the 
heteronuclear NOE data (Figure 2.8A). To further ascertain whether the domains in IsdHN2N3 
might be significantly interacting with one another in IsdHN2N3, we produced 15N samples of 
IsdHN2 and IsdHN3. The 1H-15N HSQC spectrum of IsdHN2 is well resolved and, when overlaid 
with the spectrum of IsdHN2N3, reveals very similar chemical shifts (data not shown). This 
suggests that, in the context of IsdHN2N3, the N2 domain does not contain a large contact surface 
that interacts with the remainder of the protein. A similar analysis using 15N-labeled IsdHN3 was 
also attempted but did not prove fruitful because the cross-peaks in its spectrum are partially 
broadened, presumably because of protein aggregation. Combined, the absence of extensive 
interaction surfaces in the linker and N2 domains suggests that, while ordered, IsdHN2N3 does not 
adopt a compact structure.  
 
2.4 Discussion 
To successfully mount an infection, S. aureus and other pathogens acquire the essential 
nutrient iron from human Hb. Two surface-displayed S. aureus receptors capture Hb on the cell 
surface, IsdB and IsdH. The receptors share a high degree of sequence homology over a region 
that contains two NEAT domains that are separated by a 70-amino acid “linker” segment (Figs. 
1A and 2). The NEAT domains in the conserved units have distinct functions; in each protein, 
the N-terminal domain binds to Hb, and the C-terminal domain interacts with heme [8, 38]. 
Interestingly, the NEAT domains in IsdB appear to function synergistically, because Lei and 
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colleagues [14) have shown that IsdB captures heme from Hb ~28–250 times faster than proteins 
that contain only a single NEAT domain. To gain insight into the molecular basis of this synergy, 
we studied the conserved bi-NEAT domain unit located within IsdH (IsdHN2N3). UV-visible 
spectroscopy measurements of heme transfer from Hb indicate that IsdHN2N3 rapidly acquires the 
heme of Hb at a rate that is 110–580 times faster than the rate at which Hb spontaneously 
releases heme into the solvent (IsdHN2N3acquires heme at a rate of 0.048 ± 0.001s-1,whereas the 
and subunits in tetrameric Hb release heme into the solvent at a rate of 0.000083 and 0.00042 
s-1, respectively) [34]. IsdB and IsdHN2N3capture heme from Hb at a similar rate, compatible with 
both proteins forming a receptor-Hb complex in which heme is actively removed. These transfer 
rates may be slower if the heme iron in Hb is in its reduced state, because IsdHN3 has been shown 
to bind ferric heme more tightly than ferrous heme [60]. Systematic dissection of IsdHN2N3 into 
its components indicates that its NEAT domains need to be part of the same polypeptide chain in 
order to rapidly acquire heme from Hb. Moreover, a linker with a specific structure and size that 
connects the domains is required for efficient heme capture; an IsdHN2-GS-N3 mutant in which the 
linker is replaced with a glycine-serine nonapeptide acquires heme slowly from Hb.  
IsdHN2N3 adopts an ordered elongated dumbbell-shaped structure in which its NEAT 
domains are separated by a helical linker domain. The NMR structure of the linker domain 
(called IsdHlinker) reveals that it adopts a three-helix bundle. First observed in the IgG-binding 
domain of S. aureus, three-helix bundles serve as robust scaffolds for molecular recognition and 
are ubiquitously found in structural proteins, enzymes, and DNA-binding proteins [61, 62]. 
Because the N and C termini in IsdHlinker are positioned at opposite ends of the bundle, in the 
context of the IsdHN2N3 receptor, the linker domain presumably acts as a spacer that holds the N2 
and N3 domains apart from another by 40 Å. This is compatible with the assigned NMR spectra 
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of the intact 39-kDa IsdHN2N3 receptor, because a comparison with the NMR spectra of IsdHlinker 
reveals that only residues located at the ends of the helical bundle near the connection points to 
the N2 and N3 domains exhibit large chemical shift differences. Moreover, the NMR chemical 
shifts of residues in the isolated IsdHN2 domain and IsdHN2N3 are similar, suggesting that N2 is 
not involved in extensive interdomain interactions in the structure of IsdHN2N3. Interestingly, 
although IsdHN2N3 adopts an elongated structure, the domains do not appear to be connected by 
flexible loops. Inspection of the heteronuclear NOE data of IsdHN2N3 reveals nearly uniform 
values over the length of the polypeptide, including amino acids that connect the domains. 
Notably, several residues at the N and C termini of the linker domain that are unstructured in the 
isolated IsdHlinker become ordered when they are located in IsdHN2N3 (in IsdHN2N3, 2 and 11 
residues preceding and following the linker domain, respectively, exhibit elevated NOE values in 
IsdHN2N3 as compared with IsdHlinker). Thus, the three domains within IsdHN2N3 adopt an 
extended conformation in which their positioning is fixed with respect to one another. IsdB can 
be assumed to adopt a similar structure because it shares significant sequence homology with 
IsdHN2N3, and we have shown that its linker region also adopts a helical conformation.  
From the ESI-MS data, IsdH extracts heme from Hb via the ordered process shown in 
Figure10A. On the cell surface, IsdB and IsdH can be expected to encounter Hb in its (ab)2 
tetrameric and dimeric forms, whose relative abundance depends on protein concentration. When 
IsdHN2N3 binds to the (ab)2 tetramer, it promotes its dissociation into dimers, which is 
presumably caused by receptor-induced steric strain that ruptures the weaker a1b2 interface of the 
tetrameric Hb [63]. Dimer formation is expected to facilitate heme transfer to IsdHN2N3 because 
dimeric Hb releases heme more readily than the (ab)2 tetramer; compared with the tetramer, the 
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rate of heme loss from the and chains in the isolated (ab) dimer is 2 and 10 times faster, 
respectively [34]. In the second step, heme is transferred from the (ab) dimer to the N3 domain 
within the IsdHN2N3 receptor. Our data do not reveal which globin chain, if any, serves as the 
preferred heme donor for IsdHN2N3. It is possible that heme is first removed from the subunit 
because it has intrinsically weaker affinity for heme as compared with the subunit [34]. 
Alternatively, structural distortions induced in the dimer by the receptor may trigger heme 
transfer from the chain, creating semi- Hb from which heme is known to be rapidly released [34]. 
In the final step, after the loss of one of its heme molecules, the (ab) dimer dissociates 
completely. Formation of monomeric species is probably driven by the greater tendency of Hb 
dimers to dissociate [59]. As the monomeric and chains quickly lose their heme to the 
environment, both globins could be expected to readily release their ligand to IsdH [34]. A 
similar transfer reaction is expected to occur when IsdH encounters an (ab) Hb dimer, but it 
would bypass the need for tetramer dissociation. An alternative heme transfer pathway is also 
possible. In it, the receptor would remove heme directly from the tetramer or concurrently with 
tetramer dissociation. Heme removal from the tetramer could be advantageous because it would 
produce semi-Hb tetramers that are prone to dissociate [64]. However, as described immediately 
below, heme capture from the Hb tetramer is not an obligate step in the transfer reaction.  
Several lines of evidence indicate that binding of the IsdHN2N3 receptor to tetrameric Hb 
induces steric strain in Hb that causes it to dissociate into dimers and that this process does not 
require heme transfer to IsdHN2N3 (Figure 2.10A). The most compelling evidence comes from 
the ESI-MS data of IsdHN2N3 and IsdHN2N3(Y642A), which indicate that both proteins readily 
disrupt the tetramer. Because IsdHN2N3(Y642A) binds heme with lower affinity, this indicates that 
structural perturbations in Hb induced by receptor binding are sufficient to cause it to dissociate. 
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This process requires two NEAT domains that are connected by a structured linker because the 
Hb tetramer does not dissociate when it is bound to an IsdHN2-GS-N3 mutant in which the linker 
domain is replaced with a flexible glycine-serine peptide. The idea that an intact bi-NEAT 
domain receptor is required to dissociate the tetramer is also consistent with a recent crystal 
structure of the IsdHN1-Hb complex, which revealed that binding of the isolated N1 NEAT 
domain to Hb induced only modest structural changes in Hb [50]. As we have shown, IsdHN2N3 
adopts a rigid structure in its apo state; this suggests that binding of IsdHN2N3 to Hb results in 
atomic overlap between the proteins that causes the tetramer to dissociate. A model of the 
structure of the IsdHN2N3-Hb complex illustrates a possible orientation of the receptor protein on 
Hb (Figure 2.10B). The orientation of the sub-domains (N1, linker, and N2) within IsdHN2N3 has 
not been experimentally determined, and only one possible orientation is shown. The model was 
constructed using the NMR structure of IsdHlinker, the crystal structure of the isolated N3 domain, 
and a homology model of the N2 domain based on the structure of IsdHN1. Based on the recently 
reported crystal structure of the isolated N1 domain bound to Hb, the N2 domain in IsdHN2N3 can 
be expected to engage the subunit of Hb via its A-helix [50]. Contacts from N2 presumably 
originate from residues located within surface loops positioned at one end of its b-barrel 
structure because these residues are conserved in N1 and N2. The relative positioning of the 
remainder of the IsdHN2N3 protein and its contacts to Hb cannot be predicted from our NMR data. 
However, assuming that IsdHN2N3 adopts an extended structure, the N3 domain could, in 
principle, be positioned adjacent to the heme pockets of either the a or b subunits. Unlike IsdB, 
the IsdH protein contains an N-terminal NEAT domain (N1) that binds to the subunit of Hb 
(Figure 2.1A) [50]. It is possible that the N1 and N2 domains in IsdH simultaneously engage the 
Hb tetramer via its two subunits. Alternatively, N1 and N2 may not simultaneously engage the 
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same tetramer. In this scenario, Hb binding by N1 may function to increase the efficiency of 
heme capture by increasing the local concentration of Hb that is proximal to IsdHN2N3. A more 
detailed understanding of the mechanism of extraction and the origin of molecular strain induced 
by the receptor on Hb will require studies of the full-length IsdH protein and the structure 
determination of IsdHN2N3 in both its free- and Hb-bound states. 
We have demonstrated that the NEAT domains within IsdH function synergistically to 
capture heme from Hb. Interestingly, several other pathogenic species of Gram-positive bacteria 
display surface proteins implicated in heme capture that contain more than one NEAT domain 
[26]. At present, only a few of these proteins have been characterized biochemically. S. pyogenes 
encodes the membrane-anchored Shr protein, which has two NEAT domains, and, similar to 
IsdB and IsdH, it has been proposed to acquire heme via a receptor-Hb complex [65, 66]. B. 
anthracis produces a Hb hemophore called IsdX2 that contains five NEAT domains [67, 68]. All 
of its domains bind Hb, and some are multifunctional because they can also bind heme. It will be 
interesting to see if subsets of these domains are also connected by structured linker segments 
that enable their NEAT domains to function synergistically. Despite the prevalence and 
importance of multi-NEAT domain proteins in Gram-positive bacteria, this present study is the 
first to address in detail the possible interactions between NEAT domains, the role of the linker 
segments, and functional synergy between these regions. Further research will be required to 
reveal if the mechanism of extraction described here can be generalized to other NEAT-
containing Hb receptors. This work could lead to small molecule antibiotics that work by 
limiting microbial access to heme-iron.  
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2.5 Materials and Methods 
2.5.1  Cloning, Protein Expression, and Purification 
Plasmids were generated encoding IsdH and IsdB receptor constructs as small 
hexahistidine-ubiquitin-like modifier (SUMO)-tagged proteins under control of an inducible 
promoter: pRM208 coding for amino acids 326–660 in IsdH (IsdHN2N3), pRM213 coding for 
amino acids 326–466 in IsdH (IsdHN2), pRM214 coding for amino acids 466–660 in IsdH 
(IsdHlinker-N3), pRM234 coding for amino acids 326–543 in IsdH (IsdHN2-linker), pRM219 coding 
for amino acids 467–543 in IsdH (IsdHlinker), and pRM221 coding for amino acids 544–600 in 
IsdH (IsdHN3). Briefly, the DNA was amplified from the S. aureus RN4220 genome by 
polymerase chain reaction (PCR) and cloned into the vector pHis-SUMO using BamHI and XhoI 
restriction enzymes [35]. pRM233 coding for amino acids 326–660 (IsdHN2-GS-N3) was generated 
from pRM208 using two-step PCR, such that the linker was replaced with a nine-amino acid 
artificial linker (GSGSGSGSG). The sequence of all plasmids was verified by DNA sequencing. 
Generation of the plasmid pRM216 coding for amino acids 326–660 in IsdH with an alanine 
substitution of Tyr642 (IsdN2N3(Y642A)) has been described earlier [36]. Protein expression in 
Escherichia coli BL21(DE3) cells (New England BioLabs) transformed with the overexpression 
plasmids in LB/kanamycin (50 g/ml) was induced with 1 mM isopropyl-b-D-thiogalactoside for 4 
h at 37 °C. For production of isotopically labeled [13C,15N]protein, the cells were grown in M9 
minimal medium containing 15NH4Cl and [13C]glucose (Cambridge Isotope Laboratories). The 
bacterial cells were harvested by centrifugation, resuspended in 50 mM NaH2 PO4, 300 mM 
NaCl, pH 7.0, and ruptured by sonication. The cell debris was removed by centrifugation, and 
the supernatant containing the SUMO-tagged proteins was purified using a Co2 -chelating 
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column (Thermo Scientific). After cleavage of the fusion proteins with ULP1 protease for 2 h at 
4 °C, they were reapplied to the Co2 chelating column to remove the protease and cleaved 
SUMO-affinity tag. The receptor proteins were further purified by gel filtration on a Superdex 75 
column (GE Healthcare) equilibrated with 20 mM NaH2 PO4, 50 mM NaCl, pH 6.0. Heme 
contents of holo- and apoproteins were determined with the pyridine hemochrome assay, and 
homogeneous apo forms of the heme-binding proteins were generated by extraction with methyl 
ethyl ketone [37]. Expression and purification of [U-2H,13C,15N]IsdN2N3(Y642A) was performed 
according to a previously published protocol [36].  
 
2.5.2 Preparation of Human Hemoglobin 
Human blood (30–40 ml) was collected with heparin anticoagulant by a health 
practitioner following appropriate institutional protocols. Red blood cells were collected by 
centrifugation at 700 g for 10 min at 4 °C. The cells were washed three times with 0.9% NaCl 
and bubbled with carbon monoxide (CO) for 5 min. The cells were then collected by 
centrifugation and lysed by resuspension in five volumes of water, followed by incubation on ice 
for 30 min. NaCl was added to a final concentration of 0.9%, resulting in aggregation of the 
membrane fractions into a gelatinous phase, which was removed by centrifugation for 15 min at 
9500 g. The supernatant containing Hb was supplemented with 1 mM EDTA and bubbled with 
CO for 5 min. After adjusting the pH to 6.9, the hemolysate was applied to an SP Sepharose Fast 
Flow column (GE Healthcare) equilibrated with 10 mM NaH2PO4, 1 mM DTT, pH 6.9, and Hb 
was eluted with 10 mM Tris-HCl, pH 8.5. The fractions containing Hb were pooled, 
supplemented with 1 mM EDTA, and bubbled with CO for 5 min. Subsequently, the sample was 
applied to a Q Sepharose Fast Flow column (GE Healthcare) equilibrated with 10 mM Tris-HCl, 
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pH 8.5. Pure Hb was eluted with 30 mM NaH2 PO4, pH 6.9, with a yield of 100 mg of protein/ml 
of blood. Hb concentrations were determined using Drabkin’s reagent (Sigma).  
 
2.5.3 Electrospray Ionization Mass Spectrometry and Circular Dichroism 
Spectroscopy 
Purified human Hb and IsdH proteins were prepared in 10 mM ammonium acetate buffer 
at pH 6.9, subsequently mixed to concentrations of 10 and 20 µM, respectively, and incubated at 
25 °C for 1 h. MS measurements of protein samples were performed on a Waters Synapt G1 
QTOF mass spectrometer (Waters Corp., Milford, MA) [35]. The protein solutions were 
electrosprayed using Proxeon glass capillary nanoelectrospray emitters at flow rates between 30 
and 50 nl/min. Quantification of Hb and Hb-receptor complexes was performed based on the 
Waters Synapt data by comparing summed peak heights. Higher resolution mass spectrometry 
experiments were performed using a 15-tesla Fourier transform ion cyclotron resonance 
instrument (SolariX hybrid Qq-FTMS, Bruker Daltonics, Billerica, MA). Circular dichroism 
spectra of 0.2 mg/ml IsdBlinker and IsdHlinker in 10 mM NaH2PO4, 50 mM NaF, pH 6.8, were 
recorded on a JASCO J-715 spectropolarimeter (JASCO Corp.) at 25 °C with a scan rate of 20 
nm/min.  
 
2.5.4 Heme Transfer Kinetics and Affinity Measurements 
Heme transfer reactions from Hb to IsdBN1N2 and various IsdH protein constructs were 
monitored by following absorbance changes using a conventional spectrophotometer (Shimadzu 
UV-1700 PharmaSpec), as described previously [14]. Human hemoglobin was purchased from 
Sigma and dissolved in 20 mM NaPO4, pH 7.5, 150 mM NaCl. Briefly, 1 µM holo-Hb (expressed 
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in tetrameric units) was mixed with 10 µM apo-receptor protein in 20 mM NaPO4, pH 7.5, 150 
mM NaCl. Entire absorbance spectra were recorded for hemin transfer from holo-Hb to apo- 
IsdHN2N3overtime. To compare the heme transfer rates from Hb to the various acceptor proteins, 
changes in absorbance at 371 and 406 nm were recorded over time at 25 °C for up to 2 h. 
Apparent rate constants for the heme transfer reactions were obtained by fitting the time courses 
of the absorbance changes A406 –371 to single or double exponential curves with Sigma-Plot 
(Systat Software Inc.). Affinities of IsdHN3 and IsdHN2N3 for heme were determined by 
fluorescence spectroscopy as described [38].  
 
2.5.5 NMR Spectroscopy and Solution Structure Determination 
NMR spectra of IsdHlinker were acquired at 25 °C on cryoprobe-equipped Bruker Avance 
500-, 600-, and 800-MHz spectrometers. Backbone and side-chain chemical shift assignments 
were obtained by analyzing the following experiments: 1H,15N HSQC, HNCO, HN(CA)CO, 
HNCACB, HNCA, CBCA- (CO)NH, 15N-edited TOCSY, HNCA, HNHA, HNHB, HBHA- 
(CO)NH, CC(CO)NH, HCCH-TOCSY, HCCH-COSY, 15N- edited NOESY, and 13C-edited 
NOESY [reviewed in Ref. 39]. TALOS was used to obtain a majority of the and dihedral angle 
restraints [40]. Additional dihedral angle restraints were obtained by analyzing HNHA spectra 
[41]. Stereo-specific assignments of methylene protons were obtained by analyzing HNHB and 
15N-edited TOCSY spectra. Distance constraints were identified in three-dimensional 15N- and 
13C-edited NOESY spectra with mixing times of 125 and 130 ms, respectively. NMR spectra 
were processed using NMRPipe and analyzed using the CARA and PIPP software packages [42, 
43]. The program UNIO was used for automated NOE assignments and structure determination 
of IsdHlinker [44]. The NOESY data were manually inspected to verify all NOE assignments and 
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identify additional NOE restraints. The structures were improved by iterative rounds of structure 
calculations in which hydrogen bond restraints, backbone torsion angle restraints obtained from 
the program TALOS, and side-chain torsion angle restraints were added [45]. A final set of 100 
conformers was generated with a standard simulated annealing protocol, as implemented in the 
program NIH-XPLOR, of which 51 had no NOE, dihedral angle, or scalar coupling violations 
greater than 0.5 Å, 5°, or 2 Hz, respectively [46]. Of these, the 20 conformers with lowest overall 
energy were chosen to represent the structure of IsdHlinker. The quality of the structural ensemble 
was evaluated with PROCHECK and visualized with PyMOL [47, 48]. Statistics for the linker 
structure are presented in Table 2.1. Details on the NMR experiments used to obtain the 
backbone chemical shifts of IsdHN2N3(Y642A) have been described [36]. 1DNH residual dipolar 
couplings were measured using protein samples partially aligned in PEG C12E5/hexanol using 
two-dimensional 15N-coupled IPAP 1H-15N HSQC experiments. Steady-state 15N heteronuclear 
NOE values for the IsdHlinker and IsdHN2N3(Y642A) were acquired on cryoprobe-equipped Bruker 
Avance 600- and 800-MHz spectrometers, respectively. The heteronuclear NOE experiments 
were carried out in an interleaved manner, with and without proton saturation, and analyzed 
using the program SPARKY [49].  
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2.6 Tables and Figures 
 
 
 
 
N3 domain. Interestingly, comparison of the secondary chem-
ical shifts suggests that helix !3 in the linker domain is length-
ened at its C terminus when it is incorporated into IsdHN2N3
(Fig. 8B). Moreover, residues immediately following this seg-
ment, based on their secondary chemical shifts, do not partici-
pate in regular secondary structure when located in IsdHN2N3
but are nevertheless highly ordered, based on the heteronuclear
NOE data (Fig. 8A). To further ascertain whether the domains
in IsdHN2N3 might be significantly interacting with one
another in IsdHN2N3, we produced 15N samples of IsdHN2
and IsdHN3. The 1H-15N HSQC spectrum of IsdHN2 is well
resolved and, when overlaid with the spectrum of IsdHN2N3,
reveals very similar chemical shifts (data not shown). This
suggests that, in the context of IsdHN2N3, the N2 domain
does not contain a large contact surface that interacts with
the remainder of the protein. A similar analysis using 15N-
labeled IsdHN3 was also attempted but did not prove fruitful
because the cross-peaks in its spectrum are partially broad-
ened, presumably because of protein aggregation. Com-
bined, the absence of extensive interaction surfaces in the
linker and N2 domains suggests that, while ordered,
IsdHN2N3 does not adopt a compact structure.
DISCUSSION
To successfully mount an infection, S. aureus and other
pathogens acquire the essential nutrient iron from human Hb.
Two surface-displayed S. aureus receptors capture Hb on the
cell surface, IsdB and IsdH. The receptors share a high degree of
sequence homology over a region that contains two NEAT
domains that are separated by a !70-amino acid “linker” seg-
ment (Figs. 1A and 2). The NEAT domains in the conserved
units have distinct functions; in each protein, the N-terminal
domain binds to Hb, and the C-terminal domain interacts with
heme (8, 38). Interestingly, the NEAT domains in IsdB appear
to function synergistically, because Lei and colleagues (14) have
shown that IsdB captures heme fromHb!28–250 times faster
than proteins that contain only a single NEAT domain. To gain
insight into the molecular basis of this synergy, we studied
the conserved bi-NEAT domain unit located within IsdH
(IsdHN2N3). UV-visible spectroscopy measurements of heme
transfer from Hb indicate that IsdHN2N3 rapidly acquires the
heme of Hb at a rate that is 110–580 times faster than the rate
at which Hb spontaneously releases heme into the solvent
(IsdHN2N3 acquires heme at a rate of 0.048" 0.001 s#1, whereas
the ! and " subunits in tetrameric Hb release heme into the
solvent at a rate of!0.000083 and!0.00042 s#1, respectively)
(34). IsdB and IsdHN2N3 capture heme fromHb at a similar rate,
compatible with both proteins forming a receptor-Hb complex
in which heme is actively removed. These transfer rates may be
slower if the heme iron in Hb is in its reduced state, because
IsdHN3 has been shown to bind ferric heme more tightly than
ferrous heme (60). Systematic dissection of IsdHN2N3 into its
components indicates that itsNEATdomains need to be part of
the same polypeptide chain in order to rapidly acquire heme
from Hb. Moreover, a linker with a specific structure and size
FIGURE 7.NMR solution structure of IsdHlinker. A, cross-eyed stereo view rep-
resentation of the ensemble of 20 lowest energy structures. The coordinates
were superimposedby aligning the backboneN, C!, and C$ atoms of residues
Val470–Asp531. B, ribbon diagram of the structured part encompassing resi-
dues Val470–Asp531 of the lowest energy conformer of IsdHlinker. The view on
the left is in a similar orientation as shown in B, whereas the structure on the
right has been rotated by 90°. The ! helices are labeled !1–!3. C, location of
the residues of the hydrophobic core of IsdHlinker. A ribbon diagram of the
structuredpart encompassing residuesVal470–Asp531 of the linker structure is
shown. The nine residues that form the hydrophobic core are indicated, and
heavy atoms of their side chains are shown in stick representation.
TABLE 1
Structural statistics for the solution structure of IsdH linker domain
The notation of the NMR structures is as follows. %SA& are the final 20 simulated
annealing structures; (SA) is the average energy-minimized structure. The number
of terms for each restraint is given in parentheses.
%SA&a (SA)
Root mean square. deviations
NOE interproton distance restraints (Å) (1469) 0.046" 0.002 0.051
Dihedral angle restraints (degrees)b (118) 0.072" 0.099 0.306
3JHNa coupling constants (Hz) (54) 0.532" 0.018 0.543
Secondary 13C shifts (ppm)
13C! (76) 1.212" 0.206 1.26713C" (76) 0.816" 0.206 0.791
Deviations from idealized covalent geometry
Bonds (Å) 0.0044" 0.0002 0.0174
Angles (degrees) 0.623" 0.028 1.538
Impropers (degrees) 0.492" 0.031 1.181
PROCHECK results (%)c
Most favorable region 96.7" 2.8 96.7
Additionally allowed region 3.3" 2.8 3.3
Generously allowed region 0.0" 0.0 0.0
Disallowed region 0.0" 0.0 0.0
Coordinate precision (Å)d
Protein backbone 0.42" 0.10
Protein heavy atoms 0.87" 0.07
a None of the structures exhibits distance violations greater than 0.5 Å, dihedral
angle violations greater than 5°, or coupling constant violations greater than 2
Hz.
b Experimental dihedral angle restraints comprised 48 #, 48 $, and 16 %1 angles.
c PROCHECK-NMR data include residues Val470–Val531 of the linker domain.
d The coordinate precision is defined as the average atomic root mean square de-
viation of the 20 individual simulated annealing structures and their mean coor-
dinates. The reported values are for residues Val470–Val531 of the linker domain.
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Figure 2.1 A homolog bidomain unit for heme capture in IsdH and IsdB  
(A) Schematic of the NEAT domains present in S. aureus IsdH and IsdB. NEAT domains 
binding to Hb or heme are colored in black/white or gray, respectively. Sequence identities of 
functionally homologous NEAT domains as well as the linker connecting them are indicated. (B) 
Spectral shifts as a function of time after mixing for the reaction of 1 µM holo-Hb with 10 µM 
apo-IsdHN2N3. Arrows indicate the increase and decrease in absorbance over time at 371and 406 
nm, respectively. (C) Time courses of DA406–371 for the heme transfer reaction from Hb to 
IsdHN2N3 or IsdBN1N2. The symbols and curves represent the observed data and the single-
exponential fitting curves, respectively, yielding heme transfer rates of 0.048 ± 0.001 s-1 and 
0.055 ± 0.001 s-1 for IsdHN2N3 and IsdBN1N2, respectively. 
ance increases and decreases, respectively. A kinetic analysis of
the heme transfer data indicates that IsdBN1N2 and IsdHN2N3
capture heme from Hb at similar rates, 0.055 ! 0.001 and
0.048! 0.001 s"1, respectively (Fig. 1C). These rates are similar
to those measured for intact IsdB and are up to 580 times faster
than the rate at which tetrameric Hb spontaneously releases
heme into the solvent, suggesting that heme tr nsfer to IsdB
and IsdH occurs via a MetHb-receptor complex (14, 34).
To determine if the NEAT domains within IsdH need to be
part of the same polyp ptide to rapidly extract heme, we me s-
ured the rate of heme transfer from MetHb to the isolated N3
domain in the presence and absence of the Hb binding N2
domain (Fig. 3,A andB). Comparedwith IsdHN2N3, the isolated
heme binding domain IsdHN3 (Leu544–Asp660) acquires heme
from MetHb very slowly, which is consistent with an indirect
transfer mechanism in which heme is first released from
MetHb into the solvent before it is acquired by IsdHN3 (Fig. 3B).
The addition of the MetHb binding IsdHN2 protein (Ala326–
Pro466) in trans to this transfer reaction fails to increase the rate
of heme transfer from MetHb to IsdHN3 (Fig. 3B, N2 # N3).
This indicates that IsdHN2 binding to MetHb itself does not
perturb its structure so as to promote heme release and subse-
quent capture by the isolated N3 domain. The presence of the
N2 domain also does not significantly alter the heme binding
affinity of the N3 domain within IsdHN2N3, because IsdHN2N3
and IsdHN3 bind hemewith similar affinities,KD values of 3.2!
0.7 and 3.4 ! 0.6 !M, respectively (Fig. 4). Combined, these
data strongly suggest that the N2 and N3 domains of IsdH
need to reside within the same polypeptide to efficiently cap-
ture heme from Hb. Because IsdB contains this conserved
unit, its NEAT domains also presumably synergistically
extract heme (Fig. 2).
The NEAT Domains within IsdH and IsdB Are Connected by
a Functionally ImportantHelical Linker—The$70-amino acid
linker segments that connect the NEAT domains in IsdB and
IsdH share 70% sequence identity (Fig. 2). To investigate their
structure, we purified polypeptides containing this segment
from IsdB (IsdBlinker, Ser263–Ser361) and IsdH (IsdHlinker,
Pro466–Val564). Their circular dichroism (CD) spectra indicate
that IsdBlinker and IsdHlinker adopt a helical conformation,
which is evident by negative bands in their CD spectra at 222
and 208 nm and a positive band at 193 nm (Fig. 5A). This is
consistent with secondary structure predictions, which pro-
pose that amino acids in this region form several "-helices. To
explore the functional role of the linker domain in IsdH, UV-
visible absorbance spectroscopy was used to follow heme cap-
ture from MetHb. IsdHlinker was unable to acquire heme from
MetHb (Fig. 3B). Moreover, the presence of IsdHlinker and
IsdHN2 did not accelerate the rate at which IsdHN3 captures
heme fromMetHb (Fig. 3C, N2# linker# N3). This indicates
that the isolated components of the conserved unit in IsdH are
unable to associate with one another via non-covalent interac-
tions to forma fully functioning receptor. To further investigate
the function of the linker, polypeptides in which the linker was
fused to either the N2 (IsdHN2-linker, Ala326–Gln543) or N3
(IsdHlinker-N3, Leu544–Asp660) domains were studied. Slow
transfer from MetHb to the isolated N3 domain was observed
when IsdHN2-linker was added in trans, indicating that MetHb
binding by IsdHN2-linker did not significantly promote heme
release and subsequent capture by IsdHN3. Similarly,
IsdHlinker-N3 captures heme slowly from MetHb in either the
presence or absence of IsdHN2, indicating that the presence of
the helical linker does not influence the N3 domain’s ability to
scavenge heme (Fig. 3C). To determine if the structure of the
linker is important for function, we studied IsdHN2-GS-N3,
which replaces the linker with a nine-residue glycine- and ser-
ine-rich polypeptide (GSGSGSGSG). Spectroscopic measure-
ments eveal that IsdHN2-GS-N3 captures heme slowly from
MetHb at a rate that is similar to that of the isolatedN3 domain
FIGURE 1. A homolog bidomain unit for heme capture in IsdH and IsdB.
A, schematic of the NEAT domains present in S. aureus IsdH and IsdB. NEAT
domains binding to Hb or heme are colored in black/white or gray, respec-
tively. Sequence identities of functionally homologous NEAT domains aswell
as the linker connecting them are indicated. B, spectral shifts as a function of
time after mixing for the reaction of 1 !M holo-Hb with 10 !M apo-IsdHN2N3.
Arrows indicate the increase anddecrease in absorbanceover time at 371 and
406 nm, respectively. C, time courses of%A406–371 for the heme transfer reac-
tion from Hb to IsdHN2N3 or IsdBN1N2. The symbols and curves represent the
observed data and the single-exponential fitting curves, respectively, yield-
ing heme transfer rates of 0.048 ! 0.001 s"1 and 0.055 ! 0.001 s"1 for
IsdHN2N3 and IsdBN1N2, respectively.
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Figure 2.2 Alignment of IsdH and IsdB  
A primary sequence alignment of IsdH (Q99TD3) and IsdB (Q7A656) was generated using 
ClustalW (69). Conserved residues are indicated by gray boxes. The predicted NEAT domains 
IsdHN1, IsdHN2/IsdBN1, and IsdHN3/IsdBN2 are highlighted by yellow, red, and green boxes, 
respectively. The IsdH and IsdB linker domains are indicated by blue boxes. 
 
(Fig. 3, compare B and C). Combined, these data indicate that
the NEAT domains in IsdB and IsdH are connected by a helical
linker, whose primary functi is to properly position the
domains so as to specifically facilitate heme transfer from
MetHb to the N3 domain.
IsdH Destabilizes Hb to Promote Heme Release—We used
ESI-mass spectrometry to investigate the mechanism through
which IsdH accelerates heme release from Hb. ESI-MS allows
the quantification of differentHboligomers in the presence and
absence of IsdH (55). Hb consists of !- and "-globin chains
each bound to a heme. The globins assemble into a noncova-
lently bound (!")2 tetramer that dissociates into (!") dimers
with a dissociation constant (KD) of 2 #M (56). This is evident
from the ESI-MS spectrum of a 10 #M solution of Hb; from the
ratio of the signal from the dimer and tetramer ions, the dimer/
tetramer ratio is 1:1.4. This is consistent with previously
reported studies (57, 58) and validates the use of ESI-MS to
estimate the relative abundances of Hb species. ESI-MS spectra
of Hb were acquired in the presence or absence of either wild-
type IsdHN2N3, IsdHN2-GS-N3, or IsdHN2N3(Y642A), which con-
tains a Y642A mutation in the N3 domain that disrupts heme
binding (Fig. 6, A–D). In all of the experiments, the receptors
were present at a 2-fold molar excess relative to Hb (expressed
in tetrameric units). The ESI-MS data are summarized in Fig.
6E, which shows a histog am plot of th relativ abundances of
the various forms ofHb (the sumof themonomeric!- or"-glo-
b s (M); (!") dimer (D); and (!")2 tetramer (T)), as well as
receptor-bound forms of the (!")2 tetramer (T:R), and (!")
dimer (D:R). Incubation of IsdHN2N3 with Hb substantially
reduces the amount of dimeric and tetrameric Hb, which is
converted intomonomeric globins. This is consistent with pre-
vious studies that have shown that Hb dissociates into its com-
ponent globins upon heme removal (58, 59). Because substoi-
chiometric amounts of the receptor were used, Hb dissociation
is not complete, leavingmostly amixture of dimeric Hb and the
(!") dimer-receptor complex. Importantly, after the IsdHN2N3
addition, most of the Hb tetramer disappears, and very little
(!")2 tetramer-receptor complex is formed. This indicates that
receptor binding and/or heme removal significantly destabi-
lizes the tetramer.
FIGURE 2. Alignment of IsdH and IsdB. A primary sequence alignment of IsdH (Q99TD3) and IsdB (Q7A656) was generated using ClustalW (69). Conserved
residues are indicated by gray boxes. The predicted NEAT domains IsdHN1, IsdHN2/IsdBN1, and IsdHN3/IsdBN2 are highlighted by yellow, red, and green boxes,
respectively. The IsdH and IsdB linker domains are indicate by blue boxes.
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Figure 2.3 Heme transfer by various fragments of IsdH 
(A) A schematic of the different fragments of IsdH used for heme transfer experiments. (B) and 
(C) Time courses for the heme transfer reaction from 1 µM holo-Hb to 10 µM apo-IsdHN2N3. 
Various IsdH receptor fragments as well as combinations thereof and the linker deletion 
construct IsdHN2-GS-N3 are displayed. Heme transfer is followed by monitoring DA406–371 over 2 
min. 
 
To gain insight into the role of the linker and hemebinding in
the acquisition process, ESI-MS spectra ofHb in the presence of
IsdHN2-GS-N3 or IsdHN2N3(Y642A) were acquired. Unlike the
wild-type receptor, when the IsdHN2-GS-N3 linker mutant is
incubated with Hb, the majority of the receptor binds to the
(!")2 tetramer to form a (!")2-IsdHN2-GS-N3 complex, and a
significant fraction of the tetramer remains intact (Fig. 6E).
Moreover, smaller amounts of Hb are converted to its mono-
meric globins, whereas roughly similar amounts of (!") dimer
and (!") dimer-receptor complex are present. The absence of
monomeric globins is compatible with the kinetic data that
showed that IsdHN2-GS-N3 extracted heme from Hb ineffi-
ciently. The fact that the linker mutant does not disrupt the
tetramer suggests that it adopts a unique structure as compared
with the wild-type protein, such that the mutant receptor can
no longer impart sufficient structural strain to rupture the
tetramer. To determine if the receptor needs to bind heme in
order to dissociate the Hb tetramer, we studied
IsdHN2N3(Y642A), which contains a Y642A mutation in the N3
domain that disrupts heme binding. When Hb is incubated
with IsdHN2N3(Y642A), the amount of tetrameric Hb is signifi-
cantly reduced as a result of its conversion into the (!")-
IsdHN2N3(Y642A) complex. However, only small amounts of
monomeric globin are produced. This suggests that heme
removal from the tetramer by the receptor is not required to
dissociate it into its dimeric state. However, heme removal
appears to be required to convert Hb into its monomeric units.
A working model of the extraction process is presented under
“Discussion.”
Structure of the Linker Domain—To gain a better under-
standing of themolecular basis of heme capture, we determined
the NMR solution structure of IsdHlinker (Protein Data Bank
accession code 2LHR). The NMR spectra of IsdHlinker are well
resolved, enabling nearly complete 1H, 13C, and 15N resonance
assignments (Fig. 5B). A total of 1793 experimentally derived
restraints were used to determine the structure, including 1469
interproton distance restraints, 118 dihedral angle restraints,
54 3JHN! restraints, and 152 13C secondary shift restraints. An
ensemble of 20 conformers representing the structure of
IsdHlinker is displayed in Fig. 7A. The structure iswell defined by
theNMRdata; the backbone and heavy atom coordinates of the
structured residues Val470–Val531 can be superimposed with a
root mean square deviation of 0.42 ! 0.10 and 0.87 ! 0.07 Å,
respectively (experimental and structural parameters are pre-
sented in Table 1).
The linker forms a three-helix bundle that is composed of
helices !1 (Asp471–Lys486), !2 (Leu490–Lys503), and !3
FIGURE 3. Heme transfer by various fragments of IsdH. A, a schematic of
the different fragments of IsdH used for heme transfer experiments. B and
C, time courses for the heme transfer reaction from 1 #M holo-Hb to 10 #M
apo-IsdHN2N3. Various IsdH receptor fragments as well as combinations
thereof a d the linker deletion construct IsdHN2-GS-N3 are displayed. Heme
transfer is followed by monitoring "A406–371 over 2 min.
FIGURE 4.Heme binding properties of IsdHN3 and IsdHN2N3. Protoporphy-
rin binding of IsdHN3 (A) or IsdHN2N3 (B) was measured following zinc-proto-
porphyrin IX fluorescence as a function of protein concentration (38). The
solid lines represent best fits of the data yielding dissociation constants (KD) of
3.4! 0.6 #M and 3.2! 0.7 #M for IsdHN3 and IsdHN2N3, respectively.
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Figure 2.4 Heme binding properties of IsdHN3 and IsdHN2N3 
Protoporphyrin binding of IsdHN3 (A) or IsdHN2N3 (B) was measured following zinc-
protoporphyrin IX fluorescence as a function of protein concentration (38). The solid lines 
represent best fits of the data yielding dissociation constants (KD) of 3.4 ± 0.6 µM and 3.2 ± 0.7 
µM for IsdHN3 and IsdHN2N3, respectively.  
 
 
To gain insight into the role of the linker and hemebinding in
the acquisition process, ESI-MS spectra ofHb in the presence of
IsdHN2-GS-N3 or IsdHN2N3(Y642A) were acquired. Unlike the
wild-type receptor, when the IsdHN2-GS-N3 linker mutant is
incubated with Hb, the majority of the receptor binds to the
(!")2 tetramer to form a (!")2-IsdHN2-GS-N3 complex, and a
significant fraction of the tetramer remains intact (Fig. 6E).
Moreover, smaller amounts of Hb are converted to its mono-
meric globins, whereas roughly similar amounts of (!") dimer
and (!") dimer-receptor complex are present. The absence of
monomeric globins is compatible with the kinetic data that
showed that IsdHN2-GS-N3 extracted heme from Hb ineffi-
ciently. The fact that the linker mutant does not disrupt the
tetramer suggests that it adopts a unique structure as compared
with the wild-type protein, such that the mutant receptor can
no longer impart sufficient structural strain to rupture the
tetramer. To determine if the receptor needs to bind heme in
order to dissociate the Hb tetramer, we studied
IsdHN2N3(Y642A), which contains a Y642A mutation in the N3
domain that disrupts heme binding. When Hb is incubated
with IsdHN2N3(Y642A), the amount of tetrameric Hb is signifi-
cantly reduced as a result of its conversion into the (!")-
IsdHN2N3(Y642A) complex. However, only small amounts of
monomeric globin are produced. This suggests that heme
removal from the tetramer by the receptor is not required to
dissociate it into its dimeric state. However, heme removal
appears to be required to convert Hb into its monomeric units.
A working model of the extraction process is presented under
“Discussion.”
Structure of the Linker Domain—To gain a better under-
standing of themolecular basis of heme capture, we determined
the NMR solution structure of IsdHlinker (Protein Data Bank
accession code 2LHR). The NMR spectra of IsdHlinker are well
resolved, enabling nearly complete 1H, 13C, and 15N resonance
assignments (Fig. 5B). A total of 1793 experimentally derived
restraints were used to determine the structure, including 1469
interproton distance restraints, 118 dihedral angle restraints,
54 3JHN! restraints, and 152 13C secondary shift restraints. An
ensemble of 20 conformers representing the structure of
IsdHlinker is displayed in Fig. 7A. The structure iswell defined by
theNMRdata; the backbone and heavy atom coordinates of the
structured residues Val470–Val531 can be superimposed with a
root mean square deviation of 0.42 ! 0.10 and 0.87 ! 0.07 Å,
respectively (experimental and structural parameters are pre-
sented in Table 1).
The linker forms a three-helix bundle that is composed of
helices !1 (Asp471–Lys486), !2 (Leu490–Lys503), and !3
FIGURE 3. Heme transfer by various fragments of IsdH. A, a schematic of
the different fragments of IsdH used for heme transfer experiments. B and
C, time courses for the heme transfer reaction from 1 #M holo-Hb to 10 #M
apo-IsdHN2N3. Various IsdH receptor fragments as well as combinatio s
thereof and the linker deletion construct IsdHN2-GS-N3 are displayed. Heme
transfer is followed by monitoring "A406–371 over 2 min.
FIGURE 4.Heme binding properties of IsdHN3 and IsdHN2N3. Protoporphy-
rin binding of IsdHN3 (A) or IsdHN2N3 (B) was measured following zinc-proto-
porphyrin IX fluorescence as a function of protein concentration (38). The
solid lines represent best fits of the data yielding dissociation constants (KD) of
3.4! 0.6 #M and 3.2! 0.7 #M for IsdHN3 and IsdHN2N3, respectively.
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Figure 2.5 The IsdH and IsdB linkers fold into soluble a-helical domains 
(A) Far UV-CD spectra of the linker domains of IsdH (solid) and IsdB (dashed).The strongly 
negative CD signals with minima around 208 and 222 nm are indicative of a-helical proteins. 
(B) 1H-15N HSQC spectrum of 1.1 mM 15N-labeled IsdHlinker acquired at 800 MHz. The amino 
(Glu506–Ala530) (Fig. 7B). In the bundle, the long axes of the
helices are co-linear and are connected by short reverse turns.
The structure is stabilized by a hydrophobic core that is formed
by nine leucine and tyrosine residues (Leu477, Leu480, Leu481,
Tyr484, Leu497, Leu500, Leu504, Tyr508, and Tyr512; Fig. 7C).
Although each helix contributes residues to the hydrophobic
core, helix !3 is longer than the other helices, such that its C
terminus projects from the bundle. This region and residues
immediately following it presumably facilitate interactionswith
the N3 domain in the intact receptor (see below). {1H}15N het-
eronuclear NOE measurements are compatible with the struc-
ture because residues Val470–Val531, whose coordinates are
precisely defined in the ensemble, exhibit largemagnitudeNOE
values, indicating that they are immobile on the picosecond
time scale (Fig. 5C).
IsdHN2N3 Adopts an Extended but Ordered Multidomain
Structure—We used NMR to investigate the structure and
dynamics of IsdHN2N3(Y642A). It is structurally identical to the
wild-type protein based on its HSQC spectrum but is reduced
in its ability to bind heme. Previously, we sequence-specifically
assigned the chemical shifts of its backbone atoms (36). To
learn whether the domains form a rigid unit within
IsdHN2N3(Y642A), we measured {1H}15N heteronuclear NOE
relaxation parameters. As shown in Fig. 8A, residues spanning
the N2, linker, and N3 domains exhibit positive and mostly
uniform {1H}15N heteronuclear NOEs, which indicates that
they are structurally ordered. Notably, residues that connect
the domains also exhibit positive NOEs. Because some of these
residues are unstructured in the isolated linker polypeptide
(Fig. 5C), this suggests that in the context of IsdHN2N3(Y642A),
they form stabilizing interactions with residues located in the
N2 and/or N3 domains and that the domains form a single
structured unit.
Although the structure of the full receptor is unknown, the
structures of the isolated linker and N3 domains are known,
and the structure of the N2 domain can be accurately modeled
using the previously determined NMR and crystal structures of
IsdHN1, which shares 54% sequence identity with N2 (50, 51,
53). To determine whether the domains undergo major struc-
tural changes upon incorporation into IsdHN2N3, we measured
15N-1H residual dipolar couplings (1DNH RDCs) in a sample of
IsdHN2N3 partially aligned in pentaethylene glycol monodode-
cyl ether (C12E5 PEG)/hexanol. The 1DNH data provide infor-
mation about the angle of each backbone N–H bond relative to
an alignment tensor. The compatibility of the individual
domain structures with the RDC data was evaluated by plotting
the back-calculated versus experimental 1DNH values (Fig. 9).
There is good agreement between the experimental data and
the individual structures of the N2, linker, and N3 domains,
which have calculatedQ-factors of 0.28, 0.10, and 0.23, respec-
tively. This indicates that incorporation of the domains into
IsdHN2N3 does not significantly alter their structure and is con-
sistent with our previously reported C! and C" backbone sec-
ondary chemical shifts of IsdHN2N3, which suggested that the
domains have similar secondary structures in isolation and
when incorporated into IsdHN2N3 (36).
The chemical shifts of IsdHN2N3(Y642A) and polypeptides
containing its isolated domains were compared with the aim of
FIGURE 5. The IsdH and IsdB linkers fold into soluble !-helical domains.
A, far-UVCDspectraof the linkerdomainsof IsdH (solid) and IsdB (dashed). The
strongly negative CD signals with minima around 208 and 222 nm are indic-
ative of !-helical proteins. B, 1H-15N HSQC spectrum of 1.1 mM 15N-labeled
IsdHlinker acquired at 800 MHz. The amino acid assignment for each cross-
peak is indicated with one-letter code and residue number. Amide #NH2 of Asn
and $NH2 of Gln are connected by lines and denoted as sc for side chain. An
asterisk indicates the cross-peak from the %NH of Arg520, which was folded in
the 15N dimension. C, {1H}-15N heteronuclear NOE data of the IsdHlinker. The
peak intensity ratio between spectra with and without 1H saturation as a
function of the residue number is shown. The average heteronuclear NOE
values and S.D. values of two experiments are displayed, and the location of
the three !-helices is indicated at the top.
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acid assignment for each cross-peak is indicated with one-letter code and residue number. Amide 
dNH2 of Asn and gNH2 of Gln are connected by lines and denoted as sc for side chain. An 
asterisk indicates the cross-peak from the eNH of Arg520, which was folded in the 15N 
dimension. (C) {1H}-15N heteronuclear NOE data of the IsdHlinker. The peak intensity ratio 
between spectra with and without 1H saturation as a function of the residue number is shown. 
The average heteronuclear NOE values and S.D. values of two experiments are displayed, and 
the location of the three a-helices is indicated at the top. 
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Figure 2.6 The IsdH and IsdB linkers fold into soluble a-helical domains 
ESI-MS analysis of Hb dissociation by the IsdH receptor. Positive MS spectra are shown for 10 
µM Hb (A) and 10 µM Hb in the presence of either 20 µM IsdHN2N3 (B), IsdHN2-GS-N3 (C), or 
IsdHN2N3(Y642A) (D). The most prominent peaks corresponding to monomeric, dimeric, or 
learning if the domains interact with one another in the context
of IsdHN2N3(Y642A). Fig. 8B shows an overlay of the secondary
chemical shifts of IsdHN2N3(Y642A) and IsdHlinker. Similar sec-
ondary chemical shifts were observed for the structured part of
the linker, suggesting that its conformation is preserved in
IsdHN2N3(Y642A). Average chemical shift differences of the
backbone amide signals of isolated linker and the correspond-
ing residues in IsdHN2N3 are displayed in Fig. 8C. In general,
small chemical shift differences were observed for residues in
the core helices of the linker, indicating that they do not form a
molecular surface that interactswith theN2 or theN3domains.
However, significant chemical shift differences in the linker
occur for residues located at the beginning of helix !2 (Leu490–
Arg492) and at its N terminus (Asp468-Glu472, Thr474–Tyr475)
and C terminus (Gln526–Ser529, Val531–Thr538, Thr540–
Gln543). Mapping these changes onto the NMR structure of the
linker reveals that they reside at distinct ends of the domain
(Fig. 8D). This is consistent with residues at the beginning of
helix !2 and the N terminus of the linker contacting the N2
domain, while residues at the C-terminal end interact with the
FIGURE 6. ESI-MS analysis of Hb dissociation by the IsdH receptor. Positive MS spectra are shown for 10 "M Hb (A) and 10 "M Hb in the presence of either
20 "M IsdHN2N3 (B), IsdHN2-GS-N3 (C), or IsdHN2N3(Y642A) (D). The most prominent peaks corresponding to monomeric, dimeric, or tetrameric Hb as well as their
complexeswith the receptor proteins are labeledby the indicated symbols. E, relative amounts of thedifferentHboligomeric states, IsdH receptor proteins, and
complexes thereof were quantified from ESI-MS spectrawhen 10"MHbwas added to either 20"M apo-IsdHN2N3 (black), 20"M apo-IsdHN2-GS-N3 (dark gray), or
20 "M apo-IsdHN2N3(Y642A) (light gray). 10 "M Hb was run as a control (white). M, monomer; D, dimer; DR, dimer-receptor complex; T, tetramer; TR, tetramer-
receptor complex.
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tetrameric Hb as well as their complexes with the receptor proteins are labeled by the indicated 
symbols. (E) relative amounts of the different Hb oligomeric states, IsdH receptor proteins, and 
complexes thereof were quantified from ESI-MS spectra when10µM Hb was added to either 20 
µM apo-IsdHN2N3 (black), 20 µM apo-IsdHN2-GS-N3 (dark gray), or 20 µM apo-IsdHN2N3(Y642A) 
(light gray). 10 µM Hb was run as a control (white). M, monomer; D, dimer; DR, dimer-receptor 
complex; T, tetramer; TR, tetramer-receptor complex. 
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Figure 2.7 NMR structure of IsdHLinker  
(A) cross-eyed stereo view representation of the ensemble of 20 lowest energy structures. The 
coordinates were superimposed by aligning the backbone N, Ca, and C’ atoms of residues 
Val470–Asp531. (B) ribbon diagram of the structured part encompassing residues Val470–
Asp531 of the lowest energy conformer of IsdHlinker. The view on the left is in a similar 
orientation as shown in B, whereas the structure on the right has been rotated by 90°. The 
a-helices are labeled a1– a3. (C) Location of the residues of the hydrophobic core of IsdHlinker. 
A ribbon diagram of the structured part encompassing residues Val470–Asp531 of the linker 
structure is shown. The nine residues that form the hydrophobic core are indicated, and heavy 
atoms of their side chains are shown in stick representation. 
N3 domain. Interestingly, comparison of the secondary chem-
ical shifts suggests that helix !3 in the linker domain is length-
ened at its C terminus when it is incorporated into IsdHN2N3
(Fig. 8B). Moreover, residues immediately following this seg-
ment, based on their secondary chemical shifts, do not partici-
pate in regular secondary structure when located in IsdHN2N3
but are nevertheless highly ordered, based on the heteronuclear
NOE data (Fig. 8A). To further ascertain w ether th domains
in IsdHN2N3 might be significantly interacting with one
another in IsdHN2N3, we produced 15N samples of IsdHN2
and IsdHN3. The 1H-15N HSQC spectrum of IsdHN2 is well
resolved and, when overlaid with the spectrum of IsdHN2N3,
reveals very similar chemical shifts (data not shown). This
suggests that, in the context of IsdHN2N3, the N2 domain
does not contain a large contact surface that interacts with
the remainder of the protein. A similar analysis using 15N-
labeled IsdHN3 was also attempted but did not prove fruitful
because the cross-peaks in its spectrum are partially broad-
ened, presumably because of protein aggregation. Com-
bined, the absence of extensive interaction surfaces in the
linker and N2 domains suggests that, while ordered,
IsdHN2N3 does not adopt a compact structure.
DISCUSSION
To successfully mount an infection, S. aureus and other
pathogens acquire the essential nutrient iron from human Hb.
Two surface-displayed S. aureus receptors capture Hb on the
cell surface, IsdB and IsdH. The receptors share a high degree of
sequence homology over a region that contains two NEAT
domains that are separated by a !70-amino acid “linker” seg-
ment (Figs. 1A and 2). The NEAT domains in the conserved
units have distinct functions; in each protein, the N-terminal
domain binds to Hb, and the C-terminal domain interacts with
heme (8, 38). Interestingly, the NEAT domains in IsdB appear
to function synergistically, because Lei and colleagues (14) have
shown that IsdB captures heme fromHb!28–250 times faster
than proteins that contain only a single NEAT domain. To gain
insight into the molecular basis of this synergy, we studied
the conserved bi-NEAT domain unit located within IsdH
(IsdHN2N3). UV-visible spectroscopy measurements of heme
transfer from Hb indicate that IsdHN2N3 rapidly acquires the
heme of Hb at a rate that is 110–580 times faster than the rate
at which Hb spontaneously releases heme into the solvent
(IsdHN2N3 acquires heme at a rate of 0.048" 0.001 s#1, whereas
the ! and " subunits in tetrameric Hb release heme into the
solvent at a rate of!0.000083 and!0.00042 s#1, respectively)
(34). IsdB and IsdHN2N3 capture heme fromHb at a similar rate,
compatible with both proteins forming a receptor-Hb complex
in which heme is actively removed. These transfer rates may be
slower if the heme iron in Hb is in its reduced state, because
IsdHN3 has been shown to bind ferric heme more tightly than
ferrous heme (60). Systematic dissection of IsdHN2N3 into its
components indicates that itsNEATdomains need to be part of
the same polypeptide chain in order to rapidly acquire heme
from Hb. Moreover, a linker with a specific structure and size
FIGURE 7.NMR solution structure of IsdHlinker. A, cross-eyed stereo view rep-
resentation of the ensemble of 20 lowest energy structures. The coordinates
were superimposedby aligning the backboneN, C!, and C$ atoms of residues
Val470–Asp531. B, ribbon diagram of the structured part encompassing resi-
dues Val470–Asp531 of the lowest energy conformer of IsdHlinker. The view on
the left is in a similar orientation as shown in B, whereas the structure on the
right has been rotated by 90°. The ! helices are labeled !1–!3. C, location of
the residues of the hydrophobic core of IsdHlinker. A ribbon diagram of the
structuredpart encompassing residuesVal470–Asp531 of the linker structure is
shown. The nine residues that form the hydrophobic core are indicated, and
heavy atoms of their side chains are shown in stick representation.
TABLE 1
Structural statistics for the solution structure of IsdH linker domain
The notation of the NMR structures is as follows. %SA& are the final 20 simulated
annealing structures; (SA) is the average energy-minimized structure. The number
of terms for each restraint is given in parentheses.
%SA&a (SA)
Root mean square. deviations
NOE interproton distance restraints (Å) (1469) 0.046" 0.002 0.051
Dihedral angle restraints (degrees)b (118) 0.072" 0.099 0.306
3JHNa coupling constants (Hz) (54) 0.532" 0.018 0.543
Secondary 13C shifts (ppm)
13C! (76) 1.212" 0.206 1.26713C" (76) 0.816" 0.206 0.791
Deviations from idealized covalent geometry
Bonds (Å) 0.0044" 0.0002 0.0174
Angles (degrees) 0.623" 0.028 1.538
Impropers (degrees) 0.492" 0.031 1.181
PROCHECK results (%)c
Most favorable region 96.7" 2.8 96.7
Additionally allowed region 3.3" 2.8 3.3
Generously allowed region 0.0" 0.0 0.0
Disallowed region 0.0" 0.0 0.0
Coordinate precision (Å)d
Protein backbone 0.42" 0.10
Protein heavy atoms 0.87" 0.07
a None of the structures exhibits distance violations greater than 0.5 Å, dihedral
angle violations greater than 5°, or coupling constant violations greater than 2
Hz.
b Experimental dihedral angle restraints comprised 48 #, 48 $, and 16 %1 angles.
c PROCHECK-NMR data include residues Val470–Val531 of the linker domain.
d The coordinate precision is defined as the average atomic root mean square de-
viation of the 20 individual simulated annealing structures and their mean coor-
dinates. The reported values are for residues Val470–Val531 of the linker domain.
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Figure 2.8 Interactions of IsdH linker with NEAT domains N2 and N3 
(A) {1H}-15N heteronuclear NOE data of IsdHN2N3. The peak intensity ratio between spectra with 
and without 1Hsaturation as a function of the residue number is shown. The average 
heteronuclear NOE values and S.D. values of two experiments are displayed. The domain 
boundaries of IsdHN2N3 and the location of predicted secondary structure elements are indicated 
at the top. (B) Comparison of the backbone conformations of the isolated IsdH linker region and 
the corresponding residues in IsdHN2N3. Chemical shift deviations of the linker (gray bars) and 
IsdHN2N3 (open bars) with respect to the corresponding random coil values are plotted versus 
amino acid residue number, after multiplication with a 1:2:1 weighing function for residues 
i-1/i/i +1 (70). Positive values for the chemical shift deviations Dd(Ca ) - Dd(Cb) are indicative 
of a helical conformation. (C) Average chemical shift differences of the backbone amide signals 
(CSP = DdH2 + (DdN/6.49)2)1⁄2) of isolated IsdHlinker and the linker in the context of the functional 
receptor IsdHN2N3. (D) Mapping of the perturbed residues on ribbon diagrams of the linker. The 
residues with CSP > 0.3 ppm are highlighted in red. 
that connects the domains is required for efficient heme cap-
ture; an IsdHN2-GS-N3 mutant in which the linker is replaced
with a glycine-serine nonapeptide acquires heme slowly
from Hb.
IsdHN2N3 adopts an ordered elongated dumbbell-shaped
structure in which its NEAT domains are separated by a helical
linke domain. TheNMR structure of the inker d main (called
IsdHlinker) reveals that it adopts a three-helix bundle. First
observed in the IgG-binding domain of S. aureus, three-helix
bundles serve as robust scaffolds for molecular recognition and
are ubiquitously found in structural proteins, enzymes, and
DNA-binding proteins (61, 62). Because the N and C termini in
IsdHlinker are positioned at opposite ends of the bundle, in the
context of the IsdHN2N3 receptor, the linker domain presum-
ably acts as a spacer that holds the N2 and N3 domains apart
from another by !40 Å. This is compatible with the assigned
NMRspectra of the intact 39-kDa IsdHN2N3 receptor, because a
comparison with the NMR spectra of IsdHlinker reveals that
only residues located at the ends of the helical bundle near the
connection points to the N2 and N3 domains exhibit large
chemical shift differences. Moreover, the NMR chemical shifts
of residues in the isolated IsdHN2 domain and IsdHN2N3 are
similar, suggesting that N2 is not involved in extensive interdo-
main intera tio s in the structure of IsdHN2N3. Interestingly,
although IsdHN2N3 adopts an elongated structure, the domains
do not appear to be connected by flexible loops. Inspection of
the heteronuclear NOE data of IsdHN2N3 reveals nearly uni-
form values over the length of the polypeptide, including amino
acids that connect the domains. Notably, several residues at the
N and C termini of the linker domain that are unstructured in
the isolated IsdHlinker become ordered when they are located in
IsdHN2N3 (in Is HN2N3, 2 and 11 sidu s pr ceding and follow-
ing the linker domain, respectively, exhibit elevatedNOEvalues
in IsdHN2N3 as compared with IsdHlinker). Thus, the three
do ains within IsdHN2N3 adopt an extended conformation in
which their positioning is fixed with respect to one another.
IsdB can be assumed to adopt a similar structure because it
shares significant sequence homology with IsdHN2N3, and we
have shown that its linker region also adopts a helical
conformation.
From the ESI-MS data, IsdHN2N3 extracts heme fromHb via
the ordered process shown in Fig. 10A. On the cell surface, IsdB
and IsdH can be expected to encounter Hb in its (!")2 tetra-
meric and !" dimeric forms, whose relative abundance
depends on protein concentration. When IsdHN2N3 binds to
the (!")2 tetramer, it promotes its dissociation into !" dimers,
which is presumably caused by receptor-induced steric strain
that ruptures the weaker !1"2 interface of the tetrameric Hb
(63). Dimer formation is expect d to facilitate heme transfer to
IsdHN2N3 because dimeric Hb releases hememore readily than
FIGURE 8. Interactions of IsdH linker with NEAT domains N2 and N3. A, {1H}-15N heteronuclear NOE data of IsdHN2N3. The peak intensity ratio between
spectrawith andwithout 1H saturationas a functionof the residuenumber is shown. TheaverageheteronuclearNOEvalues andS.D. valuesof twoexperiments
are displayed. The domain boundaries of IsdHN2N3 and the location of predicted secondary structure elements are indicated at the top. B, comparison of the
backbone conformations of the isolated IsdH linker region and the corresponding residues in IsdHN2N3. Chemical shift deviations of the linker (gray bars) and
IsdHN2N3 (open bars) with respect to the corresponding random coil values are plotted versus amino acid residue number, after multiplication with a 1:2:1
weighing function for residues i " 1/i/i # 1 (70). Positive values for the chemical shift deviations $#(C!) " $#(C") are indicative of a helical conformation.
C, average chemical shift differences of the backbone amide signals (CSP% ($#H
2# ($#N/6.49)
2)1⁄2) of isolated IsdHlinker and the linker in the context of the
functional receptor IsdHN2N3. D, mapping of the perturbed residues on ribbon diagrams of the linker. The r sidues with CSP& 0.3 ppm are highlighted in red.
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Figure 2.9 Comparison of experimental and back-calculated RDC values 
of backbone amide protons in IsdHN2N3(Y642A) 
(A) Observed 1DNH RDCs for the N2 domain were plotted versus back-calculated RDCs from a 
homology model of IsdHN2. (B) Experimentally measured 1DNH RDCs for the linker domain 
were plotted versus back-calculated RDCs from the solution structure of the isolated linker. (C) 
observed 1DNH RDCs for the N3 domain were plotted versus back-calculated RDCs from the 
crystal structure of IsdHN3 (Protein Data Bank entry 2Z6F). The correlation factors, R2, are 
indicated in the plots. 
the (!")2 tetramer; compared with the tetramer, the rate of
heme loss from the ! and " chains in the isolated (!") dimer is
2 and 10 times faster, respectively (34). In the second step, heme
is transferred from the (!") dimer to the N3 domain within the
IsdHN2N3 receptor. Our data do not reveal which globin chain,
if any, serves as the preferred heme donor for IsdHN2N3. It is
possible that heme is first removed from the " subunit because
it has intrinsically weaker affinity for heme as compared with
the ! subunit (34). Alternatively, structural distortions induced
in the dimer by the receptormay trigger heme transfer from the
! chain, creating semi-" Hb from which heme is known to be
rapidly released (34). In the final step, after the loss of one of its
hememolecules, the (!") dimer dissociates completely. Forma-
tion of monomeric species is probably driven by the greater
tendency of Hb dimers to di sociate (59). As the monomeric !
and " chains quickly lose their heme to the environment, both
globins could be expected to readily release their ligand to IsdH
(34). A similar transfer reaction is expected to occur when IsdH
encounters an (!") Hb dimer, but it would bypass the need for
tetramer dissociation. An alternative heme transfer pathway is
also possible. In it, the receptor would remove heme directly
from the tetramer or concurrently with tetramer dissociation.
Heme removal from the tetramer could be advantageous
because it would produce semi-Hb tetramers that are prone to
dissociate (64). However, as described immediately below,
heme capture from the Hb tetramer is not an obligate step in
the transfer reaction.
FIGURE 9. Comparison of experimental and back-calculated RDC values
of backbone amide protons in IsdHN2N3(Y642A). A, observed 1DNH RDCs for
the N2 domain were plotted versus back-calculated RDCs from a homology
model of IsdHN2.B, experimentallymeasured 1DNHRDCs for the linker domain
were plotted versus back-calculated RDCs from the solution structure of the
isolated linker. C, observed 1DNH RDCs for the N3 domain were plotted versus
back-calculated RDCs from the crystal structure of IsdHN3 (Protein Data Bank
entry 2Z6F). The correlation factors R are indicated in the plots.
FIGURE 10. Model of heme extraction by IsdH. A, a model for the mecha-
nism of heme acquisition by the surface receptor IsdHN2N3. A schematic dia-
gram shows the binding equilibria involved in the extraction process. Wild-
type IsdHN2N3 binds to the ! chain of Hb promoting its dissociation into (!")
dimers. Heme acquisition by the receptor protein results in further dissocia-
tionofHb into itsmonomeric subunits. See “Discussion” for details.B, amodel
of IsdHN2N3 in complex with Hb. IsdHN2 (red) wasmodeled based on the solu-
tion structure of IsdHN1 (Protein Data Bank entry 2H3K). The complex model
with Hb was generated by superposition over the crystal structure of the
IsdHN1-Hb complex (Protein Data Bank entry 3SZK). A possible orientation of
the linker (blue) and IsdHN3 (green; Protein Data Bank entry 2Z6F) allowing
productive heme transfer from a Hb (!") dimer (yellow-orange) to IsdH is
indicated. The orientation of the subdomains (N1, linker, and N2) within
IsdHN2N3 has not been experimentally determined, and only one possible
orientation is shown. The protein backbones are shown as schematics. The
heme groups in Hb are shown in stick representation.
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Figure 2.10  Model of heme extraction by IsdH 
(A) A model for the mechanism of heme acquisition by the surface receptor IsdHN2N3. A 
schematic diagram shows the binding equilibria involved in the extraction process. Wild- type 
IsdHN2N3 binds to the a-chain of Hb promoting its dissociation into (ab) dimers. Heme 
acquisition by the receptor protein results in further dissociation of Hb into its monomeric 
subunits. See “Discussion” for details. (B) A model of IsdHN2N3 in complex with Hb. IsdHN2 
(red) was modeled based on the solution structure of IsdHN1 (Protein Data Bank entry 2H3K). 
The complex model with Hb was generated by superposition over the crystal structure of the 
IsdHN1-Hb complex (Protein Data Bank entry 3SZK). A possible orientation of the linker (blue) 
and IsdHN3 (green; Protein Data Bank entry 2Z6F) allowing productive heme transfer from a Hb 
(ab) dimer (yellow-orange) to IsdH is indicated. The orientation of the subdomains (N1, linker, 
and N2) within IsdHN2N3 has not been experimentally determined, and only one possible 
orientation is shown. The protein backbones are shown as schematics. The heme groups in Hb 
are shown in stick representation. 
the (!")2 tetramer; compared with the tetramer, the rate of
heme loss from the ! and " chains in the isolated (!") dimer is
2 and 10 times faster, respectively (34). In the second step, heme
is transferred from the (!") dimer to the N3 domain within the
IsdHN2N3 receptor. Our data do not reveal which globin chain,
if any, serves as the preferred heme donor for IsdHN2N3. It is
possible that heme is first removed from the " subunit because
it has intrinsically weaker affinity for heme as compared with
the ! subunit (34). Alternatively, structural distortions induced
in the dimer by the receptormay trigger heme transfer from the
! chain, creating semi-" Hb from which heme is known to be
rapidly released (34). In the final step, after the loss of one of its
hememol cules, the (!") dimer dissociates completely. Forma-
tion of monomeric species is probably driven by the greater
tendency of Hb dimers to dissociate (59). As the monomeric !
a d " chains q ickly lo e their heme to the environment, both
globins could be expected to readily release their ligand to IsdH
(34). A similar transfer reaction is expected to occur when IsdH
encounters an (!") Hb dimer, but it would bypass the need for
tetramer dissociation. An alternative heme transfer pathway is
also possible. In it, the receptor would remove heme directly
from the tetramer or concurrently with tetramer dissociation.
Heme removal from the tetramer could be advantageous
because it would produce semi-Hb tetramers that are prone to
dissociate (64). However, as described immediately below,
heme capture from the Hb tetramer is not an obligate step in
the transfer reaction.
FIGURE 9. Comparison of experimental and back-calculated RDC values
of backbone amide protons in IsdHN2N3(Y642A). A, observed 1DNH RDCs for
the N2 domain were plotted versus back-calculated RDCs from a homology
model of IsdHN2.B, experimentallymeasured 1DNHRDCs for the linker domain
were plotted versus back-calculated RDCs from the solution structure of the
isolated linker. C, observed 1DNH RDCs for the N3 domain were plotted versus
back-calculated RDCs from the crystal structure of IsdHN3 (Protein Data Bank
entry 2Z6F). The correlation factors R are indicated in the plots.
FIGURE 10. Model of heme extraction by IsdH. A, a model for the mecha-
nism of heme acquisition by the surface receptor IsdHN2N3. A schematic dia-
gram shows the binding equilibria involved in the extraction process. Wild-
type IsdHN2N3 binds to the ! chain of Hb promoting its dissociation into (!")
dimers. Heme acquisition by the receptor protein results in further dissocia-
tionofHb into itsmonomeric subunits. See “Discussion” for details.B, amodel
of IsdHN2N3 in complex with Hb. IsdHN2 (red) wasmodeled based on the solu-
tion structure of IsdHN1 (Protein Data Bank entry 2H3K). The complex model
with Hb was generated by superposition over the crystal structure of the
IsdHN1-Hb complex (Protein Data Bank entry 3SZK). A possible orientation of
the linker (blue) and IsdHN3 (green; Protein Data Bank entry 2Z6F) allowing
productive heme transfer from a Hb (!") dimer (yellow-orange) to IsdH is
indicated. The orientation of the subdomains (N1, linker, and N2) within
IsdHN2N3 has not been experimentally determined, and only one possible
orientation is shown. The protein backbones are shown as schematics. The
heme groups in Hb are shown in stick representation.
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3.1 Overview 
Staphylococcus aureus is a medically important bacterial pathogen that during infections 
acquires iron from human hemoglobin (Hb). It uses two closely related iron regulated surface 
determinant (Isd) proteins to capture and extract the oxidized form of heme (hemin) from Hb, 
IsdH and IsdB. Both receptors rapidly extract hemin using a conserved tri-domain unit consisting 
of two NEAr iron Transporter (NEAT) domains connected by a helical linker domain. To gain 
insight into the mechanism of extraction we used NMR to investigate the structure and dynamics 
of the 38.8 kDa tri-domain IsdH protein (IsdHN2N3, A326-D660 with a Y642A mutation that 
prevents hemin binding). The structure was modeled using long-range paramagnetic relaxation 
enhancement (PRE) distance restraints, dihedral angle, small angle x-ray scattering, residual 
dipolar coupling and inter-domain NOE data. The receptor adopts an extended conformation 
wherein the linker and N3 domains pack against each other via a hydrophobic interface. In 
contrast, the N2 domain contacts the linker domain via a hydrophilic interface, and based on 
NMR relaxation data undergoes inter-domain motions enabling it to reorient with respect to the 
body of the protein. Ensemble calculations were used to estimate the range of N2 domain 
positions compatible with the PRE data. A comparison of the Hb-free and -bound forms reveals 
that Hb binding alters the positioning of the N2 domain. We propose that binding occurs through 
a combination of conformational selection and induced fit mechanisms that may promote hemin 
release from Hb by altering the position of its F-helix.  
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3.2 Introduction 
Staphylococcus aureus causes a range of illnesses from minor skin infections, to life-
threatening diseases such as meningitis, pneumonia, osteomyelitis, endocarditis, toxic shock 
syndrome and septicemia [1]. In the United States S. aureus is a leading cause of life-threatening 
hospital and community acquired infections [2]. There is a growing need to understand the 
mechanism through which it causes disease as many strains of S. aureus have become resistant to 
conventional antibiotics, such as highly virulent methicillin-resistant strains of S. aureus 
(MRSA). S. aureus’ ability to replicate within its host is critically dependent on access to iron, 
since this metal functions as a key biocatalyst and/or electron carrier in microbial enzymes that 
mediate metabolism [3]. Free iron is scarce in the human body and must therefore be actively 
procured during infections [4]. Heme (protoporphyrin IX + iron) bound to human hemoglobin 
(Hb) contains ~75-80% of the body’s total iron content and is preferentially utilized by S. aureus 
[5]. An understanding of how S. aureus captures Hb and extracts its heme is therefore of 
fundamental importance and could potentiate the development of novel antimicrobial agents that 
work by disrupting heme acquisition.  
S. aureus acquires heme-iron from human Hb using nine iron-regulated surface 
determinant (Isd) proteins [6–8]. Four Isd proteins (IsdA, IsdB, IsdC, and IsdH/HarA) bind heme 
and are covalently linked to the peptidoglycan cell wall by sortase transpeptidases [9–11]. 
Biochemical and cellular localization studies suggest that heme capture and transfer across the 
cell wall is mediated by an ordered set of heme transfer reactions. In this process, IsdB and IsdH 
first bind Hb and extract its heme [10,12]. Heme is then passed from IsdB/IsdH to IsdA, which is 
partially buried within the cell wall. Next, IsdA passes heme to the IsdC protein, which has 
recently been shown to occur via a transient ultra-weak IsdA-IsdC heme transfer complex 
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[10,13–16]. Holo-IsdC then delivers the heme to the IsdDEF complex, a bacterial ABC 
transporter that pumps heme into the cytoplasm. Free iron is then obtained when the heme 
oxidase, IsdG (or its paralog IsdI), degrades heme [17,18]. Hb and heme binding by the IsdA, 
IsdB, IsdC, and IsdH proteins is mediated by NEAr iron Transporter (NEAT) domains. These 
conserved binding modules are ~125 residues in length and were originally named based on the 
location of their parent genes, which are typically proximal to genes encoding putative Fe3+ 
siderophore transporter genes [19]. NEAT domains adopt a conserved β-sandwich fold and 
depending upon the domain, can bind to distinct ligands, including heme, Hb, haptoglobin, and 
other host proteins [20–23]. Additionally, these domains are also found in other Gram-positive 
bacteria containing systems similar to the Isd system [19,24,25].  
The IsdB and IsdH surface receptors each contain a highly conserved tri-domain unit that 
rapidly extracts heme from Hb [26]. In IsdH, the tri-domain unit consists of the second (N2) and 
third (N3) NEAT domains that are connected by a helical linker domain (Figure 3.1a). The 
NEAT domains have distinct functions, N2 binds Hb, while the N3 domain binds to heme 
[20,22,27]. Heme extraction by the tri-domain occurs up to ~270 times faster than the rate at 
which Hb spontaneously releases heme into the solvent [26,28] (Figure 3.1b-d). All three 
domains are required for rapid heme extraction from Hb and must be located within the same 
polypeptide chain to function synergistically. IsdB likely operates through a similar mechanism 
as IsdH, since based on primary sequence homology it also contains the tri-domain unit that 
rapidly captures heme from Hb [14].  
To gain insight into the mechanism of heme extraction, Gell and colleagues recently 
reported a 4.2 Å crystal structure of oxidized Hb in complex with the tri-domain unit from IsdH 
(IsdHN2N3, residues A326-D660) [29]. In the crystal four IsdHN2N3 proteins bind to Hb, each 
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interacting with one of the globin chains. Each IsdHN2N3 protein adopts an extended 
conformation in which its N2 domain engages the A and E helices of the globin, while the linker 
domain positions the N3 domain near the heme molecule that is bound to the same globin chain. 
Because the structure was determined at low resolution, the mechanism through which IsdHN2N3 
triggers heme release is not well understood, and the structure of the intact receptor remains 
unknown because the structure of the peptide segments that join the three domains could not be 
determined. Moreover, the structure and dynamics of the receptor in its Hb-free state have yet to 
be determined, so it is not known if the receptor adopts a rigid, preformed binding surface for 
Hb, or if its domains flexibly reorient with respect to one another prior to engaging Hb. To 
address these issues we used solution state NMR and small angle x-ray scattering (SAXS) data to 
characterize the structure and dynamics of the 38.8 kDa tri-domain IsdHN2N3 protein in its Hb-
free state, providing insight into the mechanism of heme extraction.  
 
3.3 Results 
3.3.1 Rate of heme transfer from Hb to IsdHN2N3 
Previous studies have shown that IsdHN2N3 containing the N2 and N3 NEAT domains 
(38.8 kDa, residues A326 to D660 of IsdH) rapidly removes the oxidized form of heme 
(hereafter referred to as hemin) from Hb through a process that requires protein complex 
formation [26]. However, the rate constant describing the transfer reaction was not accurately 
defined because the kinetics were measured using a conventional UV-Vis instrument that failed 
to capture the early steps in the transfer process. To overcome this limitation, we re-measured the 
transfer kinetics using a stopped-flow UV-Vis spectrophotometer that has a significantly shorter 
dead time (dead time ~3 ms versus 5 s). Upon mixing methemoglobin (metHb) with excess apo-
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IsdHN2N3, a rapid shift in the UV absorbance spectrum of metHb is observed as hemin is 
transferred to apo-IsdHN2N3 (Figure 3.1b). Curve fitting of the time-dependent spectral changes 
reveals biphasic behavior with fast and slow rate constants of 0.85 ± 0.11 and 0.099 ± 0.14 s-1, 
respectively (Figure 3.1c). As a negative control similar experiments were performed using a 
mutant in which the linker domain is replaced with a glycine-serine nonapeptide, IsdHN2-GS-N3. 
As expected, it does not acquire hemin from metHb over the timeframe of the experiment 
indicating the linker domain plays a critical role in hemin capture [26]. When metHb is mixed 
with an excess of H64Y/V68F apo-Mb as a hemin scavenging agent, the rates of simple hemin 
release are much slower [30] (Figure 3.1d). As shown, simple thermal dissociation from metHb 
also shows a biphasic time course with a beta chain rate of ~ 0.003 s-1 and an alpha chain rate of 
~0.0002 s-1 [28]. The fast and slow phases of hemin transfer to apo-IsdHN2N3 may therefore 
correspond to hemin removal from the beta and alpha chains of metHb, respectively. Regardless 
of the exact interpretation, it is clear that the receptor dramatically accelerates the rate of hemin 
release from the beta and alpha subunits of metHb by ~250-500 fold.  
 
3.3.2 NMR relaxation measurements reveal the presence of motions between 
the N2 and linker domains  
To investigate the mobility of the receptor we quantitatively measured 15N relaxation 
parameters of IsdHN2N3 containing a Y642A mutation in the N3 domain that disrupts hemin 
binding. The 1H-15N HSQC spectrum of this protein is well resolved (Figure 3.2a) and the 
mutation does not significantly alter the structure of the protein (not shown) [31]. Unless 
otherwise indicated, all NMR and SAXS studies made use of this Y642A mutant of IsdHN2N3. 
For this protein 15N spin-spin (R2), 15N spin-lattice (R1) and {1H}-15N heteronuclear NOE 
 96 
relaxation parameters were measured for 155, 142, and 238 backbone amides, respectively 
(Figure 3.S1). The NMR relaxation data indicate that the domains within IsdHN2N3 
predominantly tumble as a single unit in solution. Measured R1 and R2 relaxation rate constants 
indicate that IsdHN2N3 has a molecular correlation time (tc) of 16.3 ± 0.1 ns, which is very similar 
to the predicted tc value for a spherical protein of similar molecular mass (Table 3.1). Moreover, 
each of the three component domains within IsdHN2N3 have tc values that are substantially larger 
than values predicted for the domains if they were to tumble independently of one-another. 
Specifically, the N2 and N3 domains within IsdHN2N3 have experimental tc values of 13.9 ± 0.1 
and 15.5 ± 0.1 ns, respectively. This indicates that they tumble as part of a larger unit, since 
significantly smaller tc values are predicted if they tumbled freely in solution. The NMR data 
also indicate that the intervening linker domain is part of the ordered unit that contains the N2 
and N3 domains. While its tc value could not be reliably determined from the relaxation data 
because the majority of its amide bond vectors are co-linear in the structure of this module, its 
15N R2 values have similar magnitudes as residues located in the surrounding N2 and N3 
domains, compatible with it being part of this ordered unit. 
Although the domains within IsdHN2N3 primarily tumble as a single unit, inter-domain 
motions enable the N2 domain to reorient with respect to the body of the protein. This is 
apparent from the experimentally determined tc value of the N2 domain, which is slightly 
smaller than the N3 domain’s tc. The N2 domain’s elevated mobility is further substantiated by 
the data shown in Figure 3.S1, which reveals that on average its residues have R2 and R1 values 
that are, respectively, slightly smaller and larger than residues located in the linker and N3 
domains. The ability of the N2 domain to reorient is also compatible with the structure of 
IsdHN2N3 as a hydrophilic interface connects it to the linker domain (vida infra). Several residues 
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connecting the domains (N465-E472 and V531-Q543) that were not determined in the crystal 
structure are ordered based on their relaxation data. Data for three residues located within the 
N2-linker connector are available for analysis (N465, D467, and V470) and are structured as 
they have R2 and NOE values of 21-37 s-1 and 0.67-0.90, respectively. Residues within the 
segment connecting the linker and N3 domains are similarly structured, as a total of 9 residues in 
this segment have R2 and NOE values of 22-43 s-1 and 0.73-0.90, respectively. 
The relaxation data also provided insight into the dynamics of the ligand binding surfaces 
within the N2 and N3 domains, which bind Hb and hemin, respectively. Both proteins use 
residues in the β7/β8 hairpin and a proximal 310 helix to bind their respective ligands. 
Interestingly, the Hb binding surface in N2 is disordered, while the hemin binding surface in N3 
is well-ordered. For example, after significant attempts were made, resonances for residues 
N358-D359, Q364-T370, K397-F399, A422, S439-S440, and Y451-T454 in N2 could not be 
assigned in the NMR spectra. These residues form the aromatic α-helix (H2) and portions of the 
β4, β6, β7, and β8 sheets in the Hb binding pocket, and presumably their absence in the NMR 
data is caused by fluctuations in their magnetic environment that occur on the micro- to milli-
second time scale. In contrast, the hemin binding pocket in N3 adopts an ordered conformation 
in its apo-state as the backbone amide resonances of its residues could be assigned, do not 
exhibit significant line-broadening, and nearly all have heteronuclear NOE values greater than 
0.8.  
 
3.3.3 Experimental restraints used to model the structure of apo-IsdHN2N3 
Resonance overlap caused by the large number of residues in IsdHN2N3 (335 amino acids) 
makes it difficult to determine its structure using conventional NOE-based NMR methods. We 
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therefore modeled the structure of the receptor using paramagnetic relaxation enhancement 
(PRE) derived distance restraints obtained from six single cysteine mutants of IsdHN2N3 that each 
contained a disulfide linked nitroxide spin label (R1, methanesulfonothioate) [32]. The samples 
have probes attached to each of the three domains: R363C (N2), E400C (N2), K499C (linker), 
E511C (linker), K528C (linker) and E559C (N3) (Figure 3.3). Probes were attached to residues 
whose side chains project into the solvent in the NMR and crystal structures of the isolated 
domains. The backbone atoms of these residues are also structured based on their NMR 
relaxation data and the attached probes do not significantly alter the NMR spectra of the receptor 
indicating that they do not perturb the structure of the receptor. The backbone assignments of 
unmodified IsdHN2N3 have been reported previously and were used to assign the 1H-15N HSQC 
spectra of each nitroxide labeled sample recorded in its paramagnetic (oxidized) and diamagnetic 
(reduced) states (Figure 3.2b). A comparison of the paramagnetic (Iox) and diamagnetic (Ired,) 
signal intensities reveal distance-dependent line-broadening of proximal amide protons. Figure 
3.3a summarizes the PRE data for each probe showing an extended representation of IsdHN2N3. 
Residues near each probe (Iox/Ired < 0.8) are colored green, while residues separated by more than 
20 Å (Iox/Ired ≥ 0.80) are colored red. All probes cause line-broadening in signals originating 
from proximal amide atoms located within the same domain. PRE-derived distance restraints 
were obtained as described in detail by Sattler and colleagues using an apparent molecular 
correlation time of 16 ns for the electron-nucleus vector [33–35]. Use of this correlation time 
provides good agreement with the probe-amide distances present in the known structures of the 
isolated domains (Figure 3.S2). As described by Clore and colleagues, in all calculations three 
conformers were used to represent the positioning of the probe to account for probe flexibility 
[36–38]. 
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The PRE-derived distance restraints were supplemented with several other types of 
experimental data. TALOS+ was used to obtain phi and psi dihedral angle restraints for residues 
within the polypeptide segments that connect the domains. Two sets of 1DHN residual dipolar 
couplings were used as domain orientational restraints and were measured for proteins aligned in 
either PEG/Hexanol or pf1 phage media. The rhombicity and magnitude of the alignment tensors 
were determined using the program by MODULE by best-fitting the RDC data to the known 
structures of the isolated N2 and N3 domains (the linker domain was not used to estimate the 
tensor values as its amide vectors are primarily co-linear) [39]. Several short-range NOE distance 
restraints were also used to define the linker-N3 domain interface and were identified by 
analyzing 3D 15N- and 13C-edited NOESY spectra recorded using a methyl selective protonated 
sample (U-[2H], Ile-[13CH3 d1], Leu, Val [13CH3,12CD3]IsdHN2N3) (Figure 3.2C). Finally, small 
angle x-ray scattering (SAXS) data was used to define the size and shape of the receptor [40]. 
The final model of IsdHN2N3 was determined using a total of 807 experimental restraints: 
108 1DNH restraints obtained using two alignment media, 629 attractive and repulsive PRE 
restraints, 19 NOE distance restraints, SAXS data collected in the range of q ≤ 0.3 Å-1, and 50 
backbone torsion angle restraints for residues locating in the polypeptide segments that connect 
the domains (26 and 24 restraints for the N2-Linker and N3-linker connectors, respectively). 
 
3.3.4 Structure Calculation  
A conjoined rigid body/torsion angle simulated annealing protocol was used to model the 
structure of the receptor [41,42]. In the calculation, the coordinates of the individual domains 
were treated as rigid bodies and are derived from the 4.2 Å crystal structure of the IsdHN2N3:Hb 
complex (PDB code: 4IJ2). The domains were allowed to reorient with respect to one another to 
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best-fit the experimental data by enabling the residues connecting the domains to move freely 
(I462-Y475 connecting the N2 and linker domains and V531-Q543 connecting the linker and N3 
domains).  
A multi-step calculation procedure was employed in which the N2-linker and linker-N3 
inter-domain interfaces were treated separately (Figure 3.4). Initially, only the structure of the 
interface between the linker and N3 domains was determined as it is better defined by the NOE 
data (a total of 1 and 7 inter-domain NOEs define the N2-linker and linker-N3 interfaces, 
respectively). In this calculation, residues connecting the linker and N3 domains were allowed to 
move freely (V531-Q543) so as to satisfy the appropriate linker-N3 inter-domain PRE, NOE, 
dihedral angle and RDC restraints. In addition, side chains located at this interface were allowed 
to move during the calculation (K488-E491, Q526-V527, S529-A530, L544, A576, Y583, K595-
D596, R603, T605-S608, I619, N630, I632, K634, and Q645-H647). The SAXS data was not 
used in this initial calculation as it is sensitive to the global structure of the intact receptor, which 
is not modeled in this calculation as N2 is not considered. This calculation led to an ensemble of 
20 conformers that define the relative positioning of the linker and N3 domains (step 1 in Figure 
3.4). The structures are compatible with the experimental data and are described in greater detail 
later in the text (Table 3.2). Next, the position of the N2 domain was determined by allowing 
amino acids connecting the N2 and linker domains to move freely (I462-Y475), while residues in 
the remainder of the protein were held rigid (atoms in the N2 domain and residues spanning the 
linker and N3 domains were treated as rigid bodies) (step 2 in Figure 3.4). The side chains of 
residues at the N2-linker domain interface were also allowed to move during the calculation 
(N348-D353, V372-P374, T376, and N476-Q478). Conformers generated from the first set of 
calculations were used as input, thus the positioning of the linker and N3 domains is a priori well 
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defined (Figure 3.5A). These calculations generated a ‘standard’ single conformer depiction of 
the structure of the intact receptor shown in Figure 3.5B (structural statistics are presented in 
Table 3.3).  
The NMR structure generated from the two step procedure agrees well with the 
experimental PRE and SAXS data. Figure 3.5D shows a summary of the attractive and repulsive 
PRE restraints demonstrating a high level of redundancy. These restraints agree well with the 
structure based on a violation analysis of the PRE-derived distance restraints for all of the probes 
versus the corresponding distance in the NMR structure (Figure 3.S3). When the experimental 
error is considered, all of the PRE-derived distance restraints are satisfied to within 2.7 Å, with 
98.7% of them agreeing to within 0.5 Å. Figure 3.6A shows a more detailed analysis of the PRE 
data as a function of residue number. The plots show for each probe the distance between the 
receptor backbone amide protons to the average position of the nitrogen atom in the spin label. 
There is a very good correspondence for the attractive restraints, while as expected, the repulsive 
restraints exhibit weaker correlation to the structure as they have no upper bound. Interestingly, a 
total of eight PRE-derived distance restraints are systematically violated by 0.5-2.7 Å in all 
conformers of the NMR ensemble. All of these restraints involve interactions with the N2 
domain and suggest that this domain may undergo inter-domain rearrangements (addressed 
below). As expected, the NMR-derived model of apo-IsdHN2N3 is compatible with small angle x-
ray scattering (SAXS) information as the structures were directly refined against this data 
(Figure 3.6b). Theoretical scattering curves were generated for each member of the NMR 
ensemble using the program CRYSOL [43]. Individual members of the NMR ensemble fit 
extremely well to the solution scattering data of apo-IsdHN2N3 with χ values of 0.96 for the lowest 
energy structure. Combined, the good agreement with the PRE and SAXS data indicates that the 
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NMR structure shown in Figure 3.5b represents the predominating conformer of the receptor 
that exists in solution.  
  
3.3.5 Model of Apo-IsdHN2N3 
IsdHN2N3 adopts an extended dumb-bell shaped structure in which the helical linker domain 
forms a handle that separates the N2 and N3 domains by ~23 Å (Figure 3.5b). The interface 
between the linker and N3 domains is primarily formed by hydrophobic residues and buries ~690 
Å2 of solvent accessible surface area (Figure 3.5c). At this interface, residues located at the C-
terminal end of helix H3 in the linker domain pack against residues in strands β4, β5, and β7 in 
the N3 domain. Additional domain-domain packing interactions occur between the turn that 
connects the H1 and H2 helices (H1/H2 turn), and residues within strands β7 and β8 in the N3 
domain. The structure of this portion of the interface is supported by inter-domain NOEs 
between the backbone amides of T489 and L490 located in the H1/H2 turn and the methyl group 
of I632 located in strand β7 (Figure 3.2c). Interestingly, all of the thirteen residues that connect 
the linker and N3 domains (V531-Q543) are well ordered in the NMR ensemble, whereas they 
were not modeled in the crystal structure of the bound protein because of the low resolution of 
the diffraction data. In apo-IsdHN2N3 they wrap around the face of the N3 domain packing against 
residues located in strands β2, β3, β5, and β6 in the N3 domain. While the side chain positioning 
for these residues is not well-defined, evidence for this interaction is provided by the NOESY 
data, as methyl-amide NOEs are observed between the N3 and linker domains (e.g. V537-methyl 
to T606-HN, V607-methyl to N541-HN and V607-methyl to D542-HN) (Figure 3.2c).  
 In contrast to the linker-N3 interface, the contact surface between the N2 and linker 
domains primarily contains hydrophilic residues that bury ~550 Å2 of solvent accessible surface 
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area (Figure 3.5c). In the IsdHN2N3:Hb complex electron density for residues N465-E472 
connecting the N2 and linker domains is missing. In apo-IsdHN2N3 these residues pack against the 
N-terminal end of the H1 helix within the linker domain, as well as residues located proximal to, 
and within, the β1a and β2 strands of the N2 domain. This connector segment is not well defined 
by the NOE data as the majority of its residues contain polar side chains whose proton 
resonances are significantly overlapped in the NOESY spectra (the N2-linker interface has only a 
single methyl-containing residue (V470) that exhibits an NOE to the backbone amide of Y475 
located in helix H1 (Fig 3.2c)). Even so, the overall orientation of the domains and intervening 
connector are reasonably well defined by the long-range PRE data and in 75% of the conformers, 
interactions are observed between the ε-amino group of K391 located in the N2 domain and the 
hydroxyl group of Y475 located in the H1 helix of the linker domain. Additional polar 
interactions between the guanidino group of R350 located in the N2 domain and the side chains 
of N464, N465, or D468 located in the connector segment were observed in 40% of conformers.  
 
3.3.6 Ensemble modeling to account for N2 domain motions 
While the structure described above shown in Figure 3.5b is the predominate form of the 
receptor in solution, it seems likely that additional, less frequently populated conformers exist in 
which the N2 domain adopts distinct positions relative to the linker and N3 domains. This 
conclusion is supported by the smaller molecular correlation time of the N2 domain compared to 
the remainder of the protein suggesting that it undergoes additional motions, and the fact that the 
single depiction of the structure results in systematic, albeit small PRE-derived distance restraint 
violations to the N2 domain. This notion is substantiated by an analysis of the eight violated PRE 
restraints. An inspection of the structure of IsdHN2N3 reveals that no single orientation of the N2 
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domain can simultaneously satisfy all of the violated restraints. This is demonstrated in Figure 
3.7a, which shows six consistently violated PRE-derived distance restraints that originate from 
the E511R1, R363R1 and E559R1 probes. Violated restraints involving the R363R1 and E559R1 
probes can only be satisfied by moving the N2 and N3 domains closer to together, whereas an 
opposing movement of the N2 domain is required to satisfy violated restraints originating from 
the E511R1 probe. Thus, both the NMR relaxation and PRE data suggest that the N2 domain 
undergoes motions that alter its poisoning relative to the remainder of the receptor resulting in a 
minor set of conformers that are distinct from the average conformation shown in Figure 3.5b.  
To gain insight into the range of conformations that are accessible to the N2 domain, a 
third set of calculations were performed in which the receptor was modeled as an ensemble of 
four molecular structures (Figure 3.4, step 3). Since all of the systematically violated restraints 
originate from the N2 domain only the polypeptide segment that connects it to the linker domain 
was allowed to move, whereas residues spanning the linker and N3 domains were held rigid 
during the calculation. As described previously, all of the probes were modeled using three 
conformers and the full suite of NMR experimental data was employed. However, in the 
ensemble calculation four conformers were used to model the structure of the receptor and the 
terms of the energy potential were ensemble averaged [36]. In particular, each member of the 
ensemble was required to have good covalently geometries and minimal atomic overlap, whereas 
the entire ensemble of four molecular structures were allowed to collectively satisfy the distance, 
RDC and SAXS data. An ensemble size of four (Ne = 4) was used because test calculations 
revealed that it provided good agreement with the experimental data, whereas calculations using 
larger ensemble sizes resulted in minimal improvement (Figure 3.7b).  
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The results of the Ne = 4 ensemble calculation indicate that the N2 domain can sample a 
range of positions relative to the linker and N3 domains that enable it to completely satisfy the 
PRE data. Figure 3.7c shows a plot of the reweighted atomic probability density map for the 
members of the ensemble (contoured at 10% (grey) and 50% (green) of the maximum value) 
[44]. Superimposed onto this map is the NMR structure of the receptor calculated assuming only 
a single position for the N2 domain. The density plot reveals that the N2 domain predominantly 
samples a narrow region of conformational space that closely matches its position in the single 
conformer depiction of the receptor (shaded green). In contrast, to more completely satisfy the 
PRE data, less frequently populated conformers exist in which the N2 adopts positions that are 
both closer or father away from the N3 domain.  
 
3.4 Discussion 
The bacterial pathogen S. aureus employs two surface receptors to capture the oxidized 
form of heme (hemin) from human hemoglobin (Hb), IsdB and IsdH. The receptors share 
extensive sequence homology over a region that contains two NEAT domains that are separated 
by a conserved helical “linker” domain (Figure 3.1a). The N-terminal NEAT domain in each 
receptor binds Hb, while the C-terminal NEAT domain interacts with hemin. In IsdH, this tri-
domain unit is comprised of the N2, linker, and N3 domains (IsdHN2N3). Based on our stopped-
flow hemin transfer experiments the domains in IsdHN2N3 function synergistically, extracting 
hemin from Hb ~250-500 times more rapidly than the rate at which Hb spontaneously releases 
hemin into the solvent (Figure 3.1) [26]. Previously we determined a 4.2 Å structure of the 
receptor bound to Hb revealing that the receptor adopts an extended structure in which the N2 
domain engages the A and E helices of each globin chain enabling the linker domain to properly 
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position the N3 domain near the hemin molecule in the same globin chain [29]. The crystal 
structure of the complex revealed the overall mode of binding, but it did not define the structure 
and dynamics of the tri-domain receptor prior to engaging Hb. We therefore used NMR 
spectroscopy and conjoined rigid body/torsion angle dynamics to model the solution structure of 
IsdHN2N3. The NMR data indicate that in the absence of Hb, the receptor adopts an elongated 
dumbbell shaped structure in which the N2 and N3 domains pack against opposite ends of the 
central linker domain (Figure 3.5). Residues located within polypeptide segments that connect 
the domains that were not modeled in the low resolution structure of the IsdHN2N3:Hb complex 
(PDB code: 4IJ2) are defined in the NMR model of the apo-form of the receptor and are 
conformationally ordered based on NMR relaxation data (Figures. 5 and S1).  
In IsdHN2N3 the N2 domain appears to undergo motions that alter its positioning relative 
to the linker domain, whereas the N3 domain is immobilized relative to the linker domain. These 
structural changes are substantiated by NMR relaxation data and the presence of two 
physiochemically distinct domain-domain interfaces. The linker-N3 interface is extensive and 
primarily hydrophobic in character with residues in the H1/H2 turn and H3 helix of the linker 
domain contacting residues within the β4 strand and β7/β8 hemin-binding pocket of the N3 
domain. This interface is further stabilized by the polypeptide segment connecting the domains, 
which wraps around the body of the N3 domain making contacts to residues in strands β2, β3, 
β5, and β6. On the contrary, the N2-linker interface is less extensive and largely hydrophilic with 
only the N-terminal portion of the linker domain packing against the N2 domain. Compatible 
with these distinct interfaces, the NMR relaxation data indicate that the N2 domain has elevated 
mobility relative to the rest of the protein as it tumbles more rapidly and has shorter R2 values 
(Table 3.1 and Figure 3.S1). A more thorough analysis of the relaxation data is necessary to 
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rigorously define the mobility of the N2 domain. In our analysis, fitting of R1 and R2 data 
yielded a slightly smaller tc value for N2. However, it is possible it undergoes more substantial 
motions. This would be the case if our R2 values were overestimated as a result of chemical 
exchange processes. Regardless of the degree of flexibility at the N2-linker interface, the 
relaxation data strongly supports the notion that the N2 domain undergoes rearrangements that 
move it relative to the body of the protein. Movement of the N2 domain is probably facilitated by 
the presence of a polar interface between it and the linker domain, whereas a hydrophobic 
interface between the linker and N3 domains presumably restricts inter-domain motions. N2 
domain rearrangements may originate at a hinge point near residues N465-D468 that connect the 
N2 and linker domains, as 15N relaxation analysis suggests that this is the location at which the 
R1 and R2 rates switch from N2’s longer and shorter times, respectively, to the times seen 
throughout the linker and N3 domains.  
We estimated the range of positions that are accessible to the N2 domain by performing 
ensemble calculations in which four molecular structures of the receptor were allowed to 
collectively satisfy the experimental data [36]. These calculations were performed because single 
conformer depictions of the receptor exhibited small, but persistent PRE-derived distance 
restraint violations to the more mobile N2 domain (Figure 3.7a). The ensemble calculation 
reveals that in order to completely satisfy the PRE-derived distance restraint data the N2 domain 
can adopt positions that differ by as much as ~10 Å from its average position (Figure 3.7c). 
These small excursions are compatible with our finding that the N2 domain has a smaller tc than 
the remainder of the protein and its hydrophilic interface with the linker domain. However, they 
presumably occur infrequently as a single depiction of the structure shown in Figure 3.5b 
satisfies nearly all of the NMR and SAXs data. The time scale of N2 domain motions has not 
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been defined by our analysis, but likely occurs in the nanosecond range, since residues in the 
polypeptide that connect the N2 domain to the body of the protein do not exhibit substantial line-
broadening and are ordered on the picosecond time scale based on their heteronuclear NOE data. 
Intriguingly, a proline (P466) is located at the center of this potential hinge suggesting it may be 
a focal point for conformational changes that reorient the domains.  
The NMR data provides insight into the mobility of the hemin and Hb ligand binding 
pockets in the receptor. In the crystal structure of the IsdHN2N3:Hb complex, residues in the H2 
and H3 helices and strands β3, β6, and β7 in the N2 domain contact the A and E helices in Hb. 
This binding surface is unstructured and flexible in the absence of Hb, as resonances for many 
residues in this region are absent in the NMR spectra, presumably because they undergo micro- 
to milli-second motions that cause line-broadening. Specifically, resonances in the H2 helix of 
the N2 domain could not be assigned (Q364-T370), as well as several residues in the underlying 
stands β4, β6, β7, and β8 (K397-F399, A422, S439-S440, and Y451-T454). Interestingly, similar 
resonance line-broadening has been observed in the N1 domains from IsdB [45] and IsdH [46], 
which also bind Hb and like the N2 domain in IsdHN2N3 contain a conserved aromatic motif 
within the H2-helix that interacts with Hb. This suggests that like IsdHN2N3, these NEAT 
domains also undergo a disordered to ordered transition upon binding Hb. 
 In contrast to the Hb binding pocket in the N2 domain, the backbone atoms of residues in 
the hemin binding pocket in the N3 domain are generally inflexible in the absence of hemin 
based on the observation that their backbone amide atoms could be assigned in the NMR spectra 
and their heteronuclear NOE values and R2 relaxation parameters. Notably, the relaxation data 
indicate that residues connecting strands β7 and β8 that form one face of the hemin pocket are 
semi-ordered in the absence of hemin (V637-E645). In particular, the amide cross-peaks of 
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residues A638 and I640-E645 are not significantly broadened in the NMR data, have R2 values 
near the average for the core of the N3 domain, and have heteronuclear NOE values > 0.5. 
Interestingly, many of these residues are absent in the electron density for two out of three N3 
domains in the 4IJ2 crystal structure. Their absence may be caused by static disorder in the 
crystal as hemin derived from denatured Hb in the crystallization drop was proposed to partially 
occupy the binding site in N3. This notion is compatible with structural studies of the isolated N3 
domain which show that hemin binding causes a small shift in the conformation of this hairpin 
which is otherwise conformationally ordered [47]. 
A comparison of the NMR model of the average structure of IsdHN2N3 with the structure 
of the receptor in the IsdHN2N3:Hb complex reveals that Hb binding repositions the N2 domain 
(Figure 3.8). As compared to the NMR structure of the apo-form of the protein, the receptor in 
the crystal structure of the complex is more compact as a result of a ~30° rotation that moves it 
~7 Å towards the N3 domain. This structural difference is substantiated by PRE-derived distance 
restraints obtained from the R363R1 and E511R1 samples, which are incompatible with the 
conformation of the bound receptor observed in the crystal structure (Figure 3.3b). For example, 
the PRE data indicate that the E511R1 probe located in the N-terminal portion of helix H3 in the 
linker domain is within ~15-20 Å of the backbone amide hydrogen atoms of several residues 
located within the N2-linker interface (H344, N348, V372, T376, I379-F379, E387) as their 
resonances are substantially broadened by the probe (Iox/Ired ratios ~0.3-0.7) (Figure 3.3b). In 
contrast, modeling studies using the crystal structure indicate that the E511R1 probe would be 
separated from these residues by at least 27 Å. Data derived from the R363R1 probe attached to 
the N2 are also incompatible with the crystal structure; the probe is at least 20 Å away from the 
backbone amides of F555, E562, S563, V628-N630, and V648-N652 located in the N3 domain 
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of apo-IsdHN2N3 as supported by Iox/Ired values greater than 0.9, but in the crystal structure they 
are closer than this distance. While the positioning of the N2 domain is different between the 
bound and unbound states of IsdHN2N3, not surprisingly the relative domain orientation at the 
extensive hydrophobic linker-N3 interface is largely unaffected by Hb binding, suggesting that 
this portion of the receptor moves as a rigid unit in solution. The incompatibility of the PRE data 
with the crystal structure of the receptor is solely due to differences in domain positioning as 
only these types of long-range distance restraints were used in our calculations. Interestingly, the 
structural differences in the N2 domain supported by the PRE data are not distinguished by the 
SAXS data. This result is demonstrated in Figure 3.6a and 6b, which shows excellent 
agreement between the SAXS data and the coordinates of the free and bound forms of IsdHN2N3, 
respectively (the χ values of the NMR and crystal structures are 0.96 and 0.92, respectively). 
It seems likely that receptor binding to Hb occurs through a combination of ‘induced fit’ 
and ‘conformational selection’ mechanisms. The results of the Ne = 4 ensemble calculation 
provide strong evidence that Hb binding in part occurs through ‘conformational selection’ in 
which Hb selects from among different forms of the receptor a binding competent conformer. 
This idea is evident in Figure 3.7d, which displays the reweighted atomic probability density 
map of apo-IsdHN2N3 superimposed onto the crystal structure of the receptor in the IsdHN2N3:Hb 
complex. The plot reveals that in the absence of Hb, the receptor may infrequently sample 
conformers that resemble its Hb-bound form in which the N2 and N3 domains are more closely 
positioned (Figure 3.8). However, as described above, the predominating form of the receptor in 
solution adopts a more open state in which the N2 domain is displaced from the N3 domain as a 
significant portion of the crystal structure resides outside the highly populated region of the 
density map (shaded green).  
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Receptor binding to Hb presumably must also occur through an induced fit mechanism in 
order to explain how the receptor captures hemin from Hb ~250-500 times faster than the rate at 
which Hb spontaneously releases hemin into the solvent (Figs. 3.1c versus 3.1d). To promote 
hemin release, the receptor must destabilize Hb-hemin interactions. Our single conformer model 
of the receptor (Figure 3.5b), in combination with the crystal structure of the complex, suggests 
how the receptor might transiently induce structural changes in Hb that promote hemin release. 
A model of Hb bound to the structure of IsdHN2N3 determined by NMR (called NMRIsdHN2N3:Hb) 
was generated by superimposing the coordinates of the N2 domain in the NMR model of 
IsdHN2N3 onto the corresponding coordinates in the crystal structure of the IsdHN2N3:Hb complex 
(Figure 3.9). The modeled structure of NMRIsdHN2N3:Hb may represent the initial binding of Hb 
to the receptor prior to it rearranging through N2 domain motions into the more stable structure 
visualized by x-ray crystallography. As seen in the NMRIsdHN2N3:Hb model, initial binding of the 
apo-receptor to Hb results in atomic overlap between residues in the F-helix and C-terminus of 
αHb (A79, N78, S81, D85, and Y140) and residues in the H1 and H2 helices of the linker 
domain (K479, K486, R492, E496, K499, and K503). Similar atomic overlap is seen when the 
apo-receptor is docked to Hb’s beta subunit (model not shown). We speculate that these 
receptor-Hb interactions may promote hemin release by altering the positioning of the F-helix 
which houses the proximal histidine that coordinates the iron in hemin (H87 in the alpha subunits 
and H92 in the beta subunits, which is conventionally referred to as HisF8). Although details of 
this process are not known, this transient distortion in Hb may increase fluctuations in the 
proximal pocket area that facilitate water penetration needed to break the Fe-HisF8 bonds in both 
subunits. The receptor would then undergo a structural transition about the N2-linker interface so 
as to adopt the more stable conformation observed in the 4.2 Å crystal structure of the 
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IsdHN2N3:Hb complex (Figure 3.8) [29].  
Receptor mediated transient distortion of Hb may also explain recent mass spectrometry 
results, which demonstrated that a hemin-binding impaired receptor can nevertheless promote Hb 
tetramer dissociation [26]. In principle, receptor binding to Hb could also accelerate hemin 
transfer by increasing the effective concentration of the N3 domain near Hb’s bound hemin 
molecule. However, this effect is expected to be small as the rate of hemin transfer exhibits a 
hyperbolic dependence on the concentration of the receptor (data not shown), compatible with 
the rate limiting step in the transfer reaction being breakage of the Fe-HisF8 bond in Hb. Based 
on the ensemble calculations Hb may also bind to other, more sparsely populated conformers of 
the receptor (‘conformational selection’) that could also induce transient structural changes in the 
F-helix to promote hemin release. This idea is intriguing, as it suggests that the plasticity of the 
N2-linker interface is critical for function. If the interface is too flexible, binding would occur 
solely through the conformational selection process and would presumably not alter Hb-hemin 
interactions needed to promote hemin release. In contrast, if the N2-linker interface was 
stabilized by extensive inter-domain interactions and therefore too structurally rigid, binding to 
Hb would be impaired as a result of sustained atomic overlap with the F-helix.  
The S. aureus IsdB protein presumably extracts hemin from Hb through a similar 
mechanism as described here for IsdHN2N3 because the proteins share 48% primary sequence 
identity, and similar to IsdHN2N3, the IsdB protein extracts hemin using functionally and 
structurally homologous NEAT domains that are separated by a helical linker segment. Recent 
results reported independently by the Lei and Murphy groups further support mechanistic 
similarity between the two Hb receptors as they imply that the linker domain in IsdB plays an 
important role in Hb binding and hemin capture [45,48,49]. This is consistent with our proposal 
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that the related region in IsdHN2N3 may transiently interact with Hb to destabilize the F-helix that 
interacts with hemin. It will be interesting to discover if similar to IsdHN2N3, the Hb binding 
NEAT domain in IsdB also undergoes domain rearrangements upon binding Hb. This would 
appear to be the case as recently reported NMR studies of the Hb binding NEAT domain in IsdB 
suggest that it does not significantly interact with the linker domain in the absence of Hb [45].  
It is also possible that IsdB and IsdH may not use identical mechanisms to extract hemin 
from Hb. The Lei group showed that a ~85 residue segment preceding the Hb-binding domain 
(called the NS in their study) is important for the rapid kinetics observed in the hemin transfer 
reaction between metHb and IsdB. It is unclear if residues preceding IsdH’s Hb-binding N1 and 
N2 domains share a similar function as the NS in IsdB. Furthermore, recent reports [48,49] have 
independently shown that IsdB constructs containing the Hb binding N1 domain and the 
analogous linker domain could bind Hb and promote hemin transfer to the isolated hemin 
binding N2 domain when provided in trans. This finding is in contrast to IsdH, where all three 
domains must be within the same polypeptide for rapid hemin transfer from metHb [26]. The 
origin of this difference needs to be resolved, but could be caused by non-covalent interactions 
between Hb and the hemin-binding domain and/or the linker domain, which are not present in 
IsdHN2N3. In order to elucidate mechanistic differences between IsdB and IsdH, the structure of 
the IsdB in its Hb-free and -bound state will need to be determined. 
In summary, our NMR results in combination with the recently determined crystal 
structure of the IsdN2N3:Hb complex suggest that the receptor may accelerate hemin release from 
Hb by transiently contacting Hb’s F-helix. A generally similar mechanism may also be used by 
IsdB based on primary sequence homology and recent biochemical studies. Many other Gram-
positive microbes use NEAT containing proteins to acquire heme from Hb [24]. How these 
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proteins operate to capture heme is only beginning to be elucidated, and is important, as it could 
lead to development of broad-spectrum anti-infective agents that target nutrient acquisition.  
 
3.5 Material and Methods 
3.5.1 Protein production for NMR studies 
Two IsdH polypeptides were characterized by NMR: (1) IsdHN2N3(Y642A), which contains 
N2, linker and N3 domains (residues A326-D660) and a Y642A mutation in the hemin pocket of 
IsdHN3 domain that disrupts hemin binding and (2) IsdHN2-Linker, which contains the N2 and 
linker domains (residues A326-Q543). As described previously, both polypeptides were 
produced from pET-28b-based expression plasmids and initially contained a removable N-
terminal hexahistidine-small-ubiquitin-like modifier (SUMO) tag to facilitate purification 
[50,51]. Several uniformly isotopically labeled samples were produced for NMR studies using 
Escherichia coli BL21 (DE3) cells (New England BioLabs, Beverly, MA). Uniformly 
isotopically labeled proteins were expressed from cells grown in M9 minimal media containing 2 
g/L [13C]-glucose and/or 1 g/L 15NH4Cl as the sole source of carbon and nitrogen, respectively 
(Cambridge Isotope Laboratories, Andover, MA). The methods to overexpress the proteins have 
been described previously [26,31]. Briefly, expression proceeded overnight at 25°C by adding 1 
mM isopropyl-β-D-thiogalactoside to cell cultures. The bacterial cells were then harvested by 
centrifugation, lysed by sonication, and the protein was purified using a Co2+-chelating column 
(Thermo Scientific, Waltham, MA). The amino terminal 6x-His-SUMO tag was then cleaved 
using ULP1 protease and reapplied to the Co2+-chelating column to remove the protease and 
cleaved SUMO tag. The final protein yield for U-[13C,15N]IsdHN2N3(Y642A) and U-
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[13C,15N]IsdHN2-Linker was 21 mg/L and 14 mg/L, respectively. Methods used to produce the U-
[2H,13C,15N]IsdHN2N3(Y642A) NMR sample have been described previously [31]. The protocol 
used to produce the methyl protonated U-[2H], Ile-[13CH3 d1], Leu, Val-[13CH3,12CD3] 
IsdHN2N3(Y642A) sample is similar to the protocol used to produce the U-
[2H,13C,15N]IsdHN2N3(Y642A) sample. However, 3 g/L of U-[13C, 2H]-glucose (Isotec, Miamisburg, 
OH) was used as the carbon source, as well as one hour prior to induction 60 mg/L of [U-13C4, 
3,3-2H2]-α-ketobutyrate (Cambridge Isotope Laboratories, Andover, MA) and 100 mg/L of 
[1,2,3,4-13C4, 3,4’,4’,4’-2H4 ]-α-ketoisovalerate (Cambridge Isotope Laboratories, Andover, MA) 
were added to the growth medium to yield 33 mg/L culture. All NMR samples were dissolved in 
NMR buffer containing 20 mM NaH2PO4, 50 mM NaCl, 0.01% NaN3, pH 6.0 supplemented 
with ~8% D2O. The following samples were used for NMR studies: 1.1 mM U-[2H, 
13C,15N]IsdHN2N3(Y642A), 1.0 mM U-[13C,15N]IsdHN2N3(Y642A), 0.8 mM U-[2H], Ile-[13CH3 d1], 
Leu, Val-[13CH3,12CD3]IsdHN2N3(Y642A), 0.675 mM U-[13C,15N]IsdHN2-Linker, and two additional 
samples of 1.2 mM U-[13C,15N]IsdHN2N3(Y642A) and 1.2 mM U-[13C,15N]IsdHN2-Linker, both 
lyophilized in NMR buffer and resolublized with an equal volume of 99.999% D2O (Isotec, 
Miamisburg, OH). 
 PRE measurements were made using four double mutants of IsdHN2N3. Each mutant 
contained the Y642A mutation that disrupts hemin binding as well as a single cysteine mutation 
at the following residues: R363C, E400C, K499C, E511C, K528C, and E559C. Expression 
plasmids producing the mutant proteins were obtained by site directed mutagenesis of plasmid 
pRM216 that produces IsdHN2N3(Y642A) with a N-terminal hexahistidine-small-ubiquitin-like 
modifier (SUMO) tag (QuikChange Site-Directed Mutagenesis Kit, Stratagene, La Jolla, CA). 
For NMR studies uniformly 15N labeled samples of each protein were produced in an identical 
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manner as describe above, with the exception that 2.5 mM dithiothreitol (DTT) was added to all 
buffers used during the purification procedure. After purification and protein concentration, the 
sampled was dialyzed against labeling buffer (50 mM Tris, 50 mM NaCl, 2.5 mM DTT, pH 7.8). 
The DTT was then removed using a desalting column (Zeba Spin Desalting Column, Thermo 
Scientific, Waltham, MA). Probes were attached to each sample by immediately incubating them 
with a ten-fold molar excess of methanesulfonothioate (MTSL; Toronto Research Chemicals, 
North York, ON, CAN) for 15 minutes, after which an additional ten-fold molar excess of MTSL 
was added followed by incubation overnight at room temperature. Disulfide bond formation 
between MTSL and the sulfhydryl group of the cysteine was confirmed via MALDI-TOF and 
any unreacted MTSL was removed by buffer exchange (Amicon centrifugation filtration device, 
Millipore, Billerica, MA) with NMR buffer. For PRE measurements, each U-[15N]-labeled 
cysteine mutant (IsdHR363C(Y642A), IsdHE400C(Y642A), IsdHK499C(Y642A), IsdHE511C(Y642A), 
IsdHK528C(Y642A), and IsdHE559C(Y642A)) was concentrated to ~0.3 mM to prevent non-specific 
intermolecular effects.  
 
3.7.2 Hemin transfer experiments 
Purified unlabeled IsdHN2N3 and IsdHN2-GS-N3 in which the linker was replaced with a 
nine-amino acid artificial linker (GSGSGSGSG) was produced as previously described [26]. The 
apo-form of IsdHN2N3 was generated by hemin extraction with methyl ethyl ketone [52] followed 
by buffer exchange into phosphate buffered saline solution, pH 7.4. Native human hemoglobin 
(Hb) was prepared in a complex with CO, as previously described [53]. Replacement of the 
bound CO by O2 was accomplished by equilibrating the HbCO solution with 1 atm O2, on ice, 
under light in a rotary evaporator. Methemoglobin (metHb) was produced by incubating the 
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oxyhemoglobin complex with excess potassium ferricyanide and loading the sample onto a G-25 
sepharose column to remove excess ferricyanide [14]. metHb was then buffer exchanged into 
phosphate buffered saline solution, pH 7.4. The concentration of hemin within metHb was 
determined using the extinction coefficient of 179 mM-1cm-1 [54]. The rates of hemin transfer 
from metHb (hemin donor) to the hemin acceptors were measured using an OLIS RSM1000 
stopped-flow spectrophotometer (OLIS, Bolgart, GA) at Rice University as previously described 
[55,56]. Holo-protein (HbA) in one syringe was mixed with apo-acceptor at ~4x molar excess in 
another syringe. The entire spectrum was recorded over 300 seconds with a dead time of ~3ms. 
The absorbance changes at 370 and 404 nm (ΔA404-370) [26] were fitted to a double phase 
exponential expression to obtain the apparent rate constants for the transfer reaction using 
GraphPad Prism version 5.01 for Windows (GraphPad Software, La Jolla, CA). The rates of 
hemin transfer from metHb to H64Y/V68F apo-Mb [30] in ~16x molar excess was measured 
using a conventional UV-vis spectrophotometer (Cary50, Varian, Inc., Palo Alto, CA) also at 
Rice University. The entire spectrum was recorded over 790 min and the absorbance change at 
409 nm was fitted to a double phase exponential equation. 
 
3.5.3 NMR data acquisition 
NMR spectra were acquired at 310 K for IsdHN2N3(Y642A) and 323 K for IsdHN2-Linker on 
Bruker Avance 500-, 600-, and 800-MHz spectrometers equipped with triple resonance 
cryogenic probes. All NMR spectra were processed using NMRPipe [57] and analyzed using 
CARA (version 1.8.4) [58] and/or SPARKY [59] software packages. Chemical shift assignments 
(1H, 13C, 15N) for the backbone of IsdHN2N3(Y642A) have been described earlier [31]. Backbone 
assignments for the U-[13C,15N]IsdHN2-Linker protein were obtained by analyzing the following 
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experiments: HNCACB, CBCA(CO)NH, HNCO, HN(CA)CO, and CC(CO)NH [60]. Side chain 
assignments were obtained by analyzing HNHA, HNHB, HBHA(CO)NH, (h)CCH-TOCSY, 
HCCH-TOCSY, and HCCH-COSY spectra acquired using U-[13C,15N]IsdHN2N3(Y642A) and U-
[13C,15N]IsdHN2-Linker samples. The majority of methyl resonance assignments were obtained by 
analyzing the following NMR spectra acquired using the methyl protonated sample: (1) 15N-
edited TROSY-NOESY (200 ms mixing time; collected with 2048, 64, and 160 complex points 
for the direct 1H, 15N, and indirect 1H dimensions, respectively, and processed to a digital 
resolution of 0.09 ppm, 0.11 Hz, and 0.03 ppm for direct 1H, 15N, and indirect 1H dimensions, 
respectively), (2) 13C-edited NOESY in H2O (200 ms mixing time; acquired with 2048, 76, and 
244 complex points for the direct 1H, 13C, and indirect 1H dimensions, respectively, and 
processed to a digital resolution of 0.14 ppm, 0.08 ppm, and 0.04 ppm for direct 1H, 13C, and 
indirect 1H dimensions, respectively), (3) (h)CCH-TOCSY, and (4) CC(CO)NH experiments 
[60].  
 1DNH residual dipolar couplings were measured on protein samples partially aligned in 
either 5% PEG C12E5/hexanol [61] or 9 mg/mL pf1 phages [62] (ASLA Biotech, Latvia). Two-
dimensional 15N-coupled IPAP 1H-15N HSQC [63] spectra were collected for both aligned and 
unaligned samples (collected with 2048, and 1200 complex points for the 1H, and 15N 
dimensions, respectively, and processed to a digital resolution of ~0.21 ppm for the 1H and ~0.90 
ppm for the 15N dimensions). 15N–1H 2D TROSY-HSQC spectra were recorded for each PRE 
spin-labeled mutant (collected with 2048 and 256 complex points for the 1H, and 15N dimensions, 
respectively, and processed to a digital resolution of ~0.25 ppm for both 1H and 15N dimensions). 
After data acquisition for the paramagnetic samples was completed, ascorbic acid (5-fold molar 
excess relative to MTSL concentration) was added to the NMR tube to generate the diamagnetic 
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sample, followed by a three-hour incubation period in the spectrometer before to acquiring the 
diamagnetic spectra. 
 15N relaxation data (T1 and T2) and heteronuclear {1H}-15N NOE data was collected on 
Bruker Avance 800-MHz spectrometer equipped with a triple resonance cryogenic probe at 
protein concentrations of 1.9 mM for T1 and T2 relaxation experiments and 1.1 mM for 
heteronuclear NOE experiments. Delays used for T1 experiments were 41, 165, 393, 662, 848, 
and 1219 ms. For T2 experiments the delays were 17, 34, 51, 68, 85, and 118 ms. The 
heteronuclear NOE experiments were collected in duplicate with a relaxation delay of 5 s. Data 
was analyzed in SPARKY [59] to generate raw relaxation and NOE parameters. 
 
3.5.4 RDC, dihedral angle, SAXS and NOE distance restraints  
1DNH couplings for 40 and 68 residues were obtained for the protein aligned in 5 % 
PEG/Hexanol and 9 mg/mL pf1 phages, respectively. Data were analyzed using the program 
MODULE [39] to determine magnitude of the alignment tensor (Da) and rhombicity (η). For the 
PEG/Hexanol data Da and η values of 16.9 Hz and 0.21 were obtained, respectively. For the 
phage data Da and η values of 10.9 Hz and 0.24 were obtained, respectively. Couplings were 
obtained by analyzing IPAP experiment data of unaligned and aligned samples using the 
published backbone chemical shifts of IsdH [31]. For both media, couplings were obtained for 
each of the three domains. An analysis of the euler angles of the alignment tensors revealed that 
they were not co-linear and aligned the protein to differing extents. The program TALOS+ [64] 
was used to obtain phi and psi dihedral angle restraints from backbone chemical shift 
assignments for the loop regions between N2-Linker (residues I462-Y475) and Linker-N3 
(residues A530-L544) as well as residues Y629-I650 in the hemin binding pocket of N3. Methyl 
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side chain resonances were assigned by analyzing 15N-NOESY, 13C-NOESY (in H2O), and 
CC(CO)NH spectra of this sample. In addition, limited side chain assignments for non-methyl 
side chains were obtained using a 13C, 15N labeled sample of IsdHN2N3(Y642A) and data from 
HCCH-COSY, HCCH-TOCSY, and (h)CCH-TOCSY spectra obtained using a 13C, 15N labeled 
sample of IsdHN2N3(Y642A). An analysis of the 3D-15N-edited and 13C-edited NOESY spectra of 
the selectively protonated samples identified a total of 1 and 8 inter-domain proton-proton NOEs 
that define the N2-linker and linker-N3 interfaces, respectively. A total of 8 hydrogen bond 
distance restraints for residues Y475-K479 and V531-E535 were included in the calculations and 
were based on alpha-helical NOE patterns observed in the 15N-edited NOESY spectrum and 
TALOS+ calculated dihedral angles. Small angle x-ray scattering (SAXS) data for 
IsdHN2N3(Y642A) was collected using an Anton Paar SAXSess instrument with a sealed tube 
source. I(0) values and P(r) curves were calculated using GIFT (Anton Paar, Graz, Austria) and 
PRIMUS [29,65]. 
 
3.5.5 PRE-derived distance restraints  
PRE-derived distance restraints were made for each cysteine mutant of U-[15N] 
IsdHN2N3(Y642A) which contained an attached MTSL nitroxide spin label: IsdHR363C(Y642A), 
IsdHE400C(Y642A) IsdHK499C(Y642A), IsdHE511C(Y642A), IsdHK528C(Y642A), and IsdHE559C(Y642A). The 
procedure used to analyze the PRE data is similar to the method described Sattler and colleagues 
[33,34,37,66–71]. The PRE effect on the transverse relaxation rate of the amide proton, R2sp, was 
back calculated from the ratio of peak intensities for the paramagnetic (Iox) and reduced 
diamagnetic (Ired) using equation 1  
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 -./-012 = 	 45	67859:;45(459:  (1)  
 
where R2 is intrinsic amide proton transverse relaxation rate, and t is the total INEPT evolution 
time recorded (11 ms). The fitted PRE rate enhancements (R2sp) were converted into distances, r, 
using a modified version of the Solomon-Bloembergen in equation 2 [66,72]  
 
 𝑟 = =459: 4𝜏@ + *ABC(DE5AB5 C F (2) 
 
where K is a constant (1.23 x 10-32 cm6 s-2) that describes the spin properties of the MTSL spin 
label [66], wh is the Larmor frequency of the proton spin, and tC is the apparent PRE correlation 
time [33]. The value for tC was estimated by comparing the agreement between distances 
calculated from the PRE data with known intra-domain distances present in the structures of the 
isolated domains (Figure 3.S2) (PDB code: 4IJ2). To prevent over estimation of PREs, only 
residues with {1H}-15N NOE values > 0.6 and isolated 1H-15N cross-peaks in the spectra were 
used to obtain PRE-derived restraints. Intensity ratios were normalized from the average ratios of 
intra-domain backbone amides known to be ≥ 28 Å away from the probe based on the NMR and 
crystal structures of the isolated domains. In the structure calculations, two types of distance 
restraints were employed: (1) attractive restraints between the nitrogen atom of the MTSL ring 
and affected amide proton if Iox/Ired was < 0.80. The distance restraint for these interactions was 
determined using equation 2 assuming an error of ± 5 Å (2) repulsive restraints were used if 
Iox/Ired ≥ 0.80. For these amide-probe interactions a lower bound distance of 20 Å was employed 
and contained no upper bound [66,69,73]. Notably, all six probes caused modest line-broadening 
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in residues within the ligand binding pockets of the N2 and N3 NEAT domains. These 
interactions were deemed to be non-specific because both binding pockets contain a large 
number of aromatic residues that are expected to non-specifically interact with MTSL [66,74]. In 
addition, the interactions are incompatible with all of the other PRE-derived distance restraints 
and SAXS data. Moreover, many of the effected residues have {1H}-15N NOE values < 0.6. It 
should be noted that the probe located in the N3 domain, E559R1, also displayed non-specific 
effects to a portion of N2 domain near the N-terminus. Those residues were also omitted from 
the calculations for the aforementioned reasons, and because data collected on an additional 
probe near the N-terminus, E343R1, did not display the reciprocal effect.  
 
3.5.6 Relaxation data analysis 
NMR relaxation data for individual residues were interpreted as described previously 
[75,76]. Briefly, the program Pdbinertia was used to calculate the principal moments of inertia 
for the NMR model of IsdHN2N3 yielding relative moments of inertia of 1.0:0.94:0.25. The 
program R2R1_tm was used to calculate an approximate correlation times (τm) on a per residue 
basis using R2 /R1 ratios. Only R2 /R1 ratios that met the following criteria were used in this 
analysis: (1) they were from isolated 1H-15N cross-peaks in each spectrum 2) they were within 
two standard deviations of the average and (3) the residue had a {1H}-15N NOE value > 0.6. The 
data was then inputted into the program Quadric_Diffusion [77,78], which indicated that the 
axially symmetric model statistically is preferred over the isotropic and anisotropic models of 
tumbling for the intact receptor and for every subdomain with the exception of the linker that 
favored isotropic model. NMR relaxation data were also interpreted to obtain the diffusion 
tensors and molecular correlation times of the individual subdomains. For this analysis NMR 
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data for 52, 10, and 29 residues in the N2, linker and N3 domains were used, respectively. These 
residues, in addition to meeting the R2/R1 criteria described above, were present in the electron 
density map of the crystal structure. Relaxation data were collecting using a 1.9 mM U-
[15N]IsdHN2N3(Y642A) dissolved in NMR buffer containing 20 mM NaH2PO4, 50 mM NaCl, 0.01% 
NaN3, pH 6.0 supplemented with ~8% D2O. The protein is monomeric based on size exclusion 
chromatography combined with multi angle light scattering (SEC-MALS).  
 
3.5.7 Structure calculations 
Structures were calculated using XPLOR-NIH (version 2.37) [79]. The coordinates of the 
N2, linker and N3 domains are derived from the 4.2 Å crystal structure of the IsdHN2N3:Hb 
complex (PDB code: 4IJ2, chain G). Polypeptide segments connecting these subdomains (N465-
E472 and V531-Q543) were added using the program COOT [80]. Because they are absent in the 
crystal structure of the IsdHN2N3:Hb complex, the coordinates for residues in the hemin-binding 
region of the receptor (V635-Q645) were modeled using the previously reported structure of the 
isolated N3 domain [47] (PDB code: 2Z6F), except that an alanine was substituted at position 
Y642. Protons were then added to the starting model using 
http://spin.niddk.nih.gov/bax/nmrserver/pdbutil and the coordinates were energy minimized. 
Three conformers of each MTSL probe were then added to each of the six aforementioned probe 
attachment sites. The coordinates of each sub-domain in the MTSL-conjugated starting structure 
were energy minimized against the appropriate RDC data to optimize their agreement, and to 
improve covalent geometry and atomic overlap. Three distinct conjoined rigid body/torsion angle 
simulated annealing calculations were performed (summarized in Figure 3.4). In the first 
calculation, the coordinates of the linker and N3 domains were held rigid, but allowed to move 
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with respect to one another so as to satisfy the relevant RDC, dihedral angle, NOE, and PRE 
data. In this process the coordinates of residues connecting the domains (V531-Q543) were 
allowed to move freely as well as the coordinates of side chains that reside at the linker-N3 
interface (K488-E491, Q526-V527, S529-A530, L544, A576, Y583, K595-D596, R603, T605-
S608, I619, N630, I632, K634, Q645-H647). Both the NOE data and the results of initial 
structure calculations indicate that the packing between the H1/H2 turn in the linker domain and 
N3 domain are similar in the Hb-free and -bound forms of the receptor. The posDiffPotTool 
module in XPLOR-NIH was therefore employed to define this region. The statistics describing 
the results of the first calculation are presented in Table 3.2. The structures generated from the 
first calculation were used as input into a second set of calculations. In this calculation the 
coordinates the appropriate position of the N2 domain was determined. The coordinates of the 
N2 domain and residues spanning from the linker domain to end of the protein (N476-I655) were 
treated as rigid bodies. These segments were allowed to reorient with respect one another by 
allowing free movement of residues I462-Y475 that connect the N2 and linker domains. In 
addition, the coordinates for side chains of inter-facial residues (N348-D353, V372-P374, T376, 
and N476-Q478) were given full degrees of freedom. All of the experimental data was employed 
in this calculation, including SAXS data. The calculation resulted in single conformer 
representations of the structure that best satisfy the experimental data (statistics described in 
Table 3.3).  
In the third set of calculations an ensemble approach was used to account for domain 
motions. This calculation is nearly identical to calculation #2, except that four conformers of the 
receptor (Ne = 4) were used to collectively satisfy the NMR data [36]. In particular, each 
member of the Ne = 4 ensemble was required to have good covalently geometries and minimal 
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atomic overlap, whereas the entire ensemble of four molecular structures were allowed to 
collectively satisfy the distance, RDC and SAXS data. The RAPPot potential in the 
posRMSDPotTools module in XPLOR-NIH was used to minimize the spread of the atomic 
coordinates [81]. A total of 100 four-member ensembles were calculated. The five lowest energy 
ensembles (20 structures total) were used to calculate a reweighted atomic probability density 
map using the program VMD-Xplor [44,82].  
The following parameters were employed in each of the three calculations. Initially, a 
total of 5000 steps of higher energy dynamics at 3500K was performed, followed by 100 cooling 
cycles in which the bath temperature was decreased from 3500K to 25 K in 12.5 K increments. 
This was followed by 5 rounds of 500 steps of Cartesian coordinate energy minimization. The 
final force constants used during simulated annealing for RDC, NOE, and dihedral angle (CDIH) 
potentials were 1.5 kcal mol-1 Hz-2, 30 kcal mol-1 Å-2, and 400 kcal mol-1 rad-2, respectively. The 
non-bonded interactions were described by a van der Waals repulsion term with a final force 
constant of 4 kcal mol-1 Å-2 and a scale factor of 0.8. A multi-dimensional torsion angle database 
of mean force (RAMA) potential was applied with a final force constant of 1 kcal mol-1. The 
bond length (BOND), bond angle (ANGL) and improper dihedral (IMPR) potentials employed 
force constants of 1 kcal mol-1Å-2, 1 kcal mol-1rad-2, and 1 kcal mol-1rad-2, respectively. All 
dynamics and minimization steps utilized the internal variable module (IVM) [81,83–86]. In the 
single conformer calculations (calculations #1 and #2), the Da and rhombicity of the two 
alignment tensors for the RDC data were held fixed during the simulated annealing, and allowed 
to float during the Cartesian coordinate energy minimization. In the third calculation the 
alignment tensor parameters were fixed throughout the calculation as to not over-fit the RDC 
data [40,87]. Calculations that included the N2 domain (#2 and #3) used SAXS data collected in 
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the range of q ≤ 0.3 Å-1. The xray force constant was optimized such that the resulting χ2 values 
were less than one, without causing violations of other restraints (final force constants of 200 and 
40 kcal mol-1 for calculation #2 and #3, respectively [40]. Structural models were inspected and 
visualized using the programs MOLMOL [88] and PyMOL [89]. 
For the PRE data a quality factor, Q, was calculated using equation 3  
 
 𝑄 =	 HIJKLKJMK+HNO: 5HNO: 5  (3) 
 
where Vbackcalc and Vexp are the back calculated and experimental Iox/Ired ratios for a given spin 
label. This equation has been described previously [33,37] and is a modified version of the PRE 
Q-factor used in previous studies, which employs peak intensity ratios in place of enhanced 
relaxation rates [36,66]. The individual members within the final ensemble of back calculated 
scattering curves were fit to the experimental data using both the CalcSAXS helper program in 
the XPLOR-NIH structure determination package (v. 2.37) [40,79] as well as the program 
CYSOL [43]. 
 
Abbreviations: Hb, hemoglobin; Isd, iron-regulated surface determinant; NEAT, near iron 
transporter; NMR, nuclear magnetic resonance; PRE, paramagnetic relaxation enhancement; 
RDC, residual dipolar coupling; MTSL, methanesulfonothioate; HSQC, heteronuclear single 
quantum coherence; NOE, nuclear Overhauser effect; SAXS, small angle x-ray scattering; 
RMSD, root mean squared deviation; Mb, Myoglobin 
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3.6 Figures and Tables 
 
Table 3.1 Predicted and experimental correlation times for the domains within IsdHN2N3  
___________________________________________________________________________________________ 
 τc (ns)        N2         N3        N2-linker-N3 (IsdHN2N3) 
____________________________________________________________________________________________________________________________________________ 
 Experimental  13.9 ± 0.1  15.5 ± 0.1  16.3 ± 0.1 
 Predicted†  8.4a (7.1b)  7.3a (6.0b)  17.9a(16.0b) 
___________________________________________________________________________________________ 
†Predicted correlation times calculated from equations based on a spherical protein using either a) molecular weight 
[90] or b) temperature and number of amino acid residues [91].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 128 
 
Table 3.2 Structural statistics for linker and N3 domain-domain interface in IsdHN2N3 
 
 
PRE distance restraints   R363R1 E400R1 K499R1 E511R1 K528R1 E559R1 
# of restraints        0     0     66     67     62     22  
# of violations > 0.5 Åa       0     0      0      0      0      0 
PRE Q-factorb      n/a   n/a    0.09    0.07    0.15    0.11 
 
NOE distance restraints   NOEs 
# of restraintsc      13/7 
# of violations > 0.5 Åa        0 
 
Orientational restraints 
Total 1H-15N residual dipolar couplings      44 
PEG C12E5/hexanol      20 
pf1 phages       22 
Dihedral Angles (Φ and ψ)       24 
 
RDC R-factor 
PEG C12E5/hexanol                  3.60 ± 0.03 
pf1 phages                  11.7 ± 0.05 
 
PROCHECK-NMR results (%)d 
most favorable region                   90.0 ± 0.6 
additionally allowed region                 10.0 ± 0.6 
generously allowed region                   0.0 ± 0.0 
disallowed region                    0.0 ± 0.0 
 
Coordinate Precision (Å)e 
Protein back bone (N476-I655)                 0.37 ± 0.11 
Protein heavy atoms (N476-I655)                 0.68 ± 0.11 
 
a Average number of distance restraints violated in the 20 lowest energy structures. 
b Quality factor of experimental Iox/Ired vs. back-calculated Iox/Ired of the ensemble. Only inter-domain restraints were included. 
c Total number of restraints, with the number of inter-domain restraints indicated after the slash. 
d PROCHECK-NMR [92] includes residues (N476-I655). 
e The coordinate precision is defined as the average atomic root mean square deviation (RMSD) of the 20 individual simulated annealing structures and their mean 
coordinates. Backbone atoms are N, Ca, C¢, and O. During the calculation the backbone coordinates of the linker (N476-A530) and N3 (L544-I655) were treated as 
rigid bodies.  
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Table 3.3 Structural statistics for intact IsdHN2N3 
 
 
PRE distance restraints   R363R1 E400R1 K499R1 E511R1 K528R1 E559R1 
# of restraintsa       87     83 133(67)      130(63)      130(68)   66(44) 
# of violations > 0.5 Åb      4.2     0   0.8    2.9     0      2 
Maximum violation (Å)     2.4   n/a   0.94    1.8    n/a     2.7 
PRE Q-factorc      0.24   0.07   0.10   0.12   0.13    0.14 
 
NOE distance restraints NOEs 
# of restraintsd    19/8 
N2-LN3d      6/1 
L-N3d     13/7 
# of violations > 0.5 Åb      0 
 
Orientational restraintsa 
Total 1H-15N residual dipolar couplings                  108(64) 
PEG C12E5/hexanol   40(20) 
pf1 phages    68(46) 
Dihedral Angles (Φ and ψ)   50(26) 
 
RDC R-factor 
    PEG C12E5/hexanol                                   9.9 ± 0.4 
    pf1 phages                  16.9 ± 0.8 
 
SAXS 
CRYSOLe  χ        0.96 
 
PROCHECK-NMR results (%)e 
most favorable region                                87.9 ± 0.6 
additionally allowed region                 12.1 ± 0.6 
generously allowed region                   0.0 ± 0.0 
disallowed region                    0.0 ± 0.0 
Molprobity (%) e 
Ramachandran outliers                   0.0 ± 0.0 
Ramachandran favored     91.13 
Bad backbone (%)       0.13 
Coordinate Precision (Å)g  
Protein back bone (A326-I655)                 0.40 ± 0.11 
Protein heavy atoms (A326-I655)                 0.73 ± 0.09 
 
a Total number of restraints, with the number of restraints to the N2 domain indicated in parentheses. 
b Average number of distance restraints violated in the 20 lowest energy structures. 
c Quality factor of experimental Iox/Ired vs. back-calculated Iox/Ired of the ensemble. Only inter-domain restraints were included. 
d Total number of restraints, with the number of inter-domain restraints indicated after the slash. 
e Fit to the experimental scattering curve for the lowest energy structure using CRYSOL [43]. The goodness of fit to the experimental scattering curve for each of the 
20 individual simulated annealing structures was also measured using the CalcSAXS helper program in the XPLOR-NIH (v. 2.37) software package [40,79] and 
yielded values of χ2 = 0.81 ± 0.02. 
e PROCHECK-NMR [92] and Molprobity [93] results includes residues (A326-I655) and are of acceptable quality for an NMR structure. 
g The coordinate precision is defined as the average atomic root mean square deviation (RMSD) of the 20 individual simulated annealing structures and their mean 
coordinates. Backbone atoms are N, Ca, C¢, and O. During the calculation the backbone coordinates of the N2 domain (A326-P461) and residues spanning the 
linker and N3 domains (N476-I655) were treated as rigid bodies. The coordinates spanning the linker and N3 domains were derived from the calculation described 
in Table 3.2. 
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Figure 3.1  S. aureus uses conserved tri-domain receptors to rapidly capture 
hemin from Hb.  
(a) Schematic of the conserved NEAT domains of S. aureus Hb receptors, IsdH and IsdB. NEAT 
domains that bind Hb and hemin (oxidized form of heme) are shown in gray and black, 
respectively. Residue numbers of the functionally homologous NEAT domains as well as the 
linker connecting them are indicated. (b) Rapid spectral changes in UV-Vis spectrum of the 
reaction of 1.5 µM metHb and 6.5 µM apo-IsdHN2N3. Arrows indicate the increase and decrease 
over time for the absorbances at 370 and 404 nm, respectively. (c) Time course of the ΔA404-370 
change after mixing 1.5 µM metHb and 6.5 µM apo-IsdHN2N3 (black line). The data was fit to a 
double-exponential equation and yielded hemin transfer rates of 0.85 ± 0.11 and 0.099 ± 0.14 s-1. 
Similar hemin transfer data is shown for the reaction containing 1.5 µM metHb and 6.5 µM apo-
IsdHN2-GS-N3, a IsdHN2N3 mutant in which the linker is replaced with a glycine-serine nonapeptide 
(grey line). (d) Time course of the ΔA409 change after mixing 2.5 µM HbA and 40 µM 
H64Y/V68F apo-Mb. The first 60 seconds of the reaction is shown in the inset for comparison. 
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Figure 3.2 NMR spectra of IsdHN2N3 
(a) A representative 15N-HSQC of IsdHN2N3. Boxed regions indicate the representative sections 
of each PRE probe’s spectra shown in (b) (E511R1 and R363R1 probes). (b) Magnified regions 
depicting selective distance dependent line-broadening for the E511R1 (bottom) and R363R1 
(top) probes. For each probe selected diamagnetic and paramagnetic spectra are shown in the left 
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and right panels, respectively. (c) Representative NMR spectra of inter-domain methyl-edited 
NOEs in IsdHN2N3. Panels show regions within the 13C-edited NOESY. Methyl-amide NOEs 
were cross validated in the 15N-edited NOESY spectra. The N2-linker interface is shown in the 
right panel and the linker-N3 interface in shown in the left panel. Inter-domain NOEs are labeled 
and any intra-domain NOEs or apodization effects were left unlabeled.  
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Figure 3.3 IsdHN2N3 PRE profile for each probe 
(a) The distance-dependent line-broadening effect observed by each spin-label mutant is mapped 
to the extended starting structure of IsdHN2N3. Attractive PRE effects (Iox/Ired < 0.80) are shown in 
green and repulsive PRE effects (Iox/Ired ≥ 0.80) are shown in red. The alpha carbon of each 
residue where the probe is located is depicted as a black sphere. Residues to which no PRE 
information is available are shown in grey. Mapping data for the following probes is shown: 
R363R1, E400R1, K499R1, E511R1 K528R1, and E559R1. (b) representative PRE profile of the 
E511R1 probe data. Normalized PRE intensity ratios (Iox /Ired) are shown as a function of residue 
number. The domain boundaries are shown in schematic above. The asterisk denotes the location 
of the probe. Green bars indicate the effect seen in the N2 domain that is not reflected in the 
 134 
crystal structure. Errors in the ratio measurements are approximately 10-15% based on signal to 
noise of the NMR spectra, and thus can lead to values in excess of 1. Errors in the intensity ratio 
can also occur as a result of manipulating the sample (adding ascorbic acid to oxidize the probe) 
and instrument instability. These errors are partially accounted for by adding ± 5.0 Å to the 
distance restraints that are obtained from the ratio data.  
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Figure 3.4 Schematic of the calculation strategy used to model the structure 
of IsdHN2N3 
In step (1), the structure of the linker-N3 inter-domain interface was determined using the 
appropriate NMR experimental restraints. In step (2), the coordinates from step (1) were used as 
input and only the structure of the N2-linker interface was refined against the NMR and SAXS 
data. The structure of the linker-N3 interface determined in step (1) is compatible with the 
experimental data, whereas the structure of the intact protein produced from step (2) exhibits 
slight, but systematic violations with the PRE distance data that originate from residues or probes 
located in the N2 domain (eight restraints have violations ranging from 0.5 to 2.7 Å). To account 
for this discrepancy, in step (3) ensemble calculations were performed in which the N2-linker 
interface calculations were using four molecular structures to represent the receptor. Color code: 
the N2, linker and N3 domains are colored green, yellow and blue, respectively, and the 
coordinates of residues that connect the domains are colored red (I462-Y475 connecting the N2 
and linker domains and V531-Q543 connecting the linker and N3 domains).  
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Figure 3.5 NMR structure model of a S. aureus tri-domain hemoglobin 
receptor, IsdHN2N3 
(a) The ensemble of the top 20 lowest energy structures for IsdHN2N3 calculated using the two 
step procedure outlined in Figure 4 (steps 1 and 2). The connector regions between each domain 
that were allowed to move during the conjoined rigid-body/torsion angle dynamics are colored in 
red. Two views are shown related by a 180°rotation. (b) Ribbon diagram of the lowest energy 
structure of IsdHN2N3. The N2, linker, and N3 domains are colored in green, yellow, and blue, 
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respectively. The residues connecting the domains are colored in red. Secondary structure 
elements are labeled for each subdomain. (c) Electrostatic surface of IsdHN2N3 showing 
positively and negatively charged residues colored in blue and red, respectively. (d) Graphical 
summary of the PRE-derived distance restraint data used to determine the structure showing its 
compatibility with the NMR structure. Data from probes providing attractive distance restraints 
are indicated by bold lines originating from spheres that correspond to the backbone position of 
each probe: R363R1 (dark blue), E400R1 (yellow), E511R1 (red), K528R1 (pink) and E559R1 
(green). Repulsive restraints are shown as light blue lines. Only inter-domain attractive and 
repulsive restraints are shown. The structures shown in panels (b to d) are presented in the same 
orientation and were generated using the program PyMOL [89]. 
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Figure 3.6 Compatibility of the structure of IsdHN2N3 with the PRE and 
SAXS data 
(a) For each probe the panels as a function of residue number a graph of the distance between the 
backbone amide protons to each probe in the top 20 lowest energy NMR structures (red dots). 
Standard deviations are represented by error bars and in some cases are too small to be seen. The 
shaded regions indicate the range of the PRE-derived distance restraints used in the calculation 
between the probe and amide proton, while the PRE-derived distance is indicated by a black dot. 
Repulsive restraints span a wide range of distances (upper half of each figure); while attractive 
restraints are assigned narrower ranges of ± 5.0 Å (bottom half each panel). Distances in the 
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structure indicated by a blue line correspond to residues in the ligand binding pockets and were 
not used in the NMR calculations. Each panel shows a violation analysis for one probe whose 
name is indicated on the upper half of the figure. Arrows indicate eight PRE-derived distance 
restraints that were systematically violated in ensemble by 0.5 to 2.7 Å (also partially shown in 
Figure 7A). (b) Fit of the experimental solution scattering of IsdHN2N3 to the theoretical 
scattering curve (colored in green) of the NMR structure (c = 0.96). The residual of the fit is 
shown at the top of the figure. The data was analyzed using the programs CalcSAXS [40] and 
CRYSOL [43]. (c) As in panel (b), but the coordinates of the crystal structure of the receptor in 
the IsdHN2N3:Hb complex (PDB code: 4IJ2) were used to generate the theoretical scattering curve 
(c = 0.92, colored green). 
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Figure 3.7 Estimation of the N2 domain motions in the Hb-free receptor  
(a) Six of the 8 consistently violated PRE-derived distance restraints mapped onto the lowest 
energy structure calculated from the two-step procedure. The blue arrows point toward the 
location of each violated restraint (backbone atoms colored red) that originate from the E511R1, 
R363R1 and E559R1 probes (shown in red spheres). (b) The top 15 calculated NOE energies as 
a function of ensemble size with the standard deviation shown in bars, where ensemble sizes 
greater than 4 results in error bars are too small to be seen. (c and d) The estimated domain 
motions of the N2 domain are shown as a reweighted atomic probability density map plotted at 
50% (green) and 10% (grey) of maximum. Two views are shown related by a 90° rotation. A 
cartoon representation of the single conformer Hb-free NMR model is shown in blue in panel (c), 
whereas a single receptor molecule from the crystal structure of the IsdHN2N3:Hb tetrameric 
complex (PDB code: 4IJ2, chain G) is shown in orange in panel (d). 
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Figure 3.8 Structural differences between the Hb-free and -bound forms of 
IsdHN2N3  
The NMR apo-model of IsdHN2N3 is shown in blue (left) and a single receptor molecule from the 
crystal structure of the IsdHN2N3:Hb tetrameric complex (PDB code: 4IJ2, chain G) is shown in 
orange (right). The distances shown are from the alpha carbon atoms of residues E362 and E559. 
The transition from the free form of the receptor into a more compact bound form is modeled in 
the figure by showing hypothetical structural intermediates of the Hb binding pocket in N2 
(middle). Structural intermediates were calculated using the Rigimol plugin for PyMOL [89]. 
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Figure 3.9 Model of hemin extraction by IsdHN2N3  
The panel on the left shows a hypothetical structure of the complex between the NMR model of 
IsdHN2N3 (blue) and dimeric Hb (αHb in pink with the F-helix colored in purple and βHb in 
yellow). The model was generated by superimposing the coordinates of the N2 domain in the 
NMR model and crystal structure of the IsdHN2N3:Hb complex (PDB code: 4IJ2, chain G). The 
panel on the right shows the structure of the IsdHN2N3:Hb complex for comparison (only one 
receptor is shown). The protein backbones of the receptors are shown in schematic and surface 
representation. The globin chains of Hb are shown in schematic and the hemin groups are 
colored red and shown in stick representation. Residues within the linker domain of IsdHN2N3 that 
are atomically overlapping with αHb are also shown in stick representation and colored green. 
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3.8 Supplementary Information 
 
The PRE-Derived NMR Model of the 38.8 kDa Tri-Domain IsdH Protein 
from Staphylococcus aureus Suggests that it Adaptively Recognizes Human 
Hemoglobin 
 
 
Figures 3.S1-3.S3 
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Figure 3.S1 15N relaxation analysis of IsdHN2N3  
(a) Backbone amide 1H-15N heteronuclear NOE for IsdHN2N3(Y642A). The peak intensity ratio 
between spectra with and without 1H saturation as a function of the residue number is shown. 
The average heteronuclear NOE values and standard deviation values of two experiments are 
displayed. A total of 238 residues yielded HetNOE values. (b) Longitudinal, R1, and (c) 
transverse, R2, spin relaxation data for IsdHN2N3(Y642A). A total of 155 and 142 residues yielded R1 
and R2 data, respectively. Secondary structure and domain boundaries are displayed at the top of 
each panel. 
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Figure 3.S2 Correlation between observed and back calculated intra-domain 
distances for each probe used the calculation of IsdHN2N3(Y642A) 
 Each panel shows a correlation plot for all intra-domain attractive (Iox/Ired < 0.8) restraints for a 
given probe in IsdHN2N3(Y642A). Dashed lines indicate ± 5 Å error bounds for the PRE-derived 
distance data. Intra-domain Q-factors for R363C (N2), E400C (N2), K499C (linker), E511C 
(linker), K528C (linker) and E559C (N3) are 0.24, 0.14, 0.28, 0.37, 0.10, 0.27, respectively.  
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Figure 3.S3 Violation analysis of the NMR model of IsdHN2N3(Y642A) determined 
from the two-step calculation procedure  
Correlation plot for all inter-domain attractive (Iox/Ired < 0.8) PRE-derived distance restraints 
used to model the intact Hb-free receptor. Dashed lines indicate ± 5 Å error bounds for the PRE-
derived distance data. The standard deviation of the back calculated distances of the top 20 
lowest energy individual simulated annealing structures are shown in error bars. The 8 
systematic violations originating to the N2 domain are shown as outliers and are from the 
following restraints: R363R1- F555, R363R1-E562, R363R1-V628, R363R1-R649, E511R1-
H344, E511R1-T376, E559R1-M356, and E559R1-G362.  
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Chapter 4 
 
The S. aureus IsdH Protein Accelerates Hemin Release from the  
a-Subunit of the Hemoglobin Tetramer by at least 10,000-fold 
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4.1 Overview   
Staphylococcus aureus is a Gram-positive pathogen that during infections actively 
acquires iron from human hemoglobin (Hb) using two iron-regulated surface determinant (Isd) 
proteins, IsdH and IsdB. These receptors use a conserved tri-domain unit consisting of two NEAr 
iron Transporter (NEAT) domains connected by a helical linker domain to capture Hb and 
rapidly extract it hemin (oxidized form of heme). Previous studies have shown that IsdH’s tri-
domain unit (IsdHN2N3, residues A326-D660) accelerates the rate of hemin release from Hb. 
However, these studies only described the overall hemin extraction process as Hb adopts various 
quaternary states that have different propensities to release hemin. We therefore developed a 
novel quantitative hemin transfer assay to probe the kinetic and thermodynamic determinants of 
hemin extraction. Utilization of a recombinant stabilized Hb tetramer (Hb0.1) and an a-globin 
specific IsdHN2N3 receptor (a-IsdH) provided the selective measurement of hemin release from 
only the a-subunit of tetrameric Hb. Using a combination of analytical ultracentrifugation, 
stopped flow UV-Vis, and ITC methods, our studies reveal that a-IsdH accelerates the rate of 
hemin release from the a-subunit by least 10,000-fold, corresponding to an activation energy that 
is lowered by ~6 kcal/mol. Furthermore, direct hemin transfer from the b-subunit to wild-type 
IsdHN2N3 was observed for the first time, illustrating the wild-type IsdHN2N3 binds both a- and b-
subunits and actively extracts their hemin. Additionally, Hb binding studies reveal that IsdHN2N3 
recognizes Hb via two energetically distinct interfaces. The first interface (N2-Hb) is an 
enthalpically favorable high affinity interface that presumably allows the receptor to maintain 
overall binding affinity so that the low affinity enthalpically unfavorable (LN3-Hb) interface can 
form. Moreover, the enthalpic penalty associated with the formation of the LN3-Hb interface is 
compatible with the receptor unwinding the iron-coordinating F-helix in Hb. 
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4.2  Introduction 
 Staphylococcus aureus is an opportunistic Gram-positive pathogen that causes a wide 
range of illnesses such as pneumonia, meningitis, endocarditis, toxic shock syndrome, bacteria, 
and septicemia [1]. Strains of S. aureus that are resistant to β-lactam antibiotics are not only a 
leading cause of life-threatening hospital-acquired infections, but have also become 
commonplace within communities [2,3]. Therefore, understanding the molecular mechanisms 
this microbe uses to survive and persist within the human host is a critical step in developing 
anti-infective treatments to counteract its virulence. Like most microorganisms, S. aureus 
requires micromolar (10-6 M) levels of iron in order to proliferate because this element functions 
as a key biocatalyst in microbial metabolism processes [4,5]. However, nutritional immunity 
mechanisms within its host limit microbial access to iron by sequestering it intracellularly 
through binding to proteins such as hemoglobin and ferritin, as well as extracellularly by being 
bound to proteins such as hemopexin and transferrin. Therefore, free iron is scarce in the human 
body and must be actively procured by S. aureus in order for it to successfully mount an 
infection [6,7]. Heme (protoporphyrin IX + iron) bound to hemoglobin (Hb) accounts for the 
~75-80% of the total iron found in the human body and is preferentially used by S. aureus as an 
iron source [8,9]. Consequently, S. aureus and other microbial pathogens have evolved elaborate 
heme-acquisition systems to take advantage of this rich iron source.  
 S. aureus uses the iron-regulated surface determinant (Isd) system to extract the oxidized 
form of heme from Hb (hereafter called hemin). It is comprised of nine proteins that form a 
hemin relay system that captures Hb and rapidly extracts its hemin, transfers hemin across the 
cell wall, and then pumps the hemin into the cytoplasm where it is degraded to release free iron 
[10–12]. Four Isd proteins (IsdA, IsdB, IsdC, and IsdH/HarA) are covalently linked to the 
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bacterial cell wall via sortase transpeptidases [13,14]. The two surface receptor proteins, IsdH 
and IsdB, first bind Hb and extract its hemin [15–19]. Then the hemin is passed to IsdA, which is 
partially buried in the cell wall [20]. Holo-IsdA subsequently transfers hemin to the fully buried 
IsdC protein via an ultra-weak handclasp complex [21–24]. Lastly, holo-IsdC delivers the hemin 
to the bacterial ABC transporter complex, IsdDEF, which pumps hemin into the cytoplasm to be 
degraded by the hemin oxygenases, IsdG or IsdI, which liberate the iron for the microbe to use 
[25,26]. The Isd system is important for S. aureus virulence, as strains lacking genes within this 
system displayed attenuated infectivity in mice compared to wild-type strains and were also 
incapable of utilizing hemin or Hb as the sole source of iron [9,13,27–29]. Systems related to Isd 
are also used by other microbes to extract hemin.  
Extraction of hemin from the oxidized form of Hb (called methemoglobin, MetHb) is 
mediated by the related IsdB and IsdH receptors [17,18,30–33]. They have similar primary 
sequences and contain NEAr iron Transporter (NEAT) domains, binding modules originally 
named because they were found in bacterial genes that are proximal to putative Fe3+ siderophore 
transporter genes [34]. Our studies of IsdH have shown that hemin extraction is mediated by a 
tri-domain unit that contains the second (N2) and third (N3) NEAT domains that are connected 
by a helical linker domain (IsdHN2N3, residues A326-D660) (Figure 4.1a). Studies using native 
MetHb have shown that this unit captures hemin from MetHb ~500-fold faster than the rate at 
which hemin spontaneously dissociates from MetHb, suggesting that hemin release is triggered 
by an activated protein-protein complex. IsdB shares a functionally similar tri-domain unit that 
likely operates via a similar mechanism as less extensive studies have shown that is extracts 
hemin from MetHb at a comparable rate as IsdHN2N3 [18,24,30,35].  
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Recent NMR and crystallography studies of the Hb-free and –bound states have provided 
insight into how IsdH promotes hemin release [31–33]. A low resolution (4.2Å) crystal structure 
of the complex revealed that the IsdHN2N3 receptor can bind to each of the four globin chains 
within tetrameric MetHb. Each receptor adopts an extended dumbbell shape structure in which 
the N2 domain engages the A- and E-helices of MetHb, while the N3 domain is positioned 
within 12 Å of the hemin molecule of the same globin chain. This structure revealed the overall 
mode of binding, but left mechanistic details elusive. Subsequently, a higher resolution (2.6 Å) 
crystal structure of the MetHb-IsdHN2N3 complex in which the IsdH protein was engineered to 
eliminate binding to the b-subunit revealed that the helical linker domain in the receptor distorted 
the F-helix in Hb that houses the iron-coordinating proximal histidine residue (HF8). The F-helix 
is partially unwound, suggesting that the receptor promotes hemin release by either weakening 
and/or exposing the HF8-iron bond to the solvent for hydrolysis. NMR studies of the apo-
receptor uncovered the presence of inter-domain mobility between the N2 and linker domains, 
revealing that the receptor adaptively recognizes Hb through a combination of conformational 
selection and induced fit mechanisms. 
We are lacking a quantitative understanding of the kinetics and thermodynamics that 
underlie hemin extraction. This is because several features of the transfer have thus far limited 
detailed biophysical characterization. First, MetHb can adopt distinct quaternary states that have 
different propensities to release hemin. This has prevented the accurate quantification of the 
transfer kinetics because MetHb adopts both tetrameric and dimeric states at concentrations 
typically used in stopped-flow UV-visible spectroscopy experiments [36,37]. Second, the α- and 
β-globin chains have distinct penchants for releasing hemin [38,39]. Thus, the measured rates of 
hemin transfer using native MetHb are an amalgamation of these distinct rates. Moreover, the 
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issue is further complicated by the fact that hemin release from one globin chain in the MetHb 
dimer or tetramer is known to increase the rate at which hemin is released from the remaining 
globin chains [40]. Finally, hemin release from the globin chains within the tetramer can cause 
MetHb to dissociate into its component globin chains, which can irreversibly aggregate [40,41]. 
As a result of these obstacles, all reported kinetics data only describe the overall process of 
hemin removal, and do not provide information about the rate at which hemin is removed from 
each globin chain when MetHb is in a defined oligomerization state. These have prevented a 
quantitative understanding of the energetics and kinetics underlying hemin extraction.  
 We have developed a novel quantitative assay that selectively monitors the kinetics of 
receptor-mediated hemin removal from only the α-globin chain of tetrameric MetHb. Using 
stopped-flow UV-vis spectroscopy, ultracentrifugation, and ITC experiments we demonstrate 
that IsdH accelerates the rate of hemin release from the a-subunit of tetrameric MetHb by at 
least 10,000-fold, significantly faster that previously reported measurements that were 
complicated by MetHb dissociation and hemin removal from the b-chain. Measurements of the 
activation energies of hemin transfer suggest that the enthalpic barrier required to hydrolyze the 
HF8-iron bond is the primary factor limiting hemin release from the a-subunit. Quantitative 
measurements of the Hb-receptor binding interactions, reveals that two molecular interfaces are 
needed to distort a-subunit to release its hemin. An interface between the N2 domain the A-helix 
of Hb is the primary contributor to overall binding affinity, and tethers the receptor to Hb 
enabling a very low affinity interaction between linker-N3 domains and the F-helix that contacts 
the hemin. Thermodynamic measurements of the binding energies indicate that interactions at 
the latter interface are enthalpically unfavorable, consistent with the notion that the receptor 
unwinds the F-helix to release hemin. Additionally, data is also presented that the shows the 
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receptor actively extracts hemin from the b-subunit. A model of the hemin extraction process is 
presented that incorporates the existing structural, kinetics and thermodynamic binding data.  
 
 
4.3  Results 
4.3.1 Development of a quantitative assay to probe hemin extraction  
 We developed an assay to quantitatively probe the kinetics of hemin transfer to the 
receptor from the a-globin chain within tetrameric MetHb. Two reagents are used in the assay. 
First, we constructed a mutant of IsdHN2N3 that only binds to the a-subunit of Hb (α-IsdH, 
residues A326-D660, with 365FYHYA369 à 365YYHYF369 mutations). α-IsdH contains F365Y 
and A369F mutations in the 310-helix of the Hb binding N2 domain (Figure 4.1b). These 
mutations do not affect hemin binding or the structure of the receptor, but have previously been 
shown by the Gel group to selectively weaken the receptor’s affinity for the b-subunit in Hb 
[33]. Second, we employed a recombinant form of Hb in which its two a-subunits are connected 
to one another to stabilize its tetrameric quaternary state. The subunits are connected by 
expressing them as a single polypeptide in which the C-terminus of one subunit is joined via a 
glycine residue to the N-terminus of the second subunit. This form of recombinant Hb (called 
Hb0.1) also contains a V1M mutation to facilitate expression in E. coli, but is otherwise 
structurally and functionally identical to native Hb and has a reduced propensity to dissociate 
into dimers [37,42].  
We initially performed a series of control experiments to ensure that the Hb0.1 and α-
IsdH protein reagents enable hemin extraction from only the a-subunit in tetrameric Hb to be 
selectively monitored. First, analytical ultracentrifugation (AUC) sedimentation equilibrium 
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experiments were performed to define the stoichiometry of the Hb0.1: α-IsdH complex at 
conditions that are to be used in stopped flow measurements of hemin transfer. To prevent 
complications caused by hemin transfer in the AUC experiments, Hb0.1 was maintained in its 
carbonmonoxy ligated state and a hemin binding deficient Y642A mutant of α-IsdH was 
employed that removes its iron coordinating tyrosine residue in the N3 domain. In the AUC 
experiments the concentration of hemoglobin is monitored by measuring the absorbance at 412 
nm, the Soret band of the bound heme molecule. AUC using only Hb0.1 reveals as expected that 
it is a stable tetramer; Hb0.1 has a weighted average molecular mass of 64,212 ± 829 Da at 
13,000 ´ g when its concentration is 5 µM (hemin units) (Table 4.1). Maintenance of its 
tetrameric state at 5 µM is desirable as native Hb at this concentration is a mixture of dimeric 
and tetrameric species. Interestingly, when the AUC experiments are repeated with a-IsdHY642A 
present at a 15-fold molar excess with respect to Hb0.1, a new complex forms that has an 
average molecular mass of 140,070 ± 2096 Da when the samples are centrifuged at 6,000 ´ g (a 
mass of 131,570 ± 894 Da is obtained when centrifuged at 13,000 ´ g). This data indicates that 
~1.8 a-IsdHY642A receptors bind to each Hb0.1 tetramer, which is compatible with the receptor 
binding to only the a-subunits. Increasing the ratio of a-IsdHY642A to Hb0.1 to 30:1 did not 
increase this stoichiometry, indicating that Hb is saturated (Figure 4.2a, red curve). In contrast, 
an IsdH receptor that does not contain alterations in its Hb contacting 310-helix binds Hb0.1 at a 
~3.2 stoichiometry, consistent with it being capable of binding to both the a- and b-subunits. 
This was demonstrated by monitoring receptor binding to Hb0.1 using IsdHY642A, which is 
identical to the wild-type IsdH protein, but contains a single amino acid change in its N3 domain 
that disrupts hemin binding. As shown in Figure 4.2a, AUC studies using a ratio of 1:30 Hb0.1: 
IsdHY642A reveal the proteins form a complex with molecular mass of 188,110 ± 1,518 Da at 
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6,000 ´ g or 175,120 ± 1045 Da at 13,000 ´ g, that is compatible with ~3.2 IsdH receptors bound 
one Hb0.1 tetramer. In principle, the ~1.8 finding stoichiometry observed for the a-
IsdHY642A:Hb0.1 complex could result from a-IsdHY642A binding to the b-subunit of hemoglobin 
(Met-b). To test for this possibility, receptor binding to isolated b-globin chains was examined 
by AUC (Figure 4.2b). In isolation, hemin bound b-globin chains have been shown to primarily 
adopt a tetrameric structure; the tetramer-monomer equilibrium constant is 1.25 ´ 10-12 M3 at pH 
7 (K4,1) [37,43]. Our AUC studies are consistent with these findings as the isolated b-globin 
chains have a molecular mass of 56,700 ± 724 Da at 6000 ´ g (56,300 ± 508 Da at 13,000 ´ g). 
Interestingly, when the AUC studies are repeated with excess IsdHY642A present, the receptor 
binds tetrameric b-subunit to form a complex in which ~2.0 IsdHY642A receptors are bound to 
each b-tetramer (molecular mass of 134,000 ± 1321 Da at 6000 ´ g). However, when similar 
experiments are performed using a-IsdHY642A no detectable binding is observed. Overall, these 
AUC results indicate that the a-IsdHY642A receptor only binds to the a-subunits within Hb0.1 and 
that both of these subunits are nearly saturated with the receptor when the proteins are present at 
a ratio of 15:1 a-IsdHY642A:Hb0.1. Data summarizing the results of the AUC experiments is 
presented in Table 4.1.  
 
 
4.3.2 Stabilization of the Hb tetramer slows the rate of hemin capture from 
the a-subunit  
It is well known that as hemin dissociates from the individual subunits within the 
hemoglobin tetramer, the rate of hemin release from the remaining subunits increases. The rate 
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acceleration is thought to be caused by two factors: irreversible tetramer dissociation into its 
component globin subunits that more rapidly release hemin, and the increased rate of hemin 
release from the semi-forms of tetrameric and dimeric Hb species. These effects greatly 
complicate kinetics measurements and are the reason why the quantitative assay was developed. 
To investigate the importance of tetramer dissociation on hemin transfer, stopped flow UV-Vis 
spectroscopy experiments were performed to measure the rate at which a-IsdH extracted hemin 
from either native MetHb or the stabilized MetHb0.1 tetramer. In these studies, the proteins were 
rapidly mixed with one another, and the amount of hemin transfer was determined by monitoring 
UV absorbance changes at 405 nm as previously described in detail. In the experiments, a 30-
fold molar excess of receptor was employed (5 and 150 µM MetHb and receptor, respectively), 
to ensure that a-IsdH bound to both of the a-globin chains. Upon mixing MetHb0.1 with excess 
apo-a-IsdH, a rapid shift in the UV-spectrum occurs indicating hemin transfer from MetHb0.1 to 
the receptor (Figure 4.3a). Plotting the time-dependent spectral changes at 405 nm reveals 
(Figure 4.3b) that the transfer reaction exhibits biphasic kinetics, with half the magnitude of the 
total spectral change characterized by a rapid event defined by the kfast rate constant and the 
remaining slower changes defined by a kslow rate constant (Figure 4.3b-d). Importantly, hemin 
transfer is completed during the time course of the stopped flow experiment, as no significant 
spectral changes are observed when the proteins are incubated overnight. As the receptor is in 
excess and has higher affinity for hemin than hemoglobin (described below), we conclude that 
all of the hemin in hemoglobin has been captured by the receptor. The observed pseudo-first-
order rate constants, kfast and kslow are 0.34 ± 0.01 s-1 and 0.026 ± 0.001 s-1, respectively (Table 
4.2). As a-IsdH only binds to the a-subunits of the stabilized Hb0.1 tetramer, we conclude that 
the rapid changes characterized by kfast describe hemin removal from the a-subunit within 
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tetrameric Hb0.1, and that the slower changes result from hemin release from the b-subunit into 
the solvent, followed by subsequent binding to excess receptor present in solution. The kinetics 
of this slower phase are consistent with this hypothesis, as the b-subunit is known to 
spontaneously release hemin into solvent with a rate constant of ~0.013 s-1 after hemin has been 
removed from the a-subunit of the tetramer [37,40]. To investigate the effects of Hb 
tetramerization on the kinetics of extraction, we performed similar experiments using native 
MetHb, which is known to dissociate into its component globin chains after hemin is removed. 
Interestingly, native MetHb loses hemin to the receptor much faster, with kfast and kslow rate 
constants of 3.27 ± 0.07 s-1 and 0.041 ± 0.001 s-1, respectively. We conclude that the increase in 
kfast is caused by a-IsdH binding to monomeric a-globin chains produced as a result of tetramer 
dissociation; the monomers have weaker affinity for hemin. Interestingly, increases in kslow are 
also observed and are presumably caused by rapid hemin release from the b-subunits that are 
produced as a result of tetramer dissociation, as the isolated b-subunits are known to release 
hemin more rapidly than b-subunits that are located in tetrameric hemoglobin [37]. 
Tetramer dissociation also increases the rate of hemin transfer to the native IsdH receptor 
that binds to both the a- and b-subunits of Hb. This was demonstrated by determining the ability 
of wild-type IsdH to remove hemin from either native MetHb or the stabilized MetHb0.1 
tetramer. As with a-IsdH, significantly slower kinetics are observed for hemin removal from 
MetHb0.1 as compared to MetHb. This is consistent with the reduced propensity of MetHb0.1 to 
dissociate into dimeric and monomeric species that release hemin more rapidly. Interestingly, 
both the fast and slow phases of hemin transfer to IsdH from the stabilized MetHb0.1 tetramer 
occur more rapidly than transfer to a-IsdH (kfast and kslow values of 0.73 ± 0.03 s-1 and 0.038 ± 
0.001 s-1, respectively). As IsdH can also bind to b-subunits of the stabilized tetramer, it seems 
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possible that its larger kfast and kslow rate constants are caused by the increased rate of hemin 
transfer from the semi-forms of Hb that are produced as hemin is removed. This is because it is 
known that hemin removal from the a-subunit increases the rate of hemin loss from the b-
subunit up to 3-fold, raising the possibility that IsdH bound to the b-subunit could more rapidly 
acquire its hemin once hemin has been lost from an adjacent a-subunit. Similar rate 
enhancements are observed for the a-subunit when hemin is first removed from the b-subunit. 
Combined, this data indicates that the propensity of Hb to dissociate during the extraction 
process increases the overall observed rate of transfer to the receptor by producing partially 
ligated states or dissociated forms of hemoglobin that have a greater predisposition to release 
their hemin molecules. Taken together, the results from the ultracentrifugation and stopped flow 
hemin transfer experiments clearly show that utilization of the stabilized Hb0.1 tetramer and 
alpha globin specific a–IsdH receptor enables the selective measurement of hemin removal from 
only the a-subunit of tetrameric Hb. 
 
4.3.3 IsdH also accelerates the rate of hemin release from the b-subunit.  
The ability of a-IsdH to rapidly remove hemin from Hb0.1 indicates that receptor can 
capture hemin from the a-subunit, but it has never been conclusively demonstrated that the 
receptor can also actively extract hemin from the b-subunit. In principle, it is possible that the 
receptor only actively extracts hemin from the a-subunit, whereas hemin loss from the b-subunit 
occurs subsequently from dissociated and semi-forms of hemoglobin. In order to investigate this 
issue, we determined the ability of the receptor to remove hemin from tetrameric Met-b,  which 
only contains b-globin chains bound to hemin (Table 4.1). Initially, to probe the rate at which it 
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spontaneously releases hemin into the solvent, we initially mixed Metb with recombinant 
H64Y/V68F apo-myoglobin (apo-Mb containing H64Y and V68F mutations) [40]. Apo-Mb does 
not physically interact with Metb and undergoes unique absorbance changes that can be used to 
monitor hemin release by a hemoprotein. As shown in Figure 4.4, when 5 µM Metb is mixed 
with excess apo-Mb only modest spectral changes are observed after 10 s. This indicates that 
apo-Mb does not actively remove hemin from Metb and that Metb does not rapidly release 
hemin into the solvent. In contrast, addition of IsdH to Metb causes rapid changes in absorbance 
at 408 nm within the first 5 s of the experiment, indicating that hemin is being transferred from 
Metb to IsdH. Furthermore, as expected, when a-IsdH is mixed with Metb under similar 
conditions, little or no active transfer is observed as it is incapable of binding to the b-subunit 
based on the AUC data. It should be noted that in all of the experiments that monitored hemin 
removal from Metb, absorbance changes are observed after ~20 s that are compatible with apo-b 
denaturation, which prevents the quantitative measurement of the extraction kinetics. These 
results clearly indicate that native IsdH can actively remove hemin from the Metb, and suggest 
that it is capable of actively removing hemin from the b-globin chain within human hemoglobin. 
This ability further highlights the need for assays to selectively monitor hemin removal from 
specific globin chains. Data summarizing the results of the stopped flow experiments are 
presented in Table 4.2.  
 
4.3.4 The IsdH receptor has a higher affinity for hemin than hemoglobin 
Towards the goal of defining the micro rate constants that describe the hemin transfer 
process, we determined the relative hemin affinities of the IsdH receptor and MetHb. Hemin 
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binding competition studies were performed using the apo-Mb reagent, which has a known 
affinity for hemin and whose binding to this ligand can readily be measured at 600 nm. Mixing 
of either 5 µM MetHb or MetHb0.1 with a 10-fold molar excess of apo-Mb results in a 
measurable increase in absorbance at 600 nm indicating that hemin is transferred to apo-Mb 
(Figure 4.5a). Transfer from MetHb or MetHb0.1 occurs very slowly, compatible with hemin 
first being released into the solvent before it is bound by apo-Mb. This transfer data is 
compatible with the previously published hemin dissociation constants (K-H) of MetHb and apo-
Mb. In particular, the K-H of apo-Mb is ~0.03 pM, which ~50-1,400x smaller than the K-H of 
dimeric MetHb (1.7 and 42 pM for a and b chains, respectively), and it is ~25-140x smaller than 
K-H of tetrameric MetHb (0.8 and 4.2 pM for a and b chains, respectively) [37]. Notably, the 
stabilized tetramer MetHb0.1 releases hemin more slowly than MetHb. This is consistent with 
previous studies that have shown that the tetrameric form of MetHb releases hemin more slowly 
than the dimeric form, and with the fact that MetHb0.1 is predominately tetrameric, whereas 
MetHb is a mixture of dimeric and tetrameric forms; at the 5 µM hemoglobin concentrations 
used in this study, ~65% of MetHb is tetrameric and ~35% is dimeric (K4,2 of 1.5 µM) [37]. 
Interestingly, similar experiments using apo-Mb and hemin-saturated IsdH reveal that the 
receptor transfers little hemin to apo-Mb, indicating that, unlike Hb and Hb0.1, the receptor has 
higher affinity for hemin than apo-Mb. Moreover, a-IsdH also did not transfer its hemin to apo-
Mb, indicating that mutations in the hemoglobin binding domain do not affect its hemin affinity 
(data not shown). Taken together, we conclude that IsdH and a-IsdH bind hemin with K-H values 
< ~0.03 pM, such that they have substantially higher affinity for hemin than MetHb. Therefore, 
during the time-frame of the stopped flow experiments used to study the transfer reaction, 
transfer of hemin from hemoglobin to the receptor is effectively irreversible.  
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4.3.5 Kinetic Scheme Describing Hemin Transfer from Hb0.1 to a-IsdH 
The ability to measure the kinetics of hemin removal from only the a-globin subunit in 
tetrameric Hb0.1 enables micro rate constants to be quantitatively measured for the first time. 
Based on the stopped flow and AUC results, it is possible to model the hemin transfer reaction as 
described in Scheme I. In the model, hemin-bound Hb0.1 forms a complex with apo-a-IsdH 
described by the association and dissociation rate constants, k1 and k-1. Within this complex 
hemin is then transferred from the a-subunit of tetrameric Hb0.1 to a-IsdH in a process 
described by the rate constant ktrans. This yields a semi-form of Hb0.1 in which one hemin 
molecule has been removed and the protein remains bound to holo-a-IsdH. At the conditions 
used in our stopped flow experiments, the measurable rate constant kfast describes the kinetics of 
this entire process and accounts for the simultaneous removal of hemin from both a-subunits. 
This is consistent with the stopped flow data, as half of the overall spectral change is described 
by kfast, which corresponds to hemin removal from the two globin chains within the tetramer.  
 
 
Scheme I 
 
To determine the micro rate constants, the kinetics of hemin transfer was measured for a series of 
reactions that contained 5 µM Hb0.1 and varying concentrations of apo-a-IsdH. At all 
receptor:Hb0.1 stoichiometries, kfast accounted for ~50% of the total spectral change consistent 
with it monitoring team removal from the a-subunit only (Figure 4.3b), and kfast increased 
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hyperbolically with increasing receptor concentrations (Figure 4.5b, dark grey circles). This is 
compatible with the rapid formation of a Hb:apo-a-IsdH complex followed by a rate-limiting 
transfer of the hemin to the receptor. In the hemin transfer experiments, apo-a-IsdH has a 
concentration more than ten times higher than the concentration of Hb0.1], such that the rate of 
hemin transfer is pseudo-first-order. The dependence of kfast on the micro rate constants and 
receptor concentration can therefore be described by Equation 1 [44], 
 
 𝑘QRST = 	 𝑘1𝑘𝑡𝑟𝑎𝑛𝑠 a−IsdH𝑘1 a−IsdH 	+	𝑘−1	+	𝑘𝑡𝑟𝑎𝑛𝑠 (1) 
 
where k1, k-1, and ktrans are the micro rate constants of the individual reaction steps in Scheme I. 
As shown in Figure 4.5b, fitting of the kinetics data using Eq. 1, yields values of 2.81 ´107 ± 
0.01 M-1×s-1, 2.41´103 ± 0.11 s-1, and 0.57 ± 0.02 s-1 for k1, k-1, and ktrans, respectively. The 
equilibrium dissociation constant (KD ) of the Hb0.1:apo-a-IsdH transfer complex calculated 
from the micro rate constants is 85.7 ± 3.8 µM, a value that is consistent with dissociation 
constants obtained using isothermal calorimetry (described below). Interestingly, measurement 
of kslow reveals that it is independent of the receptor concentration under pseudo-first order 
conditions (Figure 4.5b, light grey circles). This observation further supports the notion that 
kslow describes the non-specific release of hemin from the b-globin chain into the solvent 
followed by hemin uptake by excess apo-a-IsdH.  
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4.3.6 An enthalpic barrier slows the rate of hemin transfer 
To gain insight into the energetic barrier that the receptor must surmount in order to 
trigger hemin release from hemoglobin, we estimated the activation energy parameters using the 
Eyring equation. Stopped flow experiments were performed at temperatures ranging from 15 to 
37°C using a molar ratio of 1:40 Hb0.1:apo-a-IsdH (Figure 4.6a). At this Hb:receptor ratio the 
contribution of k1, k-1 to the measured kfast rate constant becomes negligible, thus kfast » ktrans [44]. 
A plot of ln(ktrans/T) versus 1/T enables the activation parameters to be determined (Figure 4.6b) 
using the linearized form of the Eyring equation, 
 
 𝑙𝑛 a` = 𝑙𝑛 `bc + ∆e‡4 − ∆g‡4a   (2) 
 
where kB, h, and R are the Boltzman, Planck, and ideal gas constants, respectively. The 
activation enthalpy (DH‡) and entropy (DS‡) are calculated from slope and intercept, respectively 
(Figure 4.6b). The overall activation energy, DG‡, is then calculated from DG‡ = DH‡ - TDS‡. 
This analysis yielded DH‡ and S‡ values of 19.45 ± 1.1 kcal/mol and 4.45 ± 0.31 cal/mol×K, 
respectively, and a DG‡ value of 18.07 ± 1.1 kcal/mol at 37°C (Table 4.3). The measured 
activation free energy associated with hemin transfer from hemoglobin to the receptor is of 
similar magnitude to previously reported energetic barrier associated with the cleavage of the 
proximal histidine-heme (Ne-Fe) bond in hemoglobin (~17 kcal/mol) [45]. This suggests that a 
similar barrier may exist in the process of receptor-mediated hemin extraction from the a-subunit 
of hemoglobin. This is compatible with the finding that DH‡ is the main contributor to the 
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activation energy describing hemin transfer, as there is presumably a large enthalpic penalty 
associated with breaking the bond to the metal.  
 Quantitative measurement of ktrans enables an estimate of how much the receptor reduces 
the activation energy associated with removing hemin from hemoglobin. Previous studies have 
shown that hemin dissociates from the a-globin chain of tetrameric Hb at a rate of 0.000083 s-1 
[37]. Based on a modified version of the Arrhenius equation, the free energy of activation 
associated with spontaneous hemin release is described by, 
 
 ∆𝐺‡ = 	−𝑅𝑇𝑙𝑛 c``ba  (3) 
 
where kB, h, and R are the Boltzman, Planck and ideal gas constants, respectively, k is the rate 
constant and T is the temperature. This indicates that the DG‡ of spontaneous hemin release is 
23.96 kcal/mol at 37°C. Measurements of ktrans indicates that the receptor accelerates the rate of 
hemin release from the a-subunit at least 10,000-fold (kfast = 0.88 s-1 vs. 0.000083 s-1 at 37°C). 
Thus, the receptor lowers the activation energy by 5.9 kcal/mol. How the receptor reduces the 
activation energy is not known, but could result from receptor-mediated distortions of 
hemoglobin that weaken the strength of the axial bond to iron.  
 
4.3.7 Residues in the linker domain contribute to the accelerated rate of 
hemin release  
In order to gain insight into the molecular mechanism of hemin extraction, the newly 
developed hemin transfer assay was used to measure the extraction kinetics of several receptor 
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mutants. Working with our collaborators, we have previously shown that residues in the helical 
linker domain of IsdH interact with the F-helix in Hb that coordinates the metal in heme [31,33] 
(Figure 4.7b). The interactions distort the F-helix which contains the iron-coordinating proximal 
histidine residue H87 (HF8). We therefore made several amino acid mutants of the receptor that 
altered residues at this interface and measured their ability to extract hemin from hemoglobin. 
These amino acid mutants included Y495A and K499A alterations that disrupted specific linker 
domain-F-helix interactions and a double Y495A/K499A mutant. In addition, a mutant receptor 
containing seven alterations in the linker domain was investigated. As shown in Figure 4.7c and 
d, the single amino acid Y495A and K499A are able to capture hemin nearly as well as the wild-
type receptor, as they have kfast values that are only ~3 and ~2 times slower than a-IsdH, 
respectively. The double alanine Y495A/K499A substitution exhibits a more pronounced ~5-fold 
reduction in kfast. Interestingly, mutation of these residues does not abolish rapid hemin 
extraction, which might be expected if they were major contributors in the triggering of hemin 
release. We therefore tested a mutant receptor in which less conservative changes are made. 
Based on our modeling previous studies using the NMR structure of apo-IsdH, seven residues in 
the linker domain were postulated to interact with Hb’s F-helix. We therefore constructed a 
mutant, termed 7-Ala, that changes these residues to alanine (7-Ala, is IsdHN2N3 containing 
K479A, K486A, R492A, Y495A, E496A, K499A, and K503A mutations) [31]. Interestingly, the 
7-Ala mutant captures hemin from Hb0.1 ~12-fold slower than a-IsdH. As 7-Ala is folded based 
on NMR studies (data not shown), this preliminary data suggests that several residues in the 
linker domain play an important role in promoting the release of hemin from hemoglobin. 
However, since the mutant can still rapidly capture hemin, receptor residues outside this contact 
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interface must also be important (discussed later). A more extensive analysis of the impact of 
these mutations on the activation energy of hemin transfer will be performed in the future. 
 
4.3.8 Two energetically distinct receptor-hemoglobin interfaces promote 
hemin release  
 Using the crystal and NMR structural data as a guide, we measured the energetics 
associated with receptor binding to hemoglobin using ITC. The structure of the Hb-receptor 
complex and NMR dynamics data suggests that the receptor interacts with Hb via two distinct 
interfaces. The N2 domain binds to the A-helix of Hb, while the linker and N3 domains form a 
rigid unit that interacts with the F-helix of the same globin chain (Figure 4.7a). Previous studies 
have shown that the N2 domain can be studied in isolation. We therefore rigorously 
characterized the binding of the intact receptor and a polypeptide fragment containing only the 
N2 domain. Binding was measured by ITC to obtain estimates of the thermodynamic parameters. 
As with the AUC experiments, the carbonmonoxy form of Hb was used to prevent hemin 
transfer during the experiment. In addition, a Y642A mutation in a-IsdHY642A mutant of the 
receptor was employed that is incapable of binding hemin. In the ITC experiments, a syringe 
filled with 200 µM a-IsdHY642A was injected incrementally into a cell containing 30 µM of 
HbCO and the ensuing heat changes were recorded. A representative binding isotherm is shown 
in Figure 4.8a, which was fit using ORIGIN software. This analysis yields the dissociation 
constant and the stoichiometry of complex formation. Consistent with the AUC studies of the 
complex, a-IsdHY642A binds Hb at a ratio of ~2:1. The measured KD value for the Hb:a-
IsdHY642A complex is 4.6 ± 0.8 µM and has a similar order of magnitude as the value obtained 
from an analysis of the kinetics data (KD = 85.7 ± 3.8 µM). At 25oC, the enthalpy (DHo) and 
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entropy (DSo) of receptor binding are -5.6 ± 0.5 kcal/mol and 5.6 ± 2.0 cal/mol×deg, respectively 
(DGo -7.3 ± 0.1 kcal/mol). Notably, the a-IsdHY642A receptor binds to tetrameric Hb0.1 with 
similar overall affinity KD = 5.3 ± 1.4 µM (DGo = -7.2 ± 0.2 kcal/mol), and similar enthalpic and 
entropic binding energies, DHo = -8.4 ± 0.3 kcal/mol and DSo = -3.9 ± 0.4 cal/mol×deg. This 
suggests that the receptor binds to the tetrameric and dimeric forms of hemoglobin in a similar 
manner. In order to selectively probe binding by the N2 domain to hemoglobin, a polypeptide 
containing only the N2 domain of a-IsdH with the appropriate amino acid mutations that confer 
binding selectivity for the a-globin chain was studied (a-IsdHN2, residues A326-P466 of a-IsdH) 
(Figure 4.8b). ITC measurements indicate that a-IsdHN2 binds HbCO with high affinity that 
approaches the affinity of the larger a-IsdH protein that contains the linker and N3 domains, a-
IsdHN2 binds to HbCO with a KD of 7.7 ± 1.3 µM and similar ~2:1 stoichiometry. Interestingly, 
DHo for a-IsdHN2 binding is similar to the intact protein (-9.6± 0.5 kcal/mol), whereas the 
entropy associated with binding is negative compared to the positive entropy of the intact protein 
(DSo = -8.7 ± 2.7 kcal/mol×deg). The latter affects can presumably be attributed to changes in the 
310-helix, since it has been shown to undergo a disordered to ordered change upon binding to Hb 
[31,46]. Similar ITC binding studies were performed using a polypeptide that contains only the 
linker and N3 domains of IsdH (IsdHLN3, residues P466-D660, containing a Y642A mutation in 
the N3 domain to prevent hemin binding). IsdHLN3 binds to HbCO with very weak affinity, 
which could not be accurately quantified using ITC (Figure 4.8c). However, it is evident from 
this ITC data that IsdHLN3 binding is endothermic with unfavorable positive changes in DHo 
occurring. The weak binding by this fragment of the receptor was further substantiated using 
NMR spectroscopy (data not shown). These results suggest that contacts at the N2-Hb interface 
are the primary contributor to the overall binding affinity, even though each interface buries a 
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similar amount of surface area (the N2-Hb and LN3-Hb interfaces bury 618 and 688 Å2, 
respectively). Moreover, they reveal that unfavorable enthalpic changes are due to linker and N3 
domain binding to the hemin pocket on the a-subunits, which is compatible with 
crystallographic data that has shown that the receptor distorts the F-helix. Data summarizing the 
results of the ITC experiments is presented in Table 4.3.  
 
 
4.5  Discussion 
 To successfully establish an infection, S. aureus acquires iron from the human host using 
two surface receptors, IsdH and IsdB, which capture hemoglobin (Hb) and rapidly extract its 
hemin (oxidized form of heme). The receptors share a conserved tri-domain unit consisting of 
two NEAr iron Transporter domains (NEAT) connected by a helical linker domain (Figure 
4.1a). The tri-domain unit in IsdH consists of the second (N2) and third (N3) domains that bind 
distinct ligands (IsdHN2N3); the N2 domain binds Hb and the N3 domain binds with hemin. 
Previously we’ve shown that the domains within IsdHN2N3 work synergistically to extract hemin 
from Hb at an accelerated rate compared to the spontaneous rate Hb releases hemin into the 
solvent. However, these results only describe the overall process of hemin removal as Hb is 
known to adopt various quaternary states that have different propensities to release hemin. We 
therefore developed a novel quantitative hemin transfer assay to selectively monitor hemin 
extraction from only the a-subunit of tetrameric Hb. Two reagents were employed in this assay. 
The first is a stabilized tetramer of Hb (Hb0.1) where both a-globin chains are expressed as a 
single polypeptide with a glycine residue connecting the C-terminus of one subunit and the N-
terminus of the other [42]. The second reagent is a version of IsdHN2N3 that only binds the a-
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subunit of Hb (a-IsdH) where two interfacial residues in the N2 domain were mutated to 
selectively remove binding to the b-globin chain [33]. Analytical ultracentrifugation (AUC) 
experiments confirmed that at the conditions used for quantitative hemin transfer measurements, 
a-IsdH binds only the a-subunits of tetrameric Hb0.1 (Figure 4.2 and Table 4.1). Stopped flow 
UV-Vis kinetic experiments reveal that a-IsdH captures hemin from MetHb0.1 in a biphasic 
manner in which the fast phase, kfast, accounts for half the magnitude of the total spectral change 
and describes the active removal of hemin from the a-subunit. Conversely, the slow phase, kslow, 
depicts the non-specific release of hemin from the b–subunit followed by subsequent uptake of 
hemin by excess apo-receptor present in solution (Figure 4.3). These experiments also illustrated 
that stabilization of the Hb tetramer reduces the rate of hemin release, as similar studies with a-
IsdH and native MetHb display hemin transfer rates that are ~10-fold faster than MetHb0.1 
(Table 4.2). This is presumably due to accelerated release of hemin from a-subunits that are in 
either in the monomeric or dimeric state as a result of Hb tetramer dissociation, as it is well 
known that quaternary structure affects the rate of hemin release from Hb’s globin chains [37]. 
This is further substantiated by previous ESI-MS studies, showing that the presence of the IsdH 
receptor promotes Hb tetramer dissociation [17]. Similar results were obtained for the wild-type 
IsdH receptor, but its rates were faster than a-IsdH. This is likely due to the fact that wild-type 
IsdH can bind both a- and b-subunits as shown by AUC (Figure 4.2). To that end, we showed 
for the first time that wild-type IsdH can directly extract hemin from Metb-globin chains; it was 
previously unclear if hemin release from the b-subunit was an active process or the accelerated 
release from dissociated and semi-forms of Hb (Figure 4.4).  
 Establishment of a selective assay for hemin removal from the a-subunit of tetrameric Hb 
enables for the first time the quantitative measurement of the micro rate constants of the hemin 
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extraction process. A model of this reaction is presented in Scheme I, in which the apo-a-IsdH 
receptor associates with Hb to form a Hb:aIsdH complex. Within this complex, hemin is 
transferred unidirectionally to the receptor by a process described by the fast phase of the 
kinetics (Figure 4.5b). The micro rate constants for this process were thereby obtained by fitting 
the observed kfast values to Eq. 1, which yielded values that are consistent with a rapid 
association of the receptor:Hb complex, followed by a rate-limiting transfer of hemin prior to 
complex dissociation. Interestingly, these experiments revealed that kslow values are independent 
of a-IsdH concentration, further supporting the notion that this rate describes the non-specific 
hemin release from Metb-subunits and subsequent uptake of hemin by excess a-IsdH present in 
solution. Additionally, kslow values are faster but on the same order as the rate of spontaneous 
hemin release from monomeric b-subunits (0.025 s-1 at 25°C vs. 0.011 s-1 at 37°C). This is 
consistent with the widely known elevated rates of spontaneous hemin release from dissociated 
or semi-globin forms. Interestingly, semi-globins have reduced helical content suggesting the 
increased rate of spontaneous hemin release is facilitated by localized unfolding of the hemin 
pocket [40,47]. 
 The energetic barrier that the IsdH receptor overcomes to trigger hemin release from Hb 
was estimated using our quantitative assay and revealed that an enthalpic component was the 
largest contributor to the overall activation energy (Figure 4.6). Our measurement of DG‡ at 
37°C is 18.07 ± 1.1 kcal/mol and is similar in magnitude to the published DG‡ for the cleavage of 
the proximal histidine-heme (Ne-Fe) bond in hemoglobin (~17 kcal/mol) [45]. This suggests that 
the large enthalpic penalty measured in our studies is associated with the breakage of this bond. 
According to Eq. 3, the activation energy of spontaneous hemin release for the a-subunit of 
tetrameric Hb is ~24 kcal/mol. Therefore a-IsdH-mediated hemin transfer effectively lowers the 
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DG‡ by ~6 kcal/mol, which is consistent with the 10,000-fold rate enhancement observed in our 
hemin transfer experiments (kfast = 0.88 s-1 vs 0.000083 s-1 at 37°C). How the receptor lowers the 
activation energy is still unclear. However, it is possible that receptor-induced perturbation of 
Hb’s F-helix could weaken the HF8-iron bond. Interestingly, various studies have reported 
helical fluctuations in globin chains, which govern overall hemin affinity [41,47–51]. Therefore, 
it is possible that the receptor exploits these fluctuations to stabilize a partially unwound state of 
the F-helix of Hb. This phenomena is also seen in the mechanism of a-hemoglobin stabilizing 
protein (AHSP), which promotes autooxidation of a-globin chains by binding to a distal site on 
the a-chain that causes localized distortions in its F-helix [52–54]. Distortion of the helix could 
presumably weaken the HF8-iron bond, however our DG‡ measurements contain a similar energy 
barrier as the energy required to cleave the Fe-Ne bond, suggesting additional factors help 
promote hemin release. It is therefore possible that the receptor triggers hemin release by 
permitting water ingress into the normally apolar hemin pocket, facilitating hydrolytic cleavage 
of the bond as water is known to compete with HF8 as a ligand for the Fe(III) hemin moiety [55]. 
The hemin would then only need to travel ~12 Å to be coordinated by the receptor’s N3 domain, 
whose interface with Hb forms a hydrophobic pathway for the hemin to partition [33]. In support 
of this notion, hemin transfer kinetics are attenuated in IsdH mutants that lack important 
interfacial residues in the linker domain that were shown to interact with Hb residues that 
normally make up a hydrophobic “cage” (Figure 4.7). These mutations presumably prevent the 
linker domain from imparting a perturbed state in the F-helix, therefore causing an increase in 
the energetic barrier that must be overcome for hemin egress. However, future work is necessary 
to test this hypothesis.  
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  Isothermal calorimetry studies of Hb binding revealed that IsdH employs two 
energetically distinct interfaces to promote hemin transfer. These interfaces were visualized by 
NMR and x-ray crystallography, where the first interface is comprised of the N2 domain that 
binds the A- and E-helices of Hb (N2-Hb), and the second interface is defined by the linker and 
N3 domains that interact with F-helix, EF- and FG-corners of Hb (LN3-Hb) (Figure 4.7a and 
b). Interestingly, ITC experiments uncovered that the N2-Hb interface binds Hb with similar 
affinity as the intact receptor, suggesting that this domain maintains the overall binding affinity 
of the complex (Figure 4.8 and Table 4.3). Conversely, the LN3-Hb interface is a much lower 
affinity complex and is enthalpically unfavorable, which is likely associated with perturbation of 
the F-helix. A model of the hemin extraction mechanism based on existing structural, kinetics 
and thermodynamic binding data is presented in Figure 4.9. The relative free energies associated 
with each step of the reaction define the Y-axis while the reaction coordinate depicting the 
progress of the transfer reaction is plotted along the X-axis. First, the N2 domain employs inter-
domain motions to adaptively recognize Hb. Second, the N2-Hb interface is formed by a high 
affinity and ethalpically favorable interaction (DGo -7.1 ± 0.1 kcal/mol). IsdH likely maintains its 
overall binding to Hb via this high affinity N2-Hb interface as the overall free energy of the 
intact receptor is similar to the energy of the N2-Hb interface alone (DGo -7.3 ± 0.1 kcal/mol). 
This would allow the linker and N3 domains to form a lower affinity interface with Hb, as ITC 
results show that the intact receptor displays a DHo value that is increased relative to a-IsdHN2 
and is likely due to unfavorable enthalpic changes associated with distorting the F-helix (-5.6 ± 
0.5 kcal/mol and -9.6 ± 0.1 kcal/mol for the intact receptor and a-IsdHN2, respectively). In 
principle these two interfaces can form simultaneously, but are presented in a two-step process 
for simplicity. The rate limiting step is depicted in step 3 and is presumed to be the hydrolytic 
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cleavage of the proximal histidine-hemin bond (Ne-Fe) as kinetic experiments show that the 
activation energy of hemin transfer is of similar magnitude as the energy required to cleave this 
bond. Once hemin is transferred, the hemin-bound receptor dissociates from Hb, which is shown 
in a two-step process for simplicity but could also happen simultaneously.  
Our quantitative hemin transfer assay has provided the first ever insight in the kinetics 
and thermodynamics of hemin extraction of Hb in a defined quaternary state. Future studies 
using this assay will further probe the energetics associated with this process. As mutations in the 
interfacial residues of the linker domain did not prevent the receptor from rapidly acquiring 
hemin from Hb, it is likely that residues outside of this interface are important in the hemin 
extraction mechanism. Furthermore, the LN3-Hb interface is also composed of residues in the 
N3 domain that make contacts with Hb residues and the hemin molecule itself. In particular, 
E562, V564, and S563 all interact with Q54 (HE3) and Y646 makes contacts with H89 (HFG1), 
H45(HCE3), and the propionate oxygens of hemin. These residues could therefore help facilitate 
hemin coordination after the iron-histidine bond is broken.  
Lastly, the role of inter-domain dynamics between the N2 and linker-N3 domains likely 
plays a role in the hemin extraction mechanism. However, it is unclear how this dynamic 
interface facilitates accelerated hemin release. One possibility is that the receptor uses the 
plasticity of the N2-LN3 interface to recognize both a- and b-subunits of Hb, which are 
structurally similar but undergo various transitions in their quaternary state that the receptor 
would need to recognize. Another prospect is that the high affinity N2-Hb interface tethers the 
linker and N3 domains with just enough flexibility to increase their effective molarity (Meff) 
relative to Hb. This would then increase the likelihood of the enthalpically unfavorable LN3-Hb 
interface to form [56]. The N2-mediated increases in Meff would not only depend on domain-
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domain interactions in the receptor but also the length and flexibility of the polypeptide segment 
that connects the N2 and linker-N3 domains. An interface that is either too long or too short 
would prevent transient inter-domain interactions from occurring, resulting in a decrease of Meff 
thus precluding the LN3-Hb interface from forming [57,58]. However, a more rigorous study on 
the effect of inter-domain mobility on receptor-mediated hemin release will have to be 
performed to test this theory.  
 
 
4.5 Materials and Methods 
4.5.1 Cloning, Protein Expression, and Purification, and Preparation 
The IsdH constructs used in this study were produced from pET-28b-based expression 
plasmids and initially contained a removable N-terminal hexahistidine-small-ubiquitin-like 
modifier (SUMO) tag under an inducible promoter to facilitate purification (pHis-SUMO) 
[59,60]. Plasmids pRM208 encoding for amino acids A326-D660 in IsdH (IsdHN2N3), pRM216 
encoding for amino acids A326-D660 in IsdH (IsdHN2N3) with an alanine substitution of Y642 
(IsdHN2N3-Y642A), and pMMS322 encoding for amino acids A326-D660 with substitution of 
FYHYA (365-369) à YYHYF (365-369) (α-IsdHN2N3) have been described previously 
[17,33,61]. The expression plasmids pMMS323 (α-IsdHN2N3-Y642A), pMMS327 (α-IsdHN2N3-
Y495A), pMMS329 (α-IsdHN2N3-K499A), pMMS333 (α-IsdHN2N3-
K479A/K486A/R492A/Y495A/E496A/K499A/K503A), pMMS334 (α-IsdHN2N3-
Y495A/K499A), and pMMS336 were generated using site directed mutagenesis (QuickChange 
site-directed mutagenesis kit, Stratagene, La Jolla, CA) and are a modified version of pMMS322. 
An expression plasmid containing recombinant sperm whale myoglobin H64Y/V68F was also 
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generated by restriction enzyme cloning between the BamHI and XhoI sites of the pHis-SUMO 
vector.  
The proteins were expressed by transforming the aforementioned plasmids into 
Escherichia coli BL21-DE3 cells (New England Biolabs, Beverly, MA). Protein expression and 
purification has been described previously [17]. Briefly, expression proceeded overnight at 25°C 
by adding 1 mM isopropyl-β-D-thiogalactoside to cell cultures. The bacterial cells were then 
harvested by centrifugation, lysed by sonication, and the proteins were purified using a Co2+-
chelating column (Thermo Scientific, Waltham, MA). The amino terminal 6x-His-SUMO tags 
were then cleaved using ULP1 protease and reapplied to the Co2+-chelating column to remove 
the protease and cleaved SUMO tags. The apo-forms of the proteins were generated by hemin 
extraction with methyl ethyl ketone [62] followed by buffer exchange into 20 mM NaH2PO4, 150 
mM NaCl, pH 7.5. To create hemin saturated proteins, a 1.5 molar excess of hemin was added to 
purified protein solutions followed by removal of excess hemin using a Sephadex G-25 column 
(GE Healthcare) that was equilibrated with 20 mM Tris-HCl, pH 8.0. The hemin saturation level 
was checked by recording UV-visible spectra and calculating the ASoret/A280.  
 
4.5.2 Preparation of Human Hemoglobin 
Human hemoglobin was purified from the blood of a healthy donor provided by the 
CFAR Virology Core Lab at the UCLA AIDS Institute and has been described previously [63]. 
Briefly, red blood cells were washed in 0.9% NaCl solution and then lysed under hypotonic 
conditions. Hb was purified from the hemolysate by two ion-exchange chromatography steps: 
the first being cation-exchange (SP Sepharose, GE Healthcare Life Sciences) and the second 
being anion-exchange chromatography (Q Sepharose, GE Healthcare Life Sciences). During Hb 
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purification, the globin chains were maintained in the carbon monoxide-ligated state to inhibit 
autooxidation and subsequent denaturation.  
Recombinant genetically stabilized human hemoglobin containing V1M mutations in 
both α- and β-globin chains and a glycine linker between the C-terminus of one α-subunit and the 
N-terminus of another α-subunit (Hb0.1) [42,64] was transformed into Escherichia coli BL21-
DE3 cells (New England Biolabs, Beverly, MA). The cells were grown in M9 minimal media 
supplemented with 3 g/L glucose and 1 g/L NH4Cl. Prior to induction, exogenous hemin was 
added to the cell cultures at a final concentration of 8 µM. Expression was performed at 16°C 
overnight by adding 1 mM isopropyl-β-D-thiogalactoside to cell cultures. After the cells were 
harvested by centrifugation, the cells were washed twice with lysis buffer (50 mM Tris-HCl, 17 
mM NaCl, pH 8.5) to remove excess hemin. Then the cell suspension was purged with a steady 
stream of CO for 15min in an ice-water bath. All buffers used during the purification were kept 
at pH 8.5 and were purged with CO to prevent oxidation. The cells were then lysed by sonication 
and purified in a single step over a Co2+-chelating column (Thermo Scientific, Waltham, MA) 
via interactions with the naturally occurring His residues on the surface of Hb. The column was 
washed with three buffers prior to elution: 5 column volumes (CV) of lysis buffer (vida supra), 5 
CVs wash 1 buffer (20 mM Tris-HCl, 500 mM NaCl, pH 8.5), and 5 CVs wash 2 buffer (20 mM 
Tris-HCl, pH 8.5). Column-bound Hb was then eluted with 5 CVs of elution buffer (20 mM Tris-
HCl, 100 mM imidazole, pH 8.5). 
Both Hb purified from human blood and Hb0.1 were converted to the ferric states by the 
same procedure. HbCO was converted to HbO2 by delivering a pure stream of oxygen over a 
cold protein solution held in an ice-water batch and illuminated with a high-intensity (100 W) 
light source. Removal of CO and conversion to HbO2 was considered complete when the ratio of 
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A577:A560 was ~1.8 [65]. Oxidation of HbO2 (Fe2+) to generate MetHb (Fe3+) was carried out by 
incubating Hb with a five-fold molar excess of potassium ferricyanide for 30 min and then the 
mixture was loaded onto a Sephadex G-25 column (GE Healthcare) to remove the excess 
ferricyanide. MetHb was then buffer exchanged into 20 mM NaH2PO4, 150 mM NaCl, pH 7.5. 
The concentration of hemin within metHb was determined using the extinction coefficient of 179 
mM−1 cm−1 at a wavelength of 405 nm [66]. 
 
4.5.3 Hemin Transfer Experiments 
 Hemin transfer reactions from MetHb (hemin donor) to the apo-IsdH receptors (hemin 
acceptors) were monitored using an Applied Photophysics SX18.MV stopped-flow 
spectrophotometer (Applied Photopysics, Surrey, UK). The samples were buffer matched using 
stopped flow buffer (20 mM NaH2PO4, 150 mM NaCl, pH 7.5 supplemented with 0.45 M 
sucrose to prevent absorbance changes due to apoprotein aggregation) [40]. Unless stated 
elsewhere, holo-protein (Hb) in one syringe was mixed with apo-acceptor at ≥ 10 molar excess 
(in hemin units) in another syringe to maintain pseudo-first-order conditions. The absorbance 
changes at 373 and 405 nm were monitored individually for 1000 s (deadtime of 3 ms). The 
observed time courses and fitted rate constants for each wavelength were in agreement with 
previously reported values [31], therefore only the change in absorbance at 405 nm was 
monitored thereafter. Each representative time course reflects a minimum of three consecutive 
traces for each condition and were analyzed by fitting the observed time courses to a double-
phase exponential expression to obtain the apparent pseudo-first-order rate constants using 
GraphPad Prism version 5.01 for Windows (GraphPad Software, La Jolla, CA). The rate of 
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hemin transfer was obtained by fitting the dependence of the observed fast phase kinetic rate 
constant to the concentration of apo-receptor according to scheme I and Equation 1 using 
Mathematica software (Wolfram Research, Inc., Mathematica, Version 9.0, Champaign, IL, 
2012). The rates of hemin transfer from MetHb, MetHb0.1, and holo-IsdHN2N3 to 10-fold molar 
excess apo-MbH64Y/V68F [40] were measured using a conventional UV–Vis spectrophotometer 
(Cary50; Varian, Inc., Palo Alto, CA) at Rice University. The entire spectrum was recorded over 
17 h and the absorbance changes at 600 nm were plotted using GraphPad Prism Software. 
 
4.5.4 Analytical Ultracentrifugation  
Sedimentation equilibrium runs were performed at 25 °C in a Beckman Optima XL-A 
analytical ultracentrifuge using absorption optics at 412 nm so that only the heme was detected. 
Samples were tested using the exact same conditions as the stopped-flow hemin transfer 
experiments (20 mM sodium phosphate, 150 mM NaCl, 0.45 M sucrose, pH 7.5) with the 
exception of an alanine substitution at Y642 for the apo-receptors and the carbon monoxide-
ligated state of Hb0.1 to prevent heme transfer over the course of the multi-day run. Three mm 
pathlength double sector cells were used for all samples and were purged with CO before sealing 
the cells to prevent oxidation. Sedimentation equilibrium profiles were measured at speeds of 
9,000 (~6,000 ´ g) and 13,000 rpm (~13,000 ´ g). Samples contained Hb0.1 or the isolated b-
globin chains at a concentration of 5 µM and were mixed with either 0, 75 µM, and 150 µM a-
IsdHY642A. Experiments using wild-type IsdHY642A made use of a 150 µM sample. Weight-
average molecular masses were determined by fitting with a non-linear least-squares exponential 
fit for a single ideal species using the Beckman Origin- based software (Version 3.01). Partial 
specific volumes were calculated from the amino acid compositions and corrected to 25 °C 
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[67,68]. They were 0.749 for the αβ Hb heterodimer and b-globin chains, 0.735 for apo-receptor, 
and 0.739 for the complex. At higher concentrations of receptor, the fitted molecular weights 
were slightly lower than lower concentrations which is compatible with the increased non-
ideality of the solution. 
4.5.5 Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) measurements were performed using a MicroCal 
iTC200 calorimeter (GE Healthcare) at 25⁰C. To prevent heat changes due to heme transfer the 
Hb was maintained in the carbonmonoxy ligated state and heme binding deficient receptor 
proteins containing an alanine substitution for Y642. The HbCO and apo-receptor proteins were 
buffer matched in ITC buffer (50 mM NaH2PO4, 150 mM NaCl, 0.45M sucrose, pH 7.5). The 
cell was filled with 30 µM HbCO and the syringe was filled with 200, 300, and 850 µM a-
IsdHY642A, a-IsdHN2, IsdHLN3(Y642A), respectively. Sixteen injections were performed using 2.5 
µL aliquots at 180 s intervals and were performed in triplicate. The data were analyzed using 
MicroCal iTC200 analysis software (GE Healthcare). 
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4.6  Figures and Tables 
Table 4.1 Stoichiometry of Hb:receptor complexes 
 Weighted average 
molecular masses (Da)a,b 
Receptor/globin 
Hb0.1c   
13,000 ´ g 64,212 ± 829  
Hb0.1 + a-IsdHY642Ac,d       
6,000 ´ g 140,070 ± 2096 2.0 
13,000 ´ g 131,570 ± 894 1.7 
Hb0.1 + a-IsdHY642Ac,e       
6,000 ´ g 134,660 ± 1,872 1.8 
13,000 ´ g 128,490 ± 1115 1.7 
Hb0.1 + IsdHY642Ac,e        
6,000 ´ g 188,110 ± 1,518 3.2 
13,000 ´ g 175,120 ± 1045 2.9 
b-globin c    
6,000 ´ g 56,700 ± 724  
13,000 ´ g 56,300 ± 508  
b-globin + a-IsdHY642Ac,e    
6,000 ´ g 54,500 ± 97 0.0 
13,000 ´ g 54,500 ± 65 0.0 
b-globin + IsdHY642Ac,e      
6,000 ´ g 134,000 ± 1321 2.0 
13,000 ´ g 116,500 ± 617 1.6 
   
a
 Samples were centrifuged at 25°C in buffer containing 20 mM sodium phosphate, 150 mM NaCl, 450 mM 
sucrose, pH 7.5  
b Molecular masses were obtained by non-linear least squares exponential fitting of data using Beckman 
Origin-based software (Version 3.01) 
c
 Globin chains were held at a concentration of 5 µM (hemin units) 
d Receptor concentrations were in a 15-fold molar excess (75 µM) 
e Receptor concentrations were in a 30-fold molar excess (150 µM) 
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Table 4.2 Apparent rate constants of hemin transfer  
Hemin donor Hemin acceptor kfast (s-1)a kslow (s-1)a 
MetHb a-IsdHb 3.27 ± 0.07 0.038 ± 0.001 
 IsdHb 3.12 ± 0.08 0.039 ± 0.001 
 apo-Mbd,e 0.004f (0.01)g 0.0002f (0.003) g 
MetHb0.1 a-IsdHb 0.34 ± 0.01 0.026 ± 0.001 
 IsdHb 0.73 ± 0.03 0.041 ± 0.001 
 a-IsdHY495Ac 0.12 ± 0.01 0.007 ± 0.001 
 a-IsdHK499Ac 0.22 ± 0.01 0.014 ± 0.002 
 a-IsdHY495A/K499Ac 0.08 ± 0.01 0.004 ± 0.002 
 a-IsdH7-Alac 0.03 ± 0.01 0.002 ± 0.001 
 apo-Mbd,e 0.0004h 0.00008h 
a
 kfast and kslow values were obtained by fitting to a double exponential expression.  
b Rates were determined at a 30-fold excess [Receptor] pH 7.5, 25°C.  
c Rates were determined at a 40-fold excess [Receptor] pH 7.5, 25°C.  
d
 Rates were determined at pH 7.0, 37°C. 
e The data are from Ref. [37]. 
f kfast and kslow are from the b- and a-globin chains in dimeric Hb, respectively.  
g kfast and kslow are from the b- and a-globin chains in monomeric Hb, respectively.  
h kfast and kslow are from the b- and a-globin chains in tetrameric Hb, respectively. These values are also the 
same for tetrameric native Hb.  
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Table 4.3 Thermodynamic parameters and affinity data for Hb binding 
 KD DH° DS° DG°a nb 
 µM kcal/mol cal/mol×K kcal/cmol  
Hb + aIsdHY642A 4.6 ± 0.8 -5.6 ± 0.5 5.6 ± 2.0 -7.3 ± 0.1    0.64 ± 0.04 
Hb + aIsdHN2 7.7 ± 1.3 -9.6 ± 0.1 -8.7 ± 2.7 -7.0 ± 0.1    0.61 ± 0.05 
Hb + aIsdHLN3(Y642A) ³ mM endothermic positive  NDc       ND 
Hb0.1 + aIsdHY642A 5.3 ± 1.4 -8.4 ± 0.3 -3.9 ± 0.4 -7.2 ± 0.2    1.00 ± 0.06 
a
 Samples were in buffer containing 20 mM sodium phosphate, 150 mM NaCl, 450 mM sucrose, pH 7.5, 298K  
bn refers to the molar ratio protein:Hb. 
c ND refers to “not determined”. 
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Figure 4.1  S. aureus uses conserved tri-domain receptors to capture Hb via 
an aromatic-rich motif.  
(a) Schematic of the conserved NEAT domains of S. aureus Hb receptors, IsdH and IsdB. NEAT 
domains that bind Hb and hemin (oxidized form of heme) are shown in gray and black, 
respectively. Residue numbers of the functionally homologous NEAT domains and the linker 
connecting them are indicated. (b) Sequence alignment of the aromatic 310-helix Hb-binding 
motif. Interfacial residues shown to interact with the A- and E-helices of Hb are colored in red, 
whereas interfacial residues proposed to bind Hb are colored in orange. 
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Figure 4.2 Stoichiometry of Hb:receptor complexes determined by 
Analytical Ultracentrifugation  
(a) Representative absorbance scans at 412 nm at equilibrium are plotted versus the distance 
from the axis of rotation for a mixture of Hb0.1 + IsdH (blue circles) and Hb0.1 + a-IsdH (red 
triangles). Hb0.1 was maintained in the carbonmonoxy ligated state, and both receptors 
contained a Y642A mutation to prevent heme transfer. Protein samples were mixed at a ratio of 5 
µM Hb0.1 and 150 µM receptor and were centrifuged at 25 °C for at least 48 h at 13,000 rpm. 
The solid lines represent the global nonlinear least squares best-fit of all the data to a single 
molecular species with a baseline fit. Residuals of the fit are shown above. (b) Representative 
scans identical to the conditions described in (a) with the exception of 5 µM isolated b-chains 
and a speed of 9,000 rpm. 
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Figure 4.3 Hemin transfer by various Hb and receptors species  
(a) Spectral changes in the UV–Vis spectrum of the reaction of 5 µM MetHb0.1 with buffer 
(solid black line), 150 µM IsdH (dotted blue line), and 150 µM a-IsdH (solid red line). Spectral 
traces were recorded at 1000 s post mixing. (b) Representative stopped flow time courses of the 
absorbance change at 405 nm after mixing 5 µM Hb with 150 µM apo-receptor. The data were fit 
to a double-exponential equation and yielded hemin transfer rate constants shown in (c) and (d). 
Spectral traces were normalized for comparison using the following equation: y = (yt - y0) / (yt + 
y0). (c) and (d) The observed pseudo-first-order kfast and kslow rate constants, respectively. Values 
were derived from the time courses in (b). A two-way ANOVA was used to access the 
significance in the difference of rates. NS and *** corresponds to p-values > 0.05 and < 0.001, 
respectively. 
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Figure 4.4 Hemin transfer from isolated b-globin chains  
Representative stopped flow time courses of the absorbance change at 408 nm after mixing 5 µM 
isolated Metb-globin chains with 150 µM apo-receptor or 50 µM apo-Mb. Relative spectral 
traces are shown for comparison in which all starting absorbance values were adjusted to one by 
addition or subtraction of a constant from the observed data. Only the first 10 s are shown as 
absorbance artifacts due to apo-globin denaturation appeared afterwards. 
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Figure 4.5  Kinetic parameters of hemin extraction mechanism 
(a) Time courses of the absorbance change at 600 nm of a mixture of H64Y/V68F apomyoglobin 
with Hb (black line), Hb0.1 (dark grey line), and IsdH (light grey line) at a final concentration of 
50 µM apo-Mb to 5 µM holo-protein. (b) Plots of the observed rate constants, kfast (dark gray 
circles) and kslow (light gray circles) versus the initial ratio of [apo-a-IsdH] to [Hb0.1]. The 
concentration of Hb0.1 was held constant at 5 µM. The observed values were obtained in 
experiments similar to those described in the legend in figure 4.3. The curves are theoretical 
curves obtained by fitting the data to Equation 1. 
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Figure 4.6 Effect of temperature on the observed rate constant  
(a) Representative normalized stopped flow time courses of the absorbance change at 405 nm 
upon mixing 5 µM Hb0.1 with 200 µM a-IsdH. Spectral traces were normalized using the 
following equation: y = (yt - y0) / (yt + y0). (b) Plots of ln(kfast /T) versus 1/T. The observed kfast 
values obtained in experiments similar to those described in the legend in figure. 4.3. The 
correlation factor, R2, is indicated on the plot. 
 198 
 
Figure 4.7 Linker domain residues play a role in the hemin transfer 
mechanism  
(a) Crystal structure of the Hb:a-IsdHN2N3 complex (pdb 4XS0). Only receptor contacts to the a-
subunit are shown. Proteins are shown as ribbon format, while the hemin group is represented by 
a space filling model. Residues in the segment connecting the N2 and linker domains that were 
not modeled into the electron density are indicated by a dashed line. (b) Close up view of the 
linker-Hb interface. a-IsdH and αHb are shown in blue and yellow, respectively, with the αHb’s 
perturbed F-helix colored in red and an overlay of the native F-helix structure is shown in green 
(PDB code: 2DN2). The hemin molecule is shown in grey surface representation with the iron 
atom shown as a red sphere. (c) Representative stopped flow time courses of the absorbance 
change at 405 nm after mixing 5 µM Hb0.1 with 200 µM apo-receptor. (d) The observed kfast rate 
constants were obtained in experiments similar to those described in the legend in figure 4.3. A 
one-way ANOVA was used to access the significance in the difference of rates. * and *** 
corresponds to p-values < 0.05 and < 0.001, respectively. 
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Figure 4.8   IsdH used two distinct interfaces to promote hemin transfer  
(a) Representative ITC data for the titration of 200 µM a-IsdHY642A into 30 µM HbCO. 
Injections were made at 180 s intervals at 25°C. (b) Representative ITC data for the titration of 
300 µM a-IsdHN2 into 30 µM HbCO. (c) Representative ITC data for the titration of 850 µM a-
IsdHLN3(Y642A) into 30 µM HbCO. The top panels show the time course of the titration (black) 
and baseline (red). The bottom panels show the integrated isotherms. The program ORIGIN was 
used to fit the data using non-linear regression to a one-site binding model to derive 
thermodynamic parameters. 
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Figure 4.9   Model of the hemin extraction mechanism  
Proposed hemin transfer reaction coordinate. The IsdH receptor recognizes Hb via two 
energetically distinct interfaces. See “discussion” for more details. Top, schematic showing the 
steps in hemin transfer. Bottom, relative free energies of the intermediates. Free energies 
calculated from this study are labeled along reaction coordinate. Steps without known energies 
are labeled with a “?”. Breakage of the axial Fe-Nε bond is presumably rate limiting (step #3). 
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Chapter 5 
 
Nitroxide Labeling and Derivation of Paramagnetic NMR Distance 
Restraints for Protein Structure Determination 
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5.1 Introduction 
 This protocol describes the use of nitroxide spin labels to derive paramagnetic relaxation 
enhancement (PRE) distance restraints for nuclear magnetic resonance (NMR) protein structure 
determination. Site-specific labeling of proteins using paramagnetic spin labels enhances the 
transverse relaxation rates of nearby nuclei leading to line-broadening effects that can be used to 
derive distant restraints for protein structure determination [1-3]. This approach has been used in 
a wide variety of studies including, but not limited to, membrane proteins [4], multi-domain 
proteins displaying inter-domain dynamics [5], protein-DNA complexes [1], transient protein-
protein [6,7] interactions, and intrinsically disordered proteins [8]. There are generally two 
approaches to obtain PRE-derived distances. The first is a quantitative measurement of 
transverse relaxation rates described in detail by Iwahara and Clore [1,2] and the other is the 
simplified measurement of peak intensity ratios described by Battiste and Wagner [3], with the 
latter method depicted in this protocol. The two most common types of spin labels used are 
EDTA-based chelators that bind paramagnetic metal ions and organic compounds with nitroxide 
radicals. The ease of sample preparation and long history of use in electron paramagnetic 
resonance (EPR) studies have made disulfide-linked nitroxide spin-labels such as the 
methanesulfonothioate compound, MTSL, the most frequently used approach for PRE studies. 
The aim of this protocol is to describe the considerations taken when designing probe locations, 
labeling of proteins with nitroxide spin labels, NMR data acquisition and analysis, and finally the 
Battiste and Wagner approach to the derivation of PRE-based distance restraints to define protein 
structure. 
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5.2 Materials and Reagents  
1. MTSL (S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl 
methanesulfonothioate, Toronto Research Chemicals, catalog number: O87500) 
2. Sodium Ascorbate (Sigma-Aldrich, catalog number: A7631) 
3. Acetonitrile (Fisher Scientific, catalog number: A996) 
4. Tris-HCl (Tris(hydroxymethyl)aminomethane Hydrochloride, Fisher Scientific, 
catalog number: BP153) 
5. Sodium Phosphate Monobasic (Fisher Scientific, catalog number: S369) 
6. Sodium Chloride (Fisher Scientifiic, catalog number: S271) 
7. DTT (Dithiothreitol, Goldbio, catalog number: DTT50) 
8. Sodium Azide (Fisher Scientific, catalog number: BP9221) 
9. Deuterium oxide (Sigma Aldrich, catalog number: 617385) 
10. Zeba Spin Desalting Column, 7k MWCO, 2 mL (Thermo Fisher, catalog number: 
89889) 
11. Amicon Ultra-15 centrifugal filter (Millipore, catalog number: UFC900308) 
12. Standard 5 mm NMR tube (Wilmad, catalog number: 535-PP-7)  
 
5.3 Equipment 
1. Centrifuge (Beckman coulter, model Allegra X-14R) 
2. SX4750A swinging bucket rotor (Beckman Coulter) 
3. MALDI-TOF Mass Spectrometer (Applied Biosystems, model Voyager-DE-STR) 
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4. NMR experiments used in this protocol are part of the Bruker standard pulse 
sequence library and were performed on Bruker Avance spectrometers equipped with 
triple-resonance cryogenic probes (Bruker Corporation) 
 
5.4 Procedure   
5.4.1  Preparation of Cysteine Mutants of Protein of Interest 
1. Check the protein’s primary sequence for any native cysteines that could be labeled by 
MTSL. If necessary, mutate these residues to alanine (for buried cysteines) or serine (for 
solvent exposed cysteines) to prevent non-specfic labeling. Check that these mutations do 
not effect protein fold and function.  
2. Choose the desired location of the spin-label probe. This location needs to be at a residue 
that is solvent exposed and known to be either in a structured loop or lie within defined 
secondary stucture. Increased flexibility of the probe leads to averageing affects that 
reduce the quantitative strength of the technique. 
3. Perform site-directed mutagenesis to incorporate a cysteine residue at the desired location 
to be labeled my MTSL. 
4. Purfiy 15N-labeled protein with the cysteine mutation. Use buffers that are supplemented 
with 2.5 mM DTT to prevent formation of inter-molecular disufide bonds that can lead to 
aggregation (see note 1). 
5. Prior to labeling the purified protein with MTSL, verify that the cysteine mutation does 
not affect the native stuctutural fold by comparing its 1H-15N-HSQC spectrum to a 
spectrum of the wild-type protein. The cross-peaks should overlay well between the two 
spectra. 
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5.4.2 Site-Specific Nitroxide-Labeling for NMR Experiments 
1. Make a 200 mM stock of MTSL by adding acetonitrile directly to the amber vial. 
Store the MTSL stock at -20°C (see notes 2 and 3). 
2. Buffer exchange the 15N-labeled protein with the cysteine mutation into MTSL 
labeling buffer that is supplemented with fresh 2.5 mM DTT. If not immediately 
labeling with MTSL, store the protein at -80°C.  
3. Immediately prior to labeling with MTSL, dilute the protein to a concentation of 250-
300 µM (total volume 1 mL) using MTSL labeling buffer without DTT. From this 
step forward do not use DTT in any of the buffers. 
4. Equilibrate a Zeba Spin Desalting Column with MTSL labeling buffer per 
manufacture’s protocol. 
5. In a clean 15 mL conical tube, pipette 2.5 mL of MTSL labeling buffer. Add a 10x 
molar amount of MTSL (relative to protein concentration). Make sure to keep MTSL 
away from light by covering the tube with foil first. 
6. Place the equilibrated desalting column into the conical tube from step 5. Slowly 
pipette the protein onto the center of the column’s resin bed. 
7. Spin as per manufacture’s protocol, check to make sure there is ~3.5 mL of sample in 
the bottom of the collection tube. Discard the column.  
8. Cover the collection tube with foil and put on a rotisserie for 15 min at room 
temperature. 
9. After 15 min, dilute the sample to a total volume of 6 mL with MTSL labeling buffer. 
Add another 10x molar excess of MTSL (20x molar excess in total). 
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10. Place tube back onto the rotisserie and let the protein:MTSL mixture incubate 
overnight at room temperature (~16hrs). 
11. Buffer exchange the MTSL-labeled protein sample into NMR buffer using a fresh 
Amicon Ultra-15 centrifugal filter to remove any excess (unligated) MTSL (see notes 
4 and 5). 
12. Check the efficiency of MTSL labeling by MALDI-TOF. Look for ~186 Da increase 
in size compared to unligated protein.  
13. Dilute the MTSL-labeled protein sample in NMR buffer supplemented with 8-10% 
D2O to a final concentration of 300 µM (see note 6). Place the sample in a standard 
NMR tube. Shield the NMR tube from light. 
 
5.4.3 NMR Experimental Set up 
1. Begin the NMR data acquitistion in the paramagnetic state using standard 1H-15N-HSQC 
pulse sequences. The 1H and 15N dimensions are usually collected with 2048 and 256 
complex points, respectively. 
2. After paramagnetic experiments conclude, add a 5x molar excess of sodium ascorbate 
(relative to MTSL concentration) to the NMR tube by carefully pipetting up and down 
with a long pipette. This will reduce MTSL’s unpaired electron and form the diamagnetic 
state. Let the sample reduce for a minimum of 3 hours. 
3. Collect the diamagnetic 1H-15N-HSQC data using identical conditions as the 
paramagnetic experiments in step 1. 
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5.5 Data Analysis 
5.5.1  Analysis of NMR 15N-HSQC Paramagetic and Diamagnetic Spectra 
1. Process both the paramagnetic and diamagnetic 1H-15N-HSQC data identically using 
standard NMRPipe [9] or Bruker TopSpinTM software. Generally, both of the 1H and 15N 
dimensions are processed to a digital resolution of ~0.25 ppm. 
2. Import the processed spectra into Sparky software [10]. Copy backbone resonance 
assignments from the assigned 1H-15N-HSQC spectrum of the native protein. Begin with 
diamagetic spectrum as it should overlay well with the native spectrum. 
3. Make sure to center the copied peak assignments on the resonances in the diamagnetic 
spectrum. Only use cross-peaks that are isolated from from other peaks (see note 7). 
4. Copy all the formatted diamagetic peak assigments to the paramagnetic spectrum. Repeat 
step 3. 
5. Once both the diamagetic and paramagnetic spectra have been assigned and throroughly 
inspected, export the assignments, peak height intensities, and linewidths to a .txt file. 
6. Import the assignments into data analysis software (e.g. Microsoft Excel). Calculate the 
ratio of the paramagetic peak height intentsities (Iox) to the diamagnetic peak hight 
intensities (Ired). 
 
5.5.2  Derivation of Paramagtic Distance Restraints 
1. Use a series of distances, r, to back calculate the spin contibution to the enhanced 
relaxation rate, R2sp, using a modified version of the Solomon-Bloembergen in equation 1 
[3,11], 
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 𝑟 = =459: 4𝜏@ + *ABC(DE5AB5 C F (1) 
 
where K is a constant (1.23 x 10-32 cm6 s-2) that describes the spin properties of the MTSL 
spin label [3], wh is the Larmor frequency of the proton spin, and tC is the apparent PRE 
correlation time [12]. 
2. From the back calculated R2sp values, back calculate Iox/Ired ratios using the equation 2 
[3], 
 -./-012 = 	 45	67859:;45(459:   (2) 
where R2 is the intrinsic amide proton transverse relaxation rate (calculated from the 
cross-peak linewidths), and t is the total INEPT evolution time recorded during the NMR 
experiments (e.g. 11 ms).  
3. Assign distances for each experimental Iox/Ired ratio based on the back calculated Iox/Ired 
ratios using equations 1 and 2. See Sjodt et al. (2015) for more information [5]. 
4. When generating a restraint table for NMR structure calculations, the restraint should be 
between the nitrogen atom of the MTSL ring and the affected amide proton. Use two 
types of distance restraints: 
a. If Iox/Ired is < 0.80, the restraint is called “attractive” and is given the assigned 
distance from step 3 and assuming an error of ± 5 Å.  
b. If Iox/Ired ≥ 0.80, the restraint is called “repulsive” and is given a lower bound 
distance of 20 Å and no upper bound distance [3,13,14].  
5. Perform NMR structure calculations using standard XPLOR-NIH software using PRE-
dervied distance restraints from step 4 as NOE parameters [15]. 
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6. Assess the quality of the calculated structures by a quality factor, Q, using equation 3,  
 
 𝑄 = 	 HIJKLKJMK+HNO: 5HNO: 5  (3) 
 
where Vbackcalc and Vexp are the back calculated and experimental Iox/Ired ratios for a given 
spin label. This equation is described in [12,16] and is a modified version of the PRE Q-
factor used in other studies and employs peak intensity ratios in place of enhanced 
relaxation rates [1,3]. See Sjodt et al. (2015) for more information [5]. 
 
5.6 Notes 
1. Make fresh DTT before each use.  
2. MTSL will precipitate at high concentrations of acetonitrile, so keep the conentration 
below 200 mM.  
3. MTSL is light and air sensitive. 
4. Make sure to extensively wash the protein in step 11. Excess MTSL will give rise to 
artifacts in the NMR experiments. 
5. The NMR buffer should be optomized for the protein of interest. For a review on buffers 
suitible for NMR see Kelly et al. (2002) [17]. 
6. The protein concentration should be kept low to prevent inter-molecular PRE effects. 
7. It has been reported that the tail of a cross-peak that is completely broadened by PRE 
effects can reduce the height of a neighboring peak by up to 15%, giving rise to false 
positive broadening effects [3]. 
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5.7 Recipes 
A. MTSL labeling buffer 
50 mM  Tris-HCl (pH 7.8) 
50 mM NaCl 
 
B. NMR buffer 
20 mM Sodium Phosphate Monobasic (pH 6.0) 
50mM  NaCl 
0.01%   NaN3 
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